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I.1.  Polycyclic aromatic hydrocarbons (PAH): sources, environmental 
occurrence and apportionment 
Polycyclic aromatic hydrocarbons (PAH) are formed during incomplete combustion of 
organic matter, i.e. fossil fuels [1,2], still the main energy source of our society. For instance, 
PAH are present in exhausts of industrial and domestic furnaces [3-5], of gasoline and diesel 
engines [6] and in tobacco smoke [7]. Furthermore, both smoked fish and meats are shown 
to contain high levels of PAH. Thus, the total burden of PAH in food is enhanced by 
pyrolysis and smoke contamination [8]. Therefore, human activity is by far the main source 
of PAH. This is augmented by natural emissions, such as from forest fires, from oil well and 
coal fires as well as from volcanic eruptions [9,10]. Another natural source of PAH is 
biosynthesis. Certain bacteria can synthesize PAH derivatives, such as perylene or 
benzo[a]pyrene (B[a]P) [11].  
Furthermore, (large) PAH (in an ionised form) are proposed to be predominant 
species in interstellar space, as has been indicated by the study of the (unidentified) 
interstellar emission bands [12]. In fact, large (ionised) PAH are proposed to represent 
almost the 20% of all carbon available in space [13]! Interestingly, PAH have also been 
identified in meteorites and have been put forward as potential precursors for fullerenes 
[14-16]. 
Although a plethora of PAH is accessible, combustion exhaust analyses has shown 
that commonly a distinct set of PAH is invariably generated [17]. This is of considerable 
interest since PAH can be biologically active; i.e. PAH are proposed to be the biologically 
active compounds that contribute to the genotoxicity and carcinogenicity associated with 
environmental pollution [18]. Hence, PAH possess a potential hazard to human health as a 
consequence of their environmental ubiquitous presence in combination with their potential 
genotoxic activity. Unfortunately, however, insight in the toxicological properties of PAH is 
limited to few PAH (vide infra) [19]. Notwithstanding, this renders PAH of relevance for 
widely different scientific areas, such as chemistry, biology, geology, astrophysics, materials 
science, etc, i.e. PAH naturally represent timely targets for interdisciplinary studies.  
Chapter I 
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PAH present in the atmosphere can undergo transformations due to (photo) 
chemical reactions, involving nitrogen and sulphur oxides, oxygen, ozone and peroxyl 
radicals, etc. [20], leading to functionalized and/or hetero-atom containing PAH. For 
instance, various representatives of the nitro-PAH class have shown to possess a extremely 
high genotoxicity [21]. In addition, PAH are deposited onto airborne particulate matter 
through condensation and adsorption processes.  
Due to their persistence and lipophilic character, PAH can also extensively 
accumulate in soils and sediments. In order to remove PAH pollution from the soil matrix, 
microbial aerobic and anaerobic degradation [22] as well as thermal treatment are the major 
processes employed [23]. However, recently it has been shown that especially the latter 
process may contribute to the undesired formation of biologically potent, viz. genotoxic, 
PAH due to thermal isomerizations and PAH build-up [24,25].  
In geochemistry, the carbon isotope signature (13C/12C ratio) of (individual) PAH 
found in soil and sediments has been used to determine the contribution from 
anthropogenic or biological contribution to the PAH burden. Due to the isotope effect, in 
many biological reactions the 12C isotope is converted with some preference. This results in a 
shift of the 13C/12C ratio relative to a standard from anthropogenic origin. In addition, 14C 
determination is also used as biomarker in this context [26]. 
 
 
I.2.  Discovery of PAH: a short historical review 
PAH research started in the beginning of the 19th century when Michael Faraday isolated 
benzene (C6H6) from oil gas in 1825 [27,28]. Subsequently, the first PAH, viz. naphthalene, 
anthracene, phenanthrene and fluoranthene, were isolated from tars and oils. Interestingly, 
even before the isolation and identification of PAH, the biological significance of 
combustion exhausts and soot was already appreciated. In 1775 Sir Percival Pott noted that 
the increment of scrotum and nasal cavity cancer cases among chimney sweepers in 
England resulted from an excessive exposure to soot [29]. Almost two hundred years later, 
the search for the active (molecular) components in soot and coal tar was initiated and 
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several biologically active PAH were identified. Dibenzo[ah]anthracene [30] was the first 
isolated chemical from coal tar to exhibit carcinogenic activity. Three years later, 
benzo[a]pyrene (B[a]P, Figure 5) was also shown to be one of the main carcinogenic 
component in coal tar [31]. Since then, B[a]P and finally the other PAH listed by the U.S. 
Environmental Protection Agency (US-EPA) are by far the most studied PAH in literature 
from a genotoxic point of view (vide infra).  
The increment in the number of cancer occurrence in our modern society is 
generally associated among others, with environmental pollution. Thus, the ubiquitous 
presence of PAH may play a role in the total cancer burden [18,19,32]. Hence, the search for 
persistent and bioactive PAH as well as the understanding of their mechanisms of action in 
causing human cancer is of paramount importance, as cancer is one of the main causes of 
mortality.  
 
 
I.3.  Cyclopenta-fused PAH (CP-PAH) 
Among PAH, a unique sub-class of special interest are the cyclopenta-fused PAH (CP-PAH). 
CP-PAH contain (at least one) externally-fused unsaturated five-membered ring (Figure 1). 
As a consequence, CP-PAH are so-called non-alternant PAH. When in a PAH consisting of 
annelated benzenoid rings the carbon atoms are alternately starred and un-starred, no 
starred carbon atom will possess a neighbouring starred atom. Alternant PAH are planar 
π−conjugated molecules that possess exclusively even-membered rings. In contrast, a PAH 
possessing two starred of two un-starred neighbouring atoms is a non-alternant. This can 
only be achieved if odd-membered rings, such as a pentagon or a heptagon, are present. For 
alternant PAH at the simple π−electron Hückel level of theory, the π-molecular orbital levels 
are symmetrically positioned around the α level of energy (theoretically defined, α = 0) and 
the electron density at each position is one [33]. However, in non-alternant PAH an 
asymmetric charge distribution may occur. Consequently, the physico-chemical properties 
of alternant and non-alternant PAH will greatly differ (vide infra). 
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Figure 1. Various CP-PAH obtained by Flash Vacuum Thermolysis (FVT). 
 
The formation of CP-PAH in combustion exhausts is generally rationalised by 
invoking either C2 or C2H2 (ethyne) accretion to PAH radicals under the applied high 
temperature conditions [34-38]. This will lead to the formation of the ethynyl-PAH (E-PAH), 
which have indeed been identified in combustion exhausts [39,40]. When the E-PAH contain 
ethynyl substituents at appropriate positions, they can be converted into CP-PAH. Hence, E-
PAH are proposed as the penultimate precursors during CP-PAH build-up in the gas phase. 
The facile conversion of E-PAH into CP-PAH under gas phase conditions is confirmed by 
 14
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Flash Vacuum Thermolysis (FVT) experiments (vide infra) [41-43]. Furthermore, it has been 
unambiguously demonstrated that under combustion conditions, consecutive thermal 
interconversions of (non)-alternant (CP)-PAH are viable and contribute to the formation of 
other CP-PAH [44]. For example, aceanthrylene (6) has been shown to rearrange to 
acephenanthrylene (5) and the latter subsequently rearranges to fluoranthene (7) with 
increasing temperature [45] (Figure 2). 
Recently, in our group the synthesis of a novel class of other non-alternant PAH, 
the cyclohepta-PAH (CH-PAH), which contain an annelated unsaturated seven-membered 
ring, has been achieved. CH-PAH were shown to be unstable under the applied high 
temperature conditions of combustion processes and were found to rapidly decompose to 
their related CP-PAH [46].  
 
 
 
 
 56 7
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Figure 2. Skeletal rearrangement of aceanthrylene (6) to acephenanthrylene (5) and finally fluoranthene 
(7) via consecutive 1,2-H and 1,2-C shifts involving carbene intermediates under FVT conditions. 
 
 
I.3.1.  CP-PAH in combustion exhausts: recurrent genotoxins 
Only in the last thirty years, a variety of CP-PAH have been unequivocally identified in 
combustion exhausts. Examples are cyclopenta[cd]pyrene (1), acephenanthrylene (5), 
aceanthrylene (6), cyclopent[hi]acephenanthrylene (9), cyclopent[hi]aceanthrylene (10) and 
acenaphthylene (13, Figure 1) [39,40,47,48]. More recently, the novel 
cyclopenta[cd]fluoranthene (11) and the three isomeric dicyclopenta pyrene congeners, i.e. 
dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3) and dicyclopenta[cd,jk]pyrene (4, Figure 1), 
have been identified in combustion effluents [39,47] after pure reference compounds became 
available [43,49,50].  
 15
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With the assessment of 1 as an extremely potent bacterial mutagen [51], the search 
for other active CP-PAH present in combustion mixtures began. CP-PAH are of great 
interest from a toxicological point of view as they are generally found to be (substantially) 
more biologically active than their parent PAH. For example, whereas pyrene and 
anthracene do not exhibit bacterial mutagenicity [52], their cyclopenta-fused congeners, viz. 
cyclopenta[cd]pyrene (1) and aceanthrylene (6, Figure 1), show a high positive response 
[51,53]. Moreover, various CP-PAH have been already identified as human cell mutagens, 
tumour initiators and cancer development agents [48,54-58]. Hence, CP-PAH can pose a 
significant health hazard to humans [18]. This is further substantiated by the observation 
that CP-PAH represent the major contributors to the genotoxicity associated with 
combustion exhausts [59]. For instance, 1 is responsible for the overall bacterial mutagenic 
activity dependent on metabolic activation observed in the non-polar fraction of combustion 
exhausts [60] and in the airborne particulate matter from the atmosphere [61]. However, 
since the amount of 1 only accounts for less than half of this activity, other still unidentified 
constituents should also contribute to the total genotoxicity.  
 
 
I.3.2.  (Multiple) CP-PAH. The FVT approach 
A prerequisite for the unequivocal identification and assessment of the bacterial mutagenic 
response of CP-PAH in combustion exhausts is the availability of pure reference 
compounds. To this end, different classical ‘wet chemical’ synthetic routes have been 
developed. Notwithstanding, these procedures are generally tedious (multiple synthetic 
steps, application of hazardous chemicals, elaborate purification, etc.) and the overall yields 
are low [62-64]. Recently, an improved ‘wet chemical’ synthetic approach towards CP-PAH 
has been reported in which (multiple) CP-PAH were obtained by using Pd(0) as catalyst 
[65]. Nevertheless, many multiple unsubstituted CP-PAH are still not accessible by this 
route. Therefore, the use of gas-phase reactions by means of either Flash Vacuum 
Thermolysis (FVT) or Flow Pyrolysis (FP) has been shown as the adequate pathway to 
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access (multiple) CP-PAH in a 50-100 mg scale. Vivid examples are compounds 2-4 (Figure 
1), which still remain inaccessible by classical ‘wet chemical’ synthesis [43,50]. 
Thus, in the present investigation the synthesis of pure CP-PAH for biological 
activity evaluation is achieved employing FVT (Figure 3). An additional attractive aspect of 
the FVT approach is that this technique also facilitates the study of the thermal behaviour of 
CP-PAH under high temperature conditions in the gas phase. Detailed analysis of 
pyrolysates (product mixture) obtained at different temperatures provides insight in the 
propensity of (CP)-PAH to undergo subsequent rearrangement and/or decomposition 
reactions [49]. In a typical FVT experiment (p ≤ 0.01 mmHg, range T = 500-1200 oC) the 
precursor is sublimed into the hot zone (residence time ms range) where it gains thermal 
energy by collision with the furnace wall. Subsequently, rearrangement and/or 
decompositions reactions may occur. The pyrolysate product mixture, which is temperature 
dependent, will deposit behind the hot zone (Figure 3). In general, precursors for CP-PAH 
are suitably substituted ethynyl-PAH (E-PAH). However, when E-PAH precursors are 
sublimed into the hot zone, the occurrence of undesired oligomerisation-polymerisation of 
the E-PAH in the solid state can hamper the sublimation process. To circumvent these 
undesired reactions of E-PAH, the corresponding 1-chloroethenyl substituted PAH 
(‘masked’ E-PAH) are frequently used instead. Under FVT conditions, the extrusion of HCl 
occurs in the low temperature regime (T = 450–500 oC) giving the desired E-PAH in situ. The 
terminal ethynyl groups isomerise into ethylidene carbenes, which are then trapped via an 
intramolecular C-H insertion yielding the CP-PAH with a high mass recovery (> 90%). In 
Figure 4, the formation of 1 from 1-(1-chloroethenyl)pyrene by FVT is shown as an 
illustrative example. It is noteworthy that despite the applied high temperature (T = 1000 oC) 
the mass recovery is excellent (ca. 90%). As it was found in many other instances, this 
demonstrates how facile and selective these thermal reactions can occur. 
 
Chapter I 
 
Figure 3.  Flash Vacuum Thermolysis (FVT) apparatus. 
 
 
Furthermore, the well-defined FVT-pyrolysates represent adequate models that can 
be considered as partial mimics of combustion effluents. Moreover, the presence of E-PAH 
is of interest since various E-PAH have been proposed as inhibitors of some isoenzymes 
from cytochrome P450 that participate in the activation of PAH to their ultimate mutagenic 
forms (vide infra) [66,67]. Thus, mutagenicity assays of FVT-pyrolysates may be of interest to 
gain insight in the mechanisms operational in complex PAH combustion mixtures.  
 
CH3COCl
AlCl3
PCl3 FVT
PCl5
o
Cl H
in situpyrene 1
1000 oC
1-(1-chloroethenyl)pyrene
 
Figure 4.  FVT synthesis of CP-PAH. The synthesis of cyclopenta[cd]pyrene (1) is given as example. 
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I.3.3.  CP-PAH properties 
The presence of the external cyclopenta moieties markedly affects the electronic properties 
of the non-alternant CP-PAH (vide supra). In fact, many CP-PAH exhibit unusual physico-
chemical properties that do not only depend on the number of cyclopenta moieties, but also 
on their distribution along the PAH perimeter [50]. CP-PAH possess characteristic one-
electron low reduction potentials, i.e. high electron affinities [68], upfield-shielded 1H NMR 
chemical shifts [50] and unusual fluorescence [69]. The influence of the cyclopenta topology 
on the anomalous properties is nicely demonstrated by the three isomeric dicyclopenta-
fused pyrene congeners 2-4 (Figure 1) [50]. Although in all isomers two unsaturated 
cyclopenta rings are present, their distribution along the pyrene core greatly influences their 
physico-chemical properties and moreover they exert considerable effects on the global 
aromaticity of the parent PAH system [70,71]. Thus, CP-PAH also represent interesting 
probe molecules for the study of the concept of aromaticity of π−conjugated polycyclic 
systems [72]. 
Although at first glance the unsaturated five-membered ring appears to be in 
conjugation with the PAH core, experimental and theoretical evidence demonstrates that the 
double bond at the cyclopenta moiety still possesses olefinic character, viz. it frequently 
represents the most localized double bond in the molecule [70-72]. Single crystal X-ray data 
show that the carbon-carbon double bond in the five-membered ring is the shortest carbon-
carbon bond in CP-PAH, such as in cyclopenta[cd]fluoranthene (11, 1.362 Å) [73] and in 
pyracyclene (14, 1.346 Å) [74]. Furthermore, it has been shown in a recent study that the 
cyclopenta moiety acts as a peri- substituent upon one-electron reduction [75].  
Due to their unusual physico-chemical properties, CP-PAH are also of considerable 
fundamental interest; they are topological surface sub-structures of fullerenes and model 
systems for the study of the concept of aromaticity [70,72]. Some CP-PAH representatives, 
such as the dicyclopenta-fused pyrene congeners 2-4 (Figure 1), have been proposed as 
precursors for fullerene formation in flames [17]. CP-PAH also played an important role in 
the development of unimolecular precursor for the fullerene C60 [46,76].  
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I.4.  Global genotoxicity of PAH mixtures and risk assessment 
The carcinogenic risk potential for humans by PAH has been deduced from a large number 
of studies in occupational exposure to complex mixtures, viz. coke plants, industries 
working with coal tar, carbon black and mineral oil, chimney sweeps, etc. [77,78]. 
Biomarkers, i.e. molecular or cellular alterations, are used for the direct measurement of 
biological events or responses that occur from the direct exposure to PAH. Examples of 
biomarkers used in several studies of occupational exposure to PAH are PAH-DNA and 
hemoglobin-PAH adducts, and hydroxylated PAH metabolites in urine, for a review see 
[79]. Risk assessment of PAH in complex mixtures is difficult due to a lack of detailed 
information about the genotoxic potency of the individual contributors and the global 
mixture, i.e. the occurrence of possible (synergetic/antagonistic) interactions between the 
components. 
For complex mixtures of combustion effluents several approaches have been 
developed. The global mixture can be assessed for genotoxicity via different experiments 
taking into account either the total mixture or after chemical fractionation of the mixture 
into polar (nitro-PAH and other oxygenated derivatives) and non-polar fractions. The 
fractions can also be further divided in different sub-fractions in order to isolate PAH based 
on the ring number criterion. Another approach is to analyse only the content of the 16 PAH 
representatives recommended by the U.S. Environmental Protection Agency (US-EPA, 
Figure 5) [80]. The total bioactivity is in general expressed by equivalency factors relative to 
B[a]P. The toxicities obtained for each individual component of the US-EPA list is then 
summed to determine (a quasi) global bioactivity of the combustion effluent. Note that 
contributions of other PAH derivatives present in complex combustion mixtures are 
disregarded. Various investigations have shown that the total genotoxicity observed can be 
not predicted by the content of B[a]P alone [81-83]. Furthermore, several studies have shown 
that a disagreement is found between predicted genotoxic potency and chemical analysis of 
the constituents [84]. This strongly suggests that synergistic (enhancement/inhibition) or 
antagonistic effects among the different exhaust constituents may be operational which will 
affect the global genotoxicity [18,85,86]. Moreover, it should be noted that since thermal 
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arrangements are operational in the gas phase, especially the CP-PAH distribution will 
change in response to changes in temperature. This will have a marked influence on the 
genotoxicity of the combustion exhaust sample [87].  
 
Naphthalene Acenaphthene FluoreneAcenaphthylene
Anthracene Phenanthrene PyreneFluoranthene
ChryseneBenzo[a]anthracene Benzo[k]fluorantheneBenzo[b]fluoranthene
B[a]P Dibenz[ah]anthraceneIndeno[1,2,3-cd]pyreneBenzo[ghi]perylene
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. List of the 16 PAH established by the US-EPA, which are generally employed to evaluate the 
genotoxicity of complex environmental PAH mixtures.  
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I.5.  Bacterial mutagenicity assays 
To test carcinogenic activity, the most valid assay is by direct demonstration of tumour 
induction in animals. However, several factors, viz. species, age, mode of administration, 
etc., greatly influence the response and, the costs are high. Whilst many carcinogens possess 
mutagenic activity, not all mutagens may act as carcinogens. Notwithstanding, (bacterial) 
mutagenicity assays are extensively used and accepted as an adequate tool for the screening 
of new compounds due to their low cost and ease to performance. Nevertheless, although 
the development of cancer does not only depend on mutagenesis, i.e. other factors are also 
important [19], agents that cause DNA damage and mutations are likely to be carcinogenic. 
Note that in chemical carcinogenesis, a multistage process involving initiation, promotion 
and progression is established. The initiation process is caused by binding of the metabolite 
to the DNA in the cell, viz. an irreversible process that alters the genome [88]. Fortunately, 
an efficient DNA-damage repair mechanism is available and can may counteract the 
imposed initial damage, for example [89]. Thus, a general correlation between the 
mutagenic and the carcinogenic potential has been established for a large number of 
chemicals [90,91]. Various short-term bacterial mutagenicity assays have been developed to 
screen large numbers of novel compounds. Each assay employs different sorts of bacteria 
and strains. The most widely used is the histidine reversion assay as outlined by Ames et. al. 
[92,93], and it is generally known as the Ames-assay. Since then, many investigations have 
followed the standard protocols, and the majority of the mutagenicity data for PAH are 
based on the Ames-assay using different strains from Salmonella typhimurium (S. 
typhimurium). Notwithstanding, other approaches have been developed, such as the forward 
mutation assay (S. typhimurium strain TM677), which is explained later. 
 
I.5.1.  Histidine/reverse mutagenicity assay: Ames-assay 
The mutagenicity assay outlined by Ames et. al. [92,93] is a widely accepted short-term 
bacterial test for identifying compounds that can produce genetic damage, leading 
ultimately to gene mutation. This histidine (His)/reversion plate incorporation method 
employs several tester strains of S. typhimurium. Each strain carries a different kind of 
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mutation in the operon coding for the biosynthesis of His (Table 1), i.e. the bacteria are 
unable to grow in the absence of exogenous His. The different standard tester strains contain 
other mutations that increase the ability to detect mutagens (Table 1). For instance, the rfa 
mutation increases the permeability to large molecules, since it causes a partial loss of the 
lipopolysaccharide barrier, i.e. surface coating of the cell wall. The uvrB mutation is a 
deletion of a gene coding for the DNA excision repairing system, resulting in greatly 
increased mutagenicity response. Since the deletion of this gene affects the biosynthesis of 
biotine, trace amounts are added to the top-agar to allow the bacteria to grow. The error-
prone DNA repair system is enhanced by the presence of the plasmid pKM101, increasing 
the chemical and spontaneous mutagenesis. 
The His/reversion assay using the S. typhimurium strain TA98, which detects frame-
shift mutations (Table 1), is employed in the present investigation to determine the 
mutagenicity of novel CP-PAH due to its simplicity and fast results. Moreover, this strain is 
widely employed in the literature and will enable a comparison of the results to those 
obtained previously for other (CP)-PAH. It has been established that a single tester stain is 
sufficient to demonstrate a positive mutagenic activity [94].  
Since the bacteria lack the oxidative enzymatic system that is present in mammals 
to metabolize foreign compounds, an exogenous metabolic activation mixture (S9-mix) is 
employed consisting of liver microsome preparations (S9-fraction) from Aroclor-1254 
treated male rats and NADPH generating co-factors as indicated in the standard protocol 
[92,93]. The microsomal protein contain in the S9-fraction is in general determined by the 
Lowry method [95]. In addition, the enzymatic activity can we as well measured, as by for 
example, with the EROD method [96]. Parallel experiments are carried out in the absence of 
S9-mix in order to detect direct-acting mutagens whose mutagenicity response may be 
decreased or annihilated by the oxidative metabolism. 
In a typical experiment, the bacteria (100 µl), the test compound (100 µl DMSO with 
different concentration doses) and the S9-mix (500 µl) or phosphate buffer (pH = 7.4, -S9-
mix), are added to the molten diluted agar (top-agar). The top-agar tube, which contains a 
trace of His and biotine (Figure 6) is mixed and poured on to the surface of a minimal-
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glucose agar plate. A homogenously distributed thin layer is set immediately. The plates are 
incubated at 37 oC during 48-72 h and afterwards the colonies are counted. In the first hours 
the whole population of auxotrophic bacteria can grow until the trace of His is consumed. 
Then, only those bacteria with mutations that reversed the existing His mutation will grow 
to form visible colonies of prototrophs (His revertants); each colony descending from a 
single revertant bacteria (Figure 7). A positive mutagenicity response is observed when the 
following criteria [94,97,98] are fulfilled: i) three-fold increase in the number of His 
revertants in treated plates as compared to the negative control (DMSO), ii) increment of His 
revertants when increasing the dose of test compound, i.e. ascending dose-response 
behaviour and iii) replication of results in at least two independent experiments. The three-
fold increase criterion alone, which is widely employed in literature, is considered 
insufficient to conclude if a compound is mutagen or not [99]. Several statistical methods 
have been developed for the analysis of the data following standard protocols [94,100,101]. 
The calculation of the specific mutagenic activity (number of His revertants/nmol) by linear 
regression of the initial linear ascending portion of the dose-response curves (mean of His 
revertants ± standard deviation per dose tested) is useful to compare the mutagenic potency 
of different (novel) CP-PAH.  
 
 
 
Table 1.  Genotypes of bacterial strains generally employed in reverse-mutation assays adapted from 
[102]. 
 
Amino acid marker Other relevant mutations 
Strain His 
mutation 
Type of 
mutation 
Main 
DNA 
target 
Cell-wall DNA-repair 
Plasmid 
TA1535 hisG46 
Base-pair 
substitution GC rfa uvrB No 
TA100 hisG46 
Base-pair 
substitution 
GC rfa uvrB pKM101 
TA1537 HisC3076 Frameshift GC rfa uvrB No 
TA1538 HisD3052 Frameshift GC rfa uvrB No 
TA98 HisD3052 Frameshift GC rfa uvrB pKM101 
TA97 HisD6610 Frameshift GC rfa uvrB pKM101 
TA102 HisG428 
Base-pair 
substitution 
AT rfa + 
pKM101 
PAQ1 
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500 µl  
S9-mix or buffer 
100 µl  
TA98 baceria  
100 µl  
Test compound 
in DMSO 
Top-agar  
(biotine, His trace) 
Bottom-agar 
37 oC, 48 h 
Number of His revertants counted 
Figure 6. Scheme representing the experimental set of the standard Ames-test adapted from [94]. 
 
 
Figure 7. Minimal agar plates showing the His revertants of the negative control, spontaneous 
mutation, and two positive mutagenicity responses at low and high concentration of test compound 
adapted from [94]. 
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I.5.2.  Forward mutation assay 
The forward mutation assay (S. typhimurium strain TM677) was developed by Thilly and co-
workers [103,104]. It is used by a limited number of laboratories, but it is proposed to 
present several advantages with respect to the widely used standard Ames-assay (vide 
supra). The tester strain S. typhimurium TM677 possess an entire functional gene that codes 
for the enzyme xanthine-guanine phosphoribosyltransferase (XGPRT) and thus, different 
kind of mutations can be detected with a single tester strain. The XGPRT converts the 
selection agent 8-azaguanine to a toxic metabolite [104]. When a colony is formed in the 
presence of 8-azaguanine, which is caused by the inability to further metabolise the selection 
agent and cause toxicity, is an indication of mutagenicity. Moreover, a quantitative 
assessment of the toxicity of the test compound independent from the mutagenicity is also 
possible. This test has been used by the group of Lafleur et. al. for testing CP-PAH, such as 
cyclopenta[cd]pyrene (1), acephenanthrylene (5), aceanthrylene (6), 
cyclopent[hi]acephenanthrylene (9) and cyclopent[hi]aceanthrylene (11, Figure 1) [48,55,60]. 
 
 
I.6.  PAH metabolism 
The metabolism of PAH is extensively studied in rat liver and also in cells and cultured 
tissues from both humans and animals. PAH can penetrate cellular membranes in the body 
due to their lipophilic nature. Subsequently, PAH are enzymatically metabolized, becoming 
more soluble in water. Note that the same mechanism for bioactivation is used to excrete 
toxins from the body. The most complete data set on the metabolism and the mechanisms of 
activation of alternant PAH in connection with exerting mutagenic activity has been 
obtained for B[a]P (for reviews see references [105-108]). B[a]P is metabolised by cytochrome 
P450 to different epoxides that may rearrange spontaneously to phenols or dihydrodiols or 
suffer detoxification processes (Figure 8). In almost all cases the metabolic activation for 
positive mutagenicity response proceeds via the 7,8-epoxide and the 7,8-dihydrodiol to the 
7,8-diol-9,10-epoxide, which is considered the ultimate carcinogen that can form DNA-
adducts [32,109].  
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Interestingly, there are also PAH derivatives that do not require metabolic 
activation to exert genotoxic behaviour, the so-called direct-acting mutagens. Nitro-PAH are 
the most well-studied compounds in this context [110]. They are responsible for the direct-
acting mutagenic activity found in the polar fraction of combustion mixtures. In the absence 
of metabolic activation mixture (S9-mix), various nitro-PAH representatives are able to react 
with DNA and induce mutation [21]. It is thought that the metabolic activation pathway 
occurs via electron transfer processes (one-electron reduction) by the enzymes present in 
some strains of test bacteria. Active metabolites are presumably formed by two consecutive 
one-electron reduction steps resulting in the formation of the corresponding nitroso-PAH 
[111] (vide infra).  
For alternant PAH, besides the metabolic oxidation pathway by cytochrome P450, 
viz. formation of hydroxy-epoxides, another mechanism involving one-electron oxidation 
reactions has been proposed to be operational [112,113]. The stabilization of de radical-
cation intermediate by delocalisation of its charge tends to favour their direct binding with 
DNA and cause mutation [113]. In studies where one-electron oxidation is predominantly 
operational, it has been demonstrated that there is an ionisation potential (IP) barrier for this 
mechanism. In PAH with IP > 7.35 eV, the formation of diol-epoxides via the oxidation 
mechanism is predominant and in PAH with IP < 7.35 eV, radical-cation formation plays a 
greater role [114,115]. Nevertheless, there are PAH in which both mechanisms have been 
found to be operational. For example, for B[a]P the isolation of diol-epoxides or tetraols is an 
indication of oxidation processes, whereas the identification of quinone formation indicates 
that the one-electron oxidation mechanism also contributes (Figure 8) [113]. In summary, the 
major mechanism of action in mutagenicity studies depends on the type of enzymes present 
in the exogenous metabolic activation mixture. 
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Figure 8. Metabolic activation pathways of B[a]P adapted from [18].
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I.6.1.  Exogenous metabolic activation dependent metabolism of CP-PAH 
Most genotoxic active non-alternant CP-PAH, like alternant-PAH, require metabolic 
activation to exert their mutagenic activity. Mammalian isoenzymes from cytochrome P450 
enzymatically transform the CP-PAH into more electrophilic species, for example via 
oxidation, which can react with nucleophiles such as nucleotides, proteins or DNA. Note 
that the enzymes responsible for bioactivation are also involved in the biotransformation 
and detoxification of these compounds. Clearly, the olefinic bond at the cyclopenta moiety 
of CP-PAH is the most favourable target for bioactivation; in general it is the most localized 
double bond (vide supra). Consequently, one-step cyclopenta-ring epoxidation has been 
postulated as the major metabolic oxidative pathway for CP-PAH [54,59]. An example is the 
formation of cyclopenta[cd]pyrene-3,4-epoxide as ultimate mutagenic active form of 
cyclopenta[cd]pyrene (1, Figure 9). The epoxide at the cyclopenta-ring can open leading to 
the mono hydroxy-carbocation that can react with DNA and induce mutation (cf. see also 
reference [89] for DNA-damage repair mechanisms). This has been demonstrated by the 
isolation of the 3,4-dihydrodiol metabolites from rat liver microsome incubation [116], the 
inactivity of its 3,4-dihydro derivative [57] and the direct-acting mutagenic activity of its 
epoxide at the five-membered ring [117]. Moreover, the isolation in vitro of the DNA-
adducts of the epoxide derivative has confirmed this proposition [118-120]. Similarly, the 
metabolites of other CP-PAH, such as aceanthrylene (6, Figure 1) and its DNA-adducts have 
been isolated and characterized [121,122]. The formation of DNA-adducts has been put 
forward as the pivotal first step for mutagenesis and carcinogenesis by chemicals [88]. 
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Figure 9. Metabolic activation of cyclopenta[cd]pyrene (1) by isoenzymes of cytochrome P450. 
 
 
I.6.2. CP-PAH potential direct-acting metabolism 
As discussed before, nitro-PAH in combustion exhausts are responsible for the direct-acting 
mutagenic activity encountered in the polar fraction (vide supra) [110]. In the non-polar 
fraction, where CP-PAH and PAH are commonly found, direct-acting activity has also been 
observed [48]. Although several representatives of pure CP-PAH have been shown to exert 
(modest) metabolic independent activity, viz. aceanthrylene (6), benz[k]aceanthrylene and 
benz[d]aceanthrylene, they could not account for the direct-acting genotoxicity in the non-
polar fraction. Note that the aceanthrylene derivatives have not been identified in the 
combustion exhausts [48,123]! Thus, still unknown (CP)-PAH contributors to the observed 
direct-acting bioactivity must be present. CP-PAH are potential direct-acting mutagens since 
reduction metabolic activation pathways are proposed to be operational in the absence of a 
metabolic activation mixture, and CP-PAH are known to possess low one-electron reduction 
potentials [68]. 
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I.7. Structure-activity relationships 
The identification of a number of PAH with carcinogenic activity has resulted in numerous 
attempts to determine structure-activity relationships (SAR) in order to define their 
mechanisms of action. SAR studies focus their attention to physico-chemical properties that 
highly correlate with the biological activity, such as the HOMO-LUMO gap, electron 
density, molecular polarizability, heats of formation and other physico-structural models, 
that can be calculated by computational methods (Hückel, AM1, PM3, ab initio). The 
difficulty for assessing SAR is connected to the high activity exerted by some PAH and the 
inactivity of other PAH even when similar structural features are present. Moreover, the 
PAH can possess different substitutions. The finding of global rules to explain the 
carcinogenic activity of PAH remains a complicated puzzle, since small structural changes 
are shown to markedly affect the biological activity.  
 
I.7.1.  Alternant PAH 
Several theories have been developed studying the relationship between the genotoxic 
behaviour of alternant PAH and their electronic properties. The ‘K-region’ theory by 
Pulman et. al. [124] supposes that a PAH must possess a ‘K-region’, i.e. a phenanthrene-type 
9,10-bond, in order to become carcinogenic (Figure 10). This bond shows a high olefinic 
character. Although this theory could not explain the carcinogenicity of all PAH, it could 
support the high mutagenic activity toward bacteria of PAH in which the epoxide at the ‘K-
region’ can be formed. Subsequently, the same group proposed that carcinogenicity is 
related to the reactivities of PAH in both their ‘K’- and ‘L-regions’; the latter is defined as the 
meso-anthracenic region. The most accepted structure-activity relationship was achieved 
with the development of the ‘bay-region’ by Jerina et. al. [106]. The ‘bay-region’ of a PAH is 
the hindered region between the 4 and the 5 positions in the phenanthrene structure and the 
10 and 11 positions of B[a]P (Figures 8 and 10). Note that all PAH with a ‘bay-region’ also 
possess ‘K-regions’. The ‘bay-region’ epoxides of the dihydrodiols on an angular benzo ring 
would be the ultimate carcinogenic forms of PAH [105,106]. Opening of their epoxide ring 
generates a benzylic dihydrodiol-mono-hydroxy-carbocation that is stabilized energetically 
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and can react with DNA to cause mutation (cf. see also reference [89] for DNA-damage 
repair mechanisms). A link between the ease of dihydrodiol-mono-hydroxy-carbocation 
formation and the carcinogenicity of several alternant PAH has been suggested [105].  
 
 
'bay-region' 'bay-region'
'bay-region'
Non-Active: Active:
phenanthrene benzo[e]pyrene 1 anthanthrene
'K-region'
 
Figure 10. Exceptions to the ‘bay-region’ theory. 
 
However, it has also been observed that some PAH representatives possessing the 
‘bay-region’ feature exhibit a lack of genotoxicity, i.e. phenanthrene and benzo[e]pyrene, 
whereas others without a ‘bay-region’ are extremely active, for example anthanthrene and 
the non-alternant CP-PAH 1 (Figure 10) [125].  
For nitro-PAH, their low first one-electron reduction potential, which is 
proportional to their electron affinity, is frequently used as a criterion to explain their direct 
positive bacterial mutagenic response [126-129]. Moreover, the substitution pattern of the 
nitro group(s) with respect to the PAH core has been shown to represent another factor that 
controls their mutagenic activity [130]. 
 
I.7.2.  Non-alternant CP-PAH 
The main metabolic activation route for CP-PAH is the one-step epoxidation at the 
externally-fused olefinic cyclopenta moiety [59]. The epoxide formed at the five-membered 
ring can readily open to form a mono hydroxy-carbocation that will react with DNA. In 
mono-CP-PAH, two mono hydroxy-carbocations are possible and the most stable would 
covalently bind to the DNA to form adducts and induce mutations (Figure 9). The stability 
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of the mono hydroxy-carbocation has been proposed as one of the determinant factors for 
ring opening and consequently for mutagenic activity [131]. In order to estimate the ease of 
epoxide formation at the cyclopenta moiety and the facile epoxide-ring opening, the thermal 
stability of both intermediates, i.e. epoxides and mono hydroxy-carbocations has been 
determined by either semi-empirical or ab initio calculations [131,132]. These studies showed 
that for most CP-PAH, the most stabilized mono hydroxy-carbocation is that at the benzylic 
position with respect to the PAH core since the positive charge is stabilized by the aromatic 
system. Moreover, the more important the difference in energy between the two possible 
mono hydroxy-carbocations, the easier the mono hydroxy-carbocation appears to be 
formed. Hence, theoretical calculations appear to be useful to elucidate the possible 
metabolic mechanisms of CP-PAH that lead to mutagenic activity and support experimental 
genotoxicity results.  
 
 
I.8.  Aims of this Thesis 
The convenient synthesis of a large set of (multiple) CP-PAH by Flash Vacuum Thermolysis 
(FVT), which have all been identified in combustion exhausts, allows their systematic 
assessment for mutagenicity in the bacterial mutagenicity assay (Ames-assay, TA98 ± S9-
mix). Consequently, the physico-chemical characterization (1H and 13C NMR, cyclic 
voltammetry, etc.) is carried out to elucidate structure-activity relationships and to explain 
the high activity exhibited by some CP-PAH, on one hand, and the inactivity of others, on 
the other hand. To gain further insight in the mechanisms for positive mutagenic response 
in the presence and in the absence of the exogenous metabolic activation mixture (± S9-mix), 
dihydro-CP-PAH derivatives are synthesised and assayed for mutagenic activity. Hence, the 
importance of the olefinic bond in the five-membered rings can be evaluated. Furthermore, 
the corresponding epoxides at the cyclopenta moieties are proposed as the ultimate 
mutagenic active forms of CP-PAH in the presence of the metabolic activation mixture. 
Their synthesis permits the evaluation of their contribution to the mutagenic activity or 
inactivity of the corresponding parent CP-PAH. In addition, FVT-pyrolysates are considered 
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as partial mimics of combustion exhausts. It is shown that the presence of E-PAH and mono-
cyclopenta-ethynyl-PAH (CP-E-PAH) intermediates in pyrolysates obtained during the 
formation of multiple CP-PAH under combustion conditions, greatly influences the global 
mutagenicity response of the effluent (model) mixture. Moreover, the results also 
demonstrate that the mutagenic activity of mixtures containing exclusively (CP)-PAH 
cannot be accounted for by the addition of the individual contributions of the constituents. 
However, in practice for general genotoxic potency screening of complex combustion 
mixtures, still only the 16 PAH listed by the US-EPA are generally taken into consideration 
(Figure 5). Consequently, the global genotoxicity is commonly reported as equivalent to that 
exerted by B[a]P. The results presented in this Ph.D. thesis show that the assumption of only 
additive processes among the combustion mixture constituents is incorrect and cannot be 
maintained. Moreover, other compounds that are more active that B[a]P are shown to 
greatly contribute to the global genotoxicity of the mixture. Semi-empirical AM1 calculations 
of the later proposed ultimate mutagenic active forms, i.e. epoxides and mono hydroxy-
carbocations at the cyclopenta moieties, are employed to support the experimental results.  
In Chapter II the bacterial mutagenicity of various mono-CP-PAH, i.e. 
cyclopenta[cd]pyrene (1), acephenanthrylene (5), aceanthrylene (6) and 
cyclopenta[hi]chrysene (8, Figure 1) ranging from either biologically active to inactive is re-
evaluated. Their behaviour is compared to that exerted by their dihydro-derivatives and 
epoxides. It is shown that their epoxides at the five-membered ring represent the ultimate 
mutagenic active forms of the CP-PAH exerting positive mutagenic activity. The results are 
further rationalized by semi-empirical AM1 calculations on the epoxides at the cyclopenta 
moiety and the mono hydroxy-carbocations derived from the epoxide-ring opening. 
In Chapter III, the bacterial mutagenic activity of the three isomeric dicyclopenta-
fused pyrene congeners, i.e. dicyclopenta[cd,mn]- (2), diyclopenta[cd,fg]- (3) and 
dicyclopenta[cd,jk]-pyrene (4, Figure 1), which were recently identified in the non-polar 
fraction of combustion exhausts is reported. The results obtained show that the mutagenic 
potency is markedly affected by the number and the topology of the cyclopenta moieties. 
The order in mutagenic potency can be explained by the results of semi-empirical AM1 
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calculations taking into consideration the stability of the proposed ultimate mutagenic active 
forms, i.e. the di-epoxides at the externally-fused cyclopenta moieties. Furthermore, two 
novel contributors, viz. dicyclopenta[cd,fg]- (3) and diyclopenta[cd,mn]pyrene (2), to the 
direct-acting mutagenic activity found in the non-polar fraction of combustion exhausts are 
as well identified. Their extraordinary direct-acting mutagenic activity is rationalized by 
invoking a different mechanism for bioactivation involving one-electron reduction 
processes.  
Chapter IV reports the synthesis and assessment for bacterial mutagenicity of the 
di-epoxides (presumably a mixture of cis- and trans- diepoxides in a close to 1:1 ratio) 
derived from the three isomeric dicyclopenta-fused pyrene congeners 2-4 (Figure 1). It is 
shown that all epoxides exert direct-acting mutagenicity response (independent on 
cytochrome P450 metabolic activation) and high toxicity. This provide strong evidence that 
indeed the di-epoxides are the ultimate mutagenic active forms. Again a marked effect of 
the position of the epoxide was found. The results show that both cis- and trans- are 
presumably biologically active. 
Chapter V reports the global mutagenic activity exerted by FVT-pyrolysates 
containing the dicyclopenta-fused pyrene congeners 2-4 (Figure 1) in the presence of their 
bis-ethynyl-PAH (E-PAH) and mono-cyclopenta-ethynyl-PAH (CP-E-PAH) precursors 
under combustion conditions. The results unequivocally show that the model mixture can 
be employed as well to rationalize synergistic and antagonistic processes.  
In Chapter VI the bacterial mutagenic activity of the fluoranthene derivatives, 
including cyclopenta[cd]fluoranthene (11, Figure 1), its corresponding epoxide at the five-
membered ring and the ethynyl substituted fluoranthene, precursor under combustion 
conditions of the cyclopenta derivative, is determined. The ethynyl derivative is active with 
and without metabolic activation mixture and the bioactivity of 11 is modest in comparison 
with other active CP-PAH. An FVT-pyrolysate containing all derivatives is also evaluated 
for mutagenic activity.  
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In Chapter VII the experimental total 1H and 13C NMR assignments of the 
dicyclopenta-fused pyrene congeners 2-4 (Figure 1) are described and compared to those 
obtained by ab initio calculations using the CTOCD-PZ2 method [133].  
This thesis concludes with a Summary and an Outlook and Perspectives sections. 
Furthermore, a summary in Dutch (Samenvatting) and in Spanish (Resumen) are also 
provided.  
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Abstract 
The bacterial mutagenic response (Ames-assay, S. typhimurium strain TA98 ± S9-mix) of a 
series of mono-cyclopenta-fused polycyclic aromatic hydrocarbons (CP-PAH) identified in 
combustion exhausts, viz. cyclopenta[cd]pyrene (1), acephenanthrylene (2), aceanthrylene (3) 
and cyclopenta[hi]chrysene (4), is re-evaluated. The results are compared to those exerted by 
their corresponding cyclopenta-hydrogenated derivatives, 3,4-dihydrocyclopenta[cd]pyrene 
(5), 4,5-dihydroacephenanthrylene (6), 1,2-dihydroaceanthrylene (7) and 4,5-
dihydrocyclopenta[hi]chrysene (8). The data show that the olefinic bond of the externally-
fused five-membered ring for 1, 3 and 4 is of importance for exerting a positive mutagenic 
response. This is substantiated by the bacterial mutagenic response of the epoxides at the 
olefinic bond of the externally-fused five-membered ring, i.e. cyclopenta[cd]pyrene-3,4-
epoxide (9), acephenanthrylene-4,5-epoxide (10), aceanthrylene-1,2-epoxide (11) and 
cyclopenta[hi]chrysene-4,5-epoxide (12), which are all independently synthesised. Their role 
as ultimate mutagenic active forms when the parents CP-PAH exhibit positive mutagenic 
response is confirmed. The experimental results are supported by semi-empirical AM1 
calculations on the formation of the CP-arene oxides (9-12) and their possible conversion 
into the mono hydroxy-carbocations (9a-12a and 9b-12b) via epoxide-ring opening. 
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II.1.  Introduction 
The non-alternant cyclopenta-fused polycyclic aromatic hydrocarbons (CP-PAH) are a 
special sub-class of PAH, which contain (at least) one externally unsaturated five-membered 
ring annelated to a PAH perimeter. Their ubiquitous environmental presence due to 
incomplete combustion of fossil fuels [1,2], and their documented enhanced bioactivity in 
comparison to that of their parent PAH lacking the cyclopenta moiety, renders these 
compounds of considerable toxicological interest. Examples of related PAH vs. CP-PAH are 
pyrene vs. cyclopenta[cd]pyrene (1) [3] and anthracene vs. aceanthrylene (3, Figure 1) [4]. 
Most identified biologically active CP-PAH require exogenous metabolic bioactivation (S9-
mix) to exert positive mutagenic activity in bacterial mutagenicity assays (Ames-assay) [4,5]. 
One of the best studied CP-PAH is 1, which exhibits a high mutagenic response dependent 
on metabolism in both bacterial [3,6] and (human) cell bioassays [7,8]. In addition, 1 also 
possesses tumour initiating and moderate cancer development potential [9-11].  
Although for most alternant PAH a ‘bay-region’ has been postulated as a 
prerequisite for metabolic activation to exert genotoxic activity [12], 1 and other active CP-
PAH lack this structural feature. In these cases, the epoxides at the externally-fused five-
membered ring obtained by oxidative metabolic activation by enzymes present in the S9-
mix, are frequently considered as the ultimate putative mutagenic active forms of CP-PAH 
[3]. It is noteworthy that for CP-PAH which also contain a ‘bay-region’ in their PAH core, it 
has been found that epoxidation of the cyclopenta moiety accounts for the majority of the 
bacterial mutagenic activity observed [13,14]. The facile formation of epoxides at the five-
membered ring is corroborated in the case of 1 by the isolation of the corresponding 
dihydro-diols (derived from the action of the epoxide-hydrolase on the epoxide) in 
metabolic studies with liver microsomes [15,16], as well as the reaction of the epoxides with 
DNA in vitro (isolation of DNA-adducts) [17-21]. The importance of the five-membered ring 
olefinic bond is substantiated by the observation that many dihydro-CP-PAH derivatives, 
which contain a saturated five-membered ring, exhibit non-mutagenic activity in bacterial 
bioassays [7,22,23]. Thus, the presence of the olefinic bond seems to be mandatory for a 
positive mutagenic response. In addition, tentative results have shown that the epoxidation 
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products at the externally-fused cyclopenta moiety in contrast to the parent bioactive CP-
PAH, are always direct-acting bacterial mutagens (without exogenous metabolic activation 
mixture, -S9-mix, see also below) and exert cytotoxicity at high concentrations [24,25].  
Previously, CP-PAH 1-4 have been assayed for mutagenicity using different strains 
of S. typhimurium in the Ames-assay (TA98, TA100, etc.). Whilst 1 was found to be active, 
CP-PAH 2 was found to be either inactive [26] or active with metabolic activation mixture in 
the forward mutation assay (S. typhimurium strain TM 677) [7,23]. Compounds 3 [4,26] and 4 
[5] have been reported to act as well as bacterial mutagens upon metabolic activation. In the 
case of 4, diols have been isolated both at the cyclopenta-ring and at the ‘bay-region’ and 
identified as active metabolites [5]. For CP-PAH exhibiting positive dependent on 
metabolism mutagenic response, the epoxides at the externally-fused five-membered ring, 
i.e. 9-12 for 1-5, respectively (Figure 1), are proposed commonly as the ultimate mutagenic 
active forms. Nevertheless, only compounds 9 and 11 have been synthesized and assayed 
for mutagenicity before [15,26]. 
Hence, the high genotoxicity observed for some CP-PAH, on one hand, and the 
lack of bioactivity reported for others, on the other hand, in the different bacterial systems 
previouslty employed in literature, have prompted us to re-evaluate the bacterial mutagenic 
response of the mono-substituted CP-PAH 1-4, which have been all unequivocally identified 
as constituents in combustion exhausts [27,28], in a single systematic study. To establish the 
importance for metabolic activation of the olefinic bond at the five-membered ring, the 
related dihydro-CP-PAH 5-8 are also synthesized and assayed for mutagenic activity. 
Furthermore, the epoxides 9-12 are synthesized and their mutagenic activity compared to 
that of the parent 1-4 in order to evaluate their potential role as ultimate mutagenic active 
forms. The experimental results are supported by semi-empirical AM1 calculations [29] on 
the epoxides 9-12 and their corresponding mono hydroxy-carbocations 9a-12a and 9b-12b 
obtained via the epoxide-ring opening (Figure 1). Note that the latter process has been 
associated with the mutagenic potency [12]. 
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Figure 1. CP-PAH 1-4, dihydro 5-8 and epoxides derivatives 9-12 assayed for mutagenicity (Ames-
assay, S. typhimurium strain TA98 ± S9-mix 2% (v/v)) [30,31], and the corresponding mono hydroxy-
carbocation species derived from epoxide-ring opening 9a-12a and 9b-12b. Their corresponding heats of 
formation (∆Hof in kcal/mol) are calculated using the semi-empirical AM1 method [29] (see Materials 
and methods).  
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II.2.  Results  
The non-alternant CP-PAH cyclopenta[cd]pyrene (1), acephenanthrylene (2), aceanthrylene 
(3) and cyclopenta[hi]chrysene (4) and the dihydro-CP-PAH 3,4-
dihydrocyclopenta[cd]pyrene (5), 4,5-dihydroacephenanthrylene (6), 1,2-
dihydroaceanthrylene (7) and 4,5-dihydrocyclopenta[hi]chrysene (8, Figure 1) in which the 
olefinic double bond at the cyclopenta moiety is selectively hydrogenated (see Materials and 
methods section: Synthesis), were evaluated for mutagenicity in the Ames-test with the S. 
typhimurium auxotropic strain TA98, with and without optimal exogenous activation 
mixture (S9-mix, 2% (v/v)), in the concentration range 0.0-20.0 µg/plate. The dose-response 
curves are shown in the top part (i) of Figures 2-5. The mono-epoxides of 1-4, viz. 
cyclopenta[cd]pyrene-3,4-epoxide (9), acephenanthrylene-4,5-epoxide (10), aceanthrylene-
1,2-epoxide (11) and cyclopenta[hi]chrysene-4,5-epoxide (12, Figure 1) were synthesized 
employing a dimethyldioxirane solution in acetone as mild epoxidation agent [32] (see 
Materials and methods section: Synthesis). Note that the mutagenic response of the 
epoxides 9-12 could only be assayed in the range 0.0-2.0 µg/plate due to the toxicity 
encountered at higher concentrations. The dose-response curves of the epoxides are 
compared with those obtained for the parent compounds in the same range (Figures 2-5). 
The specific mutagenic activity of 1-12 is reported in Table 1.  
In Figure 2, the mutagenic response for 1 is presented and compared to that of its 
dihydro (5) and epoxide (9) derivatives, respectively. As expected [3], 1 exhibits a high 
specific mutagenic activity in the presence of the metabolic activation mixture (+S9-mix 2%, 
(v/v), 64.6 His revertants/nmol, Table 1), but is non-mutagenic in the absence of S9-mix. 
Whilst 5 is non-active both with and without S9-mix, epoxide 9 is a potent mutagen both 
with and without activation mixture (specific mutagenic activity 61.8 and 61.0 His 
revertants/nmol, respectively, Table 1). 
In Figure 3, the mutagenic response of 2 and its related dihydro and epoxide 
derivatives 6 and 10, respectively, is presented. In this series 2 exhibits no mutagenic 
response both in the absence and in the presence of S9-mix (Figure 2). In contrast, its 
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dihydro derivative 6 exerts a (weak) positive dependent on metabolism response (specific 
mutagenic activity of 1.1 His revertants/nmol). The epoxide 10 shows a positive response 
with S9-mix 2% (v/v) and a direct-acting mutagenic activity (specific mutagenic activity of 
1.0 and 2.5 His revertants/nmol, respectively, Table 1).  
Compound 3 exerts a positive specific mutagenic activity with S9-mix (2.4 His 
revertants/nmol, Figure 4). Its dihydro derivative 7 is again non-mutagenic both with and 
without S9-mix. The epoxide derivative of 3, i.e. 11 is as well assayed. Unfortunately, its 
mutagenic response could not be determined due to the high toxicity observed. At the low 
dose range tested, a lack in the background lawn is observed and small amounts of His 
(revertants) are scored (See Appendix (Table A3)).  
In Figure 5 the mutagenic activity of 4 and its corresponding dihydro 8 and 
epoxide 12 derivatives are shown. CP-PAH 4 exhibits a (weak) dependent on metabolism 
specific mutagenic activity of 1.2 His revertants/nmol, and 8 is non-mutagenic both with and 
without S9-mix. However, the epoxide 12 shows a high mutagenic response both in the 
presence and in the absence of S9-mix (specific mutagenic activity of 2.8 and 11.3 His 
revertants/nmol, respectively, Table 1).  
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Figure 2. Comparison of the dose-response curves of i) cyclopenta[cd]pyrene (1,  ■: +S9-mix 2% (v/v), □: 
-S9-mix) and its corresponding 3,4-dihydrocyclopenta[cd]pyrene (5, ▲: +S9-mix 2% (v/v), △: -S9-mix) 
and ii) cyclopenta[cd]pyrene (1, ■: +S9-mix 2% (v/v), □: -S9-mix) and its corresponding 
cyclopenta[cd]pyrene-3,4-epoxide (9, ▲: +S9-mix 2% (v/v), △: -S9-mix).a The standard protocol by Ames 
et. al. [30,31] was followed using the S. typhimurium strain TA98.  
a Note the different scales for the His revertants/plate in i) and ii). Furthermore, in ii) the concentration 
range is 0.0-2.0 µg/plate for 9, see text. 
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Figure 3. Comparison of the dose-response curves of i) acephenanthrylene (2, ■: +S9-mix 2% (v/v), □: -
S9-mix) and its corresponding 3,4-dihydroacephenanthrylene (6, ▲: +S9-mix 2% (v/v), △: -S9-mix) and 
ii) acephenanthrylene (2, ■: +S9-mix 2% (v/v), □: -S9-mix) and its corresponding acephenanthrylene-3,4-
epoxide (10, ▲: +S9-mix 2% (v/v), △: -S9-mix).a The standard protocol by Ames et. al. [30,31] was 
followed using the S. typhimurium strain TA98. 
a Note that in ii) the concentration range is 0.0-2.0 µg/plate for 10, see text. 
 54
CP-Arene Oxides 
i)
0
50
100
150
200
0.0 5.0 10.0 15.0 20.0
µg/plate
H
is
 re
ve
rt
an
ts
/p
la
te
3 + S9
3 - S9
7 + S9
7 - S9
ii)
0
50
100
150
200
0.0 1.0 2.0 3.0 4.0 5.0
µg/plate
H
is
 re
ve
rt
an
ts
/p
la
te
3 + S9
3 - S9
11 + S9
11 - S9
 
Figure 4. Comparison of the dose-response curves of i) aceanthrylene (3, ■: +S9-mix 2% (v/v), □: -S9-
mix) and its corresponding 1,2-dihydroaceanthrylene (7, ▲: +S9-mix 2% (v/v), △: -S9-mix) and ii) 
aceanthrylene (2, ■: +S9-mix 2% (v/v), □: -S9-mix) and its corresponding aceanthrylene-1,2-epoxide (11, 
▲: +S9-mix 2% (v/v), △: -S9-mix).a The standard protocol by Ames et. al. [30,31] was followed using the 
S. typhimurium strain TA98.  
a Note that in ii) the concentration range is 0.0-2.0 µg/plate for 11, see text. 
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Figure 5. Comparison of the dose-response curves of i) cyclopenta[hi]chrysene (4, ■: +S9-mix 2% (v/v), 
□: -S9-mix) and its corresponding 4,5-dihydrocyclopenta[hi]chrysene (8, ▲: +S9-mix 2% (v/v), △: -S9-
mix) and ii) cyclopenta[hi]chrysene (4, ■: +S9-mix 2% (v/v), □: -S9-mix) and its corresponding 
cyclopenta[hi]chrysene-4,5-epoxide (12, ▲: +S9-mix 2% (v/v), △: -S9-mix).a The standard protocol by 
Ames et. al. [30,31] was followed using the S. typhimurium strain TA98.  
a Note that in ii) the concentration range is 0.0-2.0 µg/plate for 12. 
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Table 1. Specific mutagenic activitiesa (His revertants/nmol) and mutagenic potencyb of 1-12. 
 
 
TA98 +S9-mix 2% (v/v) 
 
TA98 -S9-mix 
 
Compound His revertants/nmol 
Mutagenic 
potencyb 
His revertants/nmol 
Mutagenic 
potencyb 
1 64.6   +++ 0.5  - 
5 ~0.05  - ~0.05  - 
9 61.8  +++ 61.0  +++ 
2 0.4  - 0.2  - 
6 1.1  + ~0.05  - 
10 1.0  -/+ 2.5  + 
3 2.4  + 0.2  - 
7 ~0.05  - ~0.05  - 
11 -c  -c -c  -c 
4 1.2  + 0.2  - 
8 ~0.05  - ~0.05  - 
12 2.8  + 11.3  ++ 
 
a Calculated by least squares regression from the initial ascending linear portion of dose-response 
curves (Figures 2-5). For 1-7, the dose range 0.0-20.0 µg/plate was used. 
b Mutagenic potency: - negative, + weakly positive, ++ positive, +++ highly positive. 
c As a consequence of high toxicity, the mutagenic activity of 11 could not be determined. 
 
 
II.3. Discussion 
II.3.1. Mutagenicity assays 
Whereas CP-PAH 1, 3 and 4 exhibit a positive dependent on metabolism bacterial 
mutagenic response in the Ames-assay (S. typhimurium strain TA98, ±S9-mix), compound 2 
exerts non-mutagenic activity under similar conditions. The lack of mutagenic response 
determined for the dihydro-CP-PAH 5, 7 and 8 indicates that the olefinic in the externally-
fused five-membered ring in 1, 3 and 4 represents the favourite site for bioactivation, i.e. 
epoxidation by the isoenzymes of cytochrome P450 present in the S9-mix. Dihydro CP-PAH 
6, however, was found to be moderately active with S9-mix under the experimental 
conditions used. This indicates that another active site may be present in the phenanthrene 
like core, viz. the ‘bay-region’, since the parent CP-PAH 2 is non-mutagenic.  
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It is well established that for most CP-PAH the double bond at the cyclopenta 
moiety possesses olefinic character; it represents the most localized double bond according 
to both theoretical (ab initio calculations) [33-35] and experimental data (crystal single X-ray 
structure) [36,37].  
Thus, the mono-epoxides 9-12 were synthesized and characterized (see Materials 
and methods section: Synthesis) and assayed for their mutagenic response. Interestingly, the 
direct-acting mutagenic activity of epoxides 9 and 12 accounts for almost all the dependent 
on metabolism mutagenic response of their parent CP-PAH 1 and 4, respectively (Table 1). 
Unfortunately, however, epoxide 11 is too toxic for the bacteria in order to assess its 
mutagenic activity. Interestingly, epoxide 10 is as well a direct-acting mutagen, whereas its 
parent CP-PAH exhibits no-mutagenic activity upon metabolic activation. Hence, 10 does 
not represent the ultimate mutagenic form of 2. 
Compound 1 is a highly active dependent on metabolism bacterial mutagen 
(specific mutagenic activity 64.6 His revertants/nmol), and its ultimate mutagenic active 
form is epoxide 9. This is confirmed in the present study. Whilst dihydro-CP-PAH 5 exerts 
no-mutagenic activity, epoxide 9 exhibits high mutagenic response both with and without 
metabolic activation mixture (specific mutagenic activity 61.8 and 61.0 His revertants/nmol). 
Since the direct-acting activity of 9 is similar to that exerted by its parent CP-PAH 1 in the 
presence of S9-mix, the formation of the epoxide at the cyclopenta moiety can be considered 
the main metabolic activation pathway for mutagenicity. 
Acephenanthrylene (2) does not show any mutagenic activity both in the presence 
and in the absence of S9-mix. However, the related epoxide 10 exhibits a direct-acting 
mutagenic response. This suggests that 2 presumably cannot be properly metabolized by the 
isoenzymes of cytochrome P450 in the S9-mix. Thus, our results show that 2 is biologically 
inactive but its corresponding epoxide 10 is considerable more active. Furthermore, the 
dihydro derivative 6, exhibits a weak specific mutagenic activity with S9-mix (1.1 His 
revertants/nmol), which may indicate that another site in the phenanthrene core is also 
prone to undergo bioactivation. Further studies with the objective to isolate and identify the 
possible metabolites are required to resolve these observations. 
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Aceanthrylene (3) has been found to act as a highly potent mutagen [4,21]. In the 
present study, 3 is also found to be mutagenic but not as potent as was previously 
determined [4], although the same S. typhimurium strain TA98 and an optimal microsome 
concentration in the S9-mix were employed. Notwithstanding, the olefinic bond at the five-
membered ring is confirmed to be the site for epoxidation, since its dihydro derivative 7 is a 
non-mutagen both in the presence and in the absence of S9-mix. Under the present 
experimental conditions, the mutagenic potency of its epoxide 11 could not be determined 
due to the high toxicity observed (lack of background lawn, see Appendix for actual data). 
Nevertheless, mono-epoxide 11 is still proposed to be the ultimate mutagenic active form of 
3.  
Cyclopenta[hi]chrysene (4) has been studied previously [5]. Note that 4 like 2 
possesses both a cyclopenta moiety and a ‘bay-region’. In the present investigation, both 
possible bio-activation sites have been studied testing 4 at low and high protein content in 
the S9-mix (2% and 10% (v/v), viz. 0.29 and 1.45 mg protein/plate, respectively). At high 
protein content, the formation of the diol-epoxide at the ‘bay-region’ is expected to be 
operational vs. the formation of the arene-epoxide at the externally-fused five-membered 
ring. In discrepancy with the results reported by Ball et. al. [5] with S9-mix 10% (v/v), no 
increment in the number of revertants is observed (data not shown). Hence, we propose that 
the main activation pathway for 4 is via epoxidation of the olefinic bond of the unsaturated 
cyclopenta moiety, i.e. by formation of epoxide 12. This is confirmed by the observation that 
the dihydro derivative 8 exerts a non-mutagenic response both with and without S9-mix. 
Since in 8 the ‘bay-region’ is still present, 8 was also assayed for mutagenicity with S9-mix 
10% (v/v) to check if the metabolic activation via the diol-epoxide at the ‘bay-region’ 
becomes operational. No positive mutagenic response is found also in this case (data not 
shown). Thus, activation via the formation of the diol-epoxide in the ‘bay region’ for 4 is 
found to be marginal in the present study. Moreover, the epoxide 12 is found to exert a 
potent direct-acting mutagenic activity (specific mutagenic activity of 11.3 His 
revertants/nmol). In the presence of S9-mix, the mutagenic activity of 12 is reduced, which 
suggests that detoxification processes become operational. 
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II.3.2. Semi-empirical AM1 calculations 
In the present study, it is shown that epoxides 9 and 12 are the ultimate mutagenic active 
forms from 1 and 4 respectively. The determination of the mutagenic potency of 11 is 
hindered due to the high toxicity exerted under the applied experimental conditions. 
Notwithstanding, 11 is still proposed to be the ultimate mutagenic active form of 3. 
Compound 10 exerts a direct-acting mutagenic activity, but its parent compound 2 is non-
mutagenic. Apparently, the enzymes present in the S9-mix cannot readily convert 2 into its 
epoxide 10. To rationalize the difference in mutagenic response exerted by the CP-PAH 1-4 
and their corresponding ultimate mutagenic active forms, i.e. the epoxides 9-12, the heats of 
formation (∆Hfο in kcal/mol, Table 2) of 1-4, 9-12 and their corresponding mono hydroxy-
carbocations 9a-12a or 9b-12b (Figure 1) obtained via epoxide-ring opening were computed 
using the semi-empirical AM1 method [29] (see Materials and methods section). It has been 
proposed previously that the most stable mono hydroxy-carbocation may react with DNA 
and can induce mutation [12]. 
 
 
Table 2. Semi-empirical AM1 energy difference (∆E, kcal/mol) of the corresponding mono-epoxides (9-
12) and the two possible mono hydroxy-carbocations (9a-12a and 9b-12b, see Figure 1).  
 
Compound 
 
∆E mono-epoxidesa 
 
∆E mono hydroxy carbocationsb 
 
  a b 
9 -18.7  131.5  137.9  
10 -18.0  138.8  139.5  
11 -17.8 128.7 137.2  
12 -18.1  135.3  138.2  
 
a∆E (mono-epoxide) = ∆Hof (mono-epoxide (9-12)) - ∆Hof (1-4) (Figure 1). 
b Estimate for ∆E (mono hydroxy-carbocation formation) = ∆Hof (mono hydroxy-carbocation (9a-12a or 
9b-12b)) - ∆Hof (9-12, Figure 1). 
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The energy difference (∆E in kcal/mol) between the parent CP-PAH 1-4 and their 
corresponding epoxides 9-12 gives an estimate of the ease of epoxidation at the cyclopenta 
moiety (Table 2). It is shown that for all CP-PAH, the ease of epoxidation is nearly the same 
(~ 18 kcal/mol, Table 2). With respect to the ease of epoxide-ring opening, two possible 
mono hydroxy-carbocations have to be taken into consideration. From epoxides 9-12 the 
most stable mono hydroxy-carbocation is the isomer with its positive charge located at a 
‘benzylic-like’ position (9a-10a) for which the positive charge is stabilized via 
facile π−delocalization. For compounds 9 and 11 the energy difference between the two 
mono hydroxy-carbocations (∆E in kcal/mol) indicates that the most stable species 9a 
(∆E(9a-9b) -6.4 kcal/mol) and 11a (∆E(11a-11b) -8.5 kcal/mol, Figure 1 and Table 2) will be 
predominantly formed. However, for 10 and 12 both hydroxy-carbocations 10a-10b and 12a-
12b, respectively, possess similar ∆Hof values which indicates that both will possess a similar 
stability (∆E(10a-10b) -0.7 kcal/mol and ∆E(12a-12b) -2.9 kcal/mol, Figure 1 and Table 2). 
Consequently, theory suggests that both forms can apparently coexist. The GC trace from 
the GC-MS spectrum of 10 and 12 corroborates these observations since two products are 
obtained from the thermal rearrangement of the epoxide into the two possible ketones are 
detected. In contrast, for 9 and 11 only one product is found (see Materials and methods 
section: Synthesis). When the ∆E values for the most stable mono hydroxy-carbocations 9a-
12a are taken into account, the order for the ease of epoxide-ring opening in the case of 9-12 
follows 11 > 9 > 12 > 10. This is the same order as found for the direct-acting mutagenic 
activity of the epoxides, with the exception to 11, which was found to be highly cytotoxic. 
 
 
II.4.  Conclusions 
The results obtained are consistent with the postulated role of the epoxides at the cyclopenta 
moiety as the ultimate mutagenic active metabolites from CP-PAH; they are direct-acting 
mutagens (-S9-mix) in the standard Ames-assay. The importance of the olefinic bond at the 
five-membered ring of CP-PAH to exert positive mutagenic activity is demonstrated by 
assaying for mutagenic activity of the partially hydrogenated dihydro-CP-PAH. Since a 
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non-mutagenic response was observed for the latter, this correlates with the fact that the 
double bond at the externally-fused five-membered ring is the favourable site for metabolic 
activation (epoxidation) by the P450 isoenzymes present in the S9-mix. This is further 
confirmed by the direct-acting mutagenicity of the epoxides at the cyclopenta moiety. The 
experimental results are supported by semi-empirical AM1 calculations on the epoxides 9-12 
and their corresponding mono hydroxy-carbocations 9a-12a and 9b-12b obtained by 
epoxide-ring opening. 
 
 
 
II.5.  Materials and methods 
II.5.1.  Test compounds and chemicals 
The CP-PAH cyclopenta[cd]pyrene (1, CAS n 27208-37-3), acephenanthrylene (2, CAS n 201-
06-9), aceanthrylene (3, CAS n 202-03-9) and cyclopenta[hi]chrysene (4, CAS n 216-48-8), 
their related partially hydrogenated derivatives 3,4-dihydrocyclopenta[cd]pyrene (5, CAS n 
25732-74-5), 4,5,-dihydroacephenanthrylene (6, CAS n 6232-48-0), 1,2-dihydroaceanthrylene 
(7, CAS n 641-48-5) and 4,5-dihydrocyclopenta[hi]chrysene (8, CAS n 4766-40-9), and their 
corresponding mono-epoxides at the externally-fused cyclopenta moiety 
cyclopenta[cd]pyrene-3,4-epoxide (9, CAS n 73473-54-8), acephenanthrylene-4,5-epoxide (10, 
CAS n 133733-26-3), aceanthrylene-1,2-epoxide (11, CAS n 133733-25-2) and 
cyclopenta[hi]chrysene-4,5-epoxide (12, CAS n 139469-80-0) were synthesized as described 
in the Synthesis section. The purity of all test compounds was at least > 98.9% (capilary GC). 
Caution: CP-PAH and their derivatives must be handled according to NIH guidelines for 
carcinogens. The positive controls benzo[a]pyrene (B[a]P, 98.8%, CAS n 50-32-8) and 1-
nitropyrene (1-NP, 99%, CAS n 5522-43-0) were purchased from Sigma-Aldrich and used 
without further purification. Dimethyl sulfoxide (DMSO, 99.9%, CAS n 67-68-5) was 
purchased from Aldrich, NADP monosodium salt (98%, CAS n 1184-16-3), D-glucose-6-
phosphate anhydrous (G-6-P 99%, CAS n 56-73-5) and potassium monopersulphate triple 
salt (caroate, CAS n 37222-66-5) from Sigma. 
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II.5.2.  Bacterial mutagenicity assays 
Bacterial mutagenic response was determined with the histidine (His)-reversion assay 
(Salmonella typhimurium strain TA98) following the standard protocol by Ames and Maron 
[30,31] either in the absence or in the presence of an exogenous metabolic activation system 
(± S9-mix). The S9-mix consists of rat liver microsome preparations (S9-fraction) obtained 
from Aroclor-1254 treated male Wistar rats and the NADPH-generating co-factors using the 
standard procedures [30,31]. The total protein content and the activity of the cytochrome 
P450 isoenzyme P450-1A were determined as 29.15 mg/ml (Lowry method) [38] and 51.58 
pmol/ml/min/mg protein (EROD method) [39], respectively. 
Compounds 1-8 were dissolved in DMSO (500 µg/ml) and tested at five different 
concentrations (0.0, 1.0, 5.0, 15.0 and 20.0 µg/plate). Note that compounds 9-12 could only be 
tested until 2.0 µg/plate due to their extreme cytotoxicity (see Results section). Parallel 
experiments were carried out with (+S9-mix 2% (v/v) 0.29 mg protein/plate) and without 
exogenous metabolic activation mixture (-S9-mix) with three plates per test dose, in at least 
two independent experiments. Positive controls, i.e. 1-NP, 5.0 µg/plate (-S9-mix > 1000) and 
B[a]P, 6.0 µg/plate (+S9-mix 133.9 ± 20.5), negative controls i.e. DMSO (-S9-mix 10.2 ± 4.7, 
+S9-mix 19.8 ± 6.5) and spontaneous reversion His revertants (-S9-mix 13.3 ± 4.7, +S9-mix 
21.6 ± 6) for TA98 were included in each experiment. The plates were incubated at 37 oC for 
48 h and the His revertant colonies counted manually. The results are presented in dose-
response curves and are expressed as mean values of revertant His colonies per dose of test 
compound of three different plates from two independent experiments with no correction 
for spontaneous reversion. To establish a positive mutagenic response the following criteria 
are used [40,41]: i) three-fold increase of His revertants in plates with test compound as 
compared to the negative control (DMSO), ii) ascending dose-response curves and iii) 
replication of results in at least two independent experiments. Note that several studies have 
demonstrated that the first criterion on itself is not sufficient for establishing a positive 
mutagenic response [42]. The specific mutagenic activities, i.e. number of His revertants 
induced per nmol of test compound (Table 1) are as well calculated by least squares  
regression from the initial ascending portion of the dose-response curves. The actual data 
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for each dose of test compound (mean value from at least six plates ± standard deviation) 
and the correlation coefficients from the calculation of the slopes of each dose-response 
curve are reported in the Appendix (Tables A1-A3).  
 
II.5.3.  Synthesis  
With the exception of the epoxidation reactions, all other reactions were carried out under a 
N2 atmosphere. Solvents were dried and purified using standard protocols. Commercial 
reagents were used as received. Column and flash chromatography were performed on 
Merk kieselgel 60 silica (230-400 ASTM) and neutral aluminium oxide W200. Thin layer 
chromatography (TLC) was carried out using TLC aluminium sheets of aluminium oxide 60 
F254 neutral (type E) and TLC silica gel 60 F254. Melting points are uncorrected. 1H and 13C 
NMR spectra were recorded on a Bruker AC 300 and a Varian Unity Inova Spectrometer 
operating at 300.13 MHz and 75.47 MHz respectively at 25 oC; either d6-acetone or CDCl3 
were used as solvents. Chemical shifts values are reported in ppm and are referred to TMS. J 
values are given in Hz (multiplicity: s = singlet, d = doublet, t = triplet, dd = double doublet 
and m = multiplet). Capillary GC chromatograms were obtained in a Varian GC 3350 and 
GC 3400: capillary column DB 5 (length 30 m, ID 0.3 mm and 1 µm film thickness), 
temperature program (Ti = 200 or 250 oC, isothermal for 10 min, heating to 280 oC at 10 oC 
min-1), injector and detector temperature 300 oC and He as carrier gas. GC-MS spectra were 
measured on a ATI Unicam Automass System 2 quadrople mass spectrometer: J & W 
Scientific DB-15ms capillary column (length 30 m, ID 0.25 mm and 0.25 mm film thickness), 
temperature program (Ti = 200 or 250 oC, isothermal for 10 min, heating to 280 oC at 10 oC 
min-1), injector and detector temperature 300 oC and He as carrier gas. Mass Spectrometer 
(MS): EI 70 eV. Caution: CP-PAH and their derivatives must be handled according to NIH 
guidelines for carcinogens due to their potential genotoxicity. Dimethyldioxirane is a 
volatile peroxide and must be synthesized with precaution. 
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Synthesis of CP-PAH 1-4  
CP-PAH 1-4 were synthesized employing Flash Vacuum Thermolysis (FVT) as described 
previously [43-46]. A commercial Thermolyne 21100 tube furnace containing an unpacked 
quartz tube (40 cm long, diameter 2.5 cm) was used at T = 900-1050 oC, p < 0.01 mmHg. The 
pyrolysate (product mixture) was deposited in the tube before the cold trap, recovered with 
dry CH2Cl2 (ca. 3 ml), and submitted to analysis before further purification for the 
mutagenicity assays (Ames-assay) or their use as precursors for further reactions. The 
spectral data was in accordance with the previously reported [43,45,46]. 
 
Synthesis of dihydro-CP-PAH 5-8 
The dihydro-CP-PAH 5-8 were prepared following standard procedures [47] by catalytic 
hydrogenation of the corresponding CP-PAH parent compounds 1-4 (ca. 20 mg) with 
hydrogen (pH2/1 atm) and Pd on activated carbon (2 mg) in dry THF (15 ml) at room 
temperature. The reactions were finished when the intense colour of the precursor solution 
disappeared (2-3 h) by filtrating the reaction mixture over celite and removing the solvent 
under reduced pressured. Anallytically pure dihydro-CP-PAH 5-8 were obtained in near 
quantitative yield as colourless solids. 
3,4-Dihydrocyclopenta[cd]pyrene (5)  
The experimental data were in agreement with previously reported results [48]. m.p. 133-
134 oC.  δH (CDCl3): 8.12 (1H, d, J 8.0), 8.06-8.00 (3H, m), 7.95 (1H, d, J 7.7), 7.93 (1H, d, J 7.7), 
7.90 (1H, t, J 7.7), 7.78 (1H, m), 3.70-3.66 (2H, m) and 3.62-3.58 (2H, m). δC (CDCl3): 144.9, 
142.1, 136.6, 133.6, 131.3, 128.3, 126.9 (C-H), 126.2 (C-H), 126.1 (C-H), 124.9 (C-H), 123.9 (C-
H), 123.8, 122.8 (C-H), 122.4, 121.6 (C-H), 118.6 (C-H), 30.9 (C-H) and 30.5 (C-H). 
4,5-Dihydroacephenanthrylene (6)  
The 1H and 13C NMR spectra were in agreement with previously published results [49]. m.p. 
106-107 oC. δH (CDCl3): 8.61-8.58 (1H, m), 8.33 (1H, d, J 8.1), 7.87-7.84 (1H, m), 7.62-7.52 (4H, 
m), 7.48 (1H, d, J 7.8) and 3.44 (4H, s). δC (CDCl3): GC-MS: m/z (relative intensity) (MS) 204 
(M·+), (100), 101 (25). 
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1,2-Dihydroaceanthrylene (7)  
The 1H and 13C NMR spectra were in agreement with previously published results [49]. m.p. 
112-113 oC. δH (CDCl3): 8.19 (1H, s), 8.07-8.04 (1H, m), 8.01-7.98 (1H, m), 7.74 (1H, d, J 8.8), 
7.48-7.41 (3H, m), 7.24 (1H, d, J 6.6), 3.80-3.76 (2H, m) and 3.59-3.55 (2H, m). δC (CDCl3): 
147.1, 142.6, 137.4, 133.7, 129.8, 129.4 (C-H), 127.7 (C-H), 127.1, 125.1 (C-H), 124.7 (C-H), 
124.5 (C-H), 122.2 (C-H), 121.3 (C-H), 117.2 (C-H), 30.5 (C-H) and 29.6 (C-H). 
4,5-Dihydrocyclopenta[hi]chrysene (8)  
m.p. 185-186 oC. δH (CDCl3): 8.80 (1H, d, J 8.3), 8.63 (1H, d, J 8.8), 8.54 (1H, s), 8.40 (1H, d, J 
8.3), 7.99 (1H, d, J 8.0), 7.94 (1H, d, J 8.8), 7.70-7.58 (3H, m), 7.48 (1H, d, J 6.6) and 3.59-3.50 
(4H, m). δC (CDCl3) 145.9, 144.8, 132.5, 130.8, 130.4, 129.0, 128.6 (C-H), 128.3 (C-H), 127.0 (C-
H), 126.2 (C-H), 126.0 (C-H), 125.7, 123.3 (C-H), 121.4 (C-H), 120.7 (C-H), 119.1 (C-H), 115.2, 
113.9 (C-H), 30.2 (C-H) and 29.2 (C-H). GC-MS: m/z (MS) 254 (M·+) (100), 226 (10), 126 (42), 
113 (22). 
 
Synthesis of mono-epoxides 9-12 
The epoxidation of CP-PAH 1-4 was carried out using dimethyldioxirane in acetone as 
epoxidation system. The dimethyldioxirane solution in acetone was prepared according to 
published methods [50,51]. Usually, 50-70 ml of 0.07-0.10 M dimethyldioxirane solutions in 
acetone were obtained. The dimethyldioxirane content was assessed by the monitoring the 
oxidation of methyl phenyl sulphide into its sulphoxide derivative by calibrated capillary 
GC. For the synthesis of the epoxides 9-12, the reaction was carried out at room temperature 
in the dark using an mg scale of the corresponding CP-PAH precursor (80-100 mmol), with 
a 1.5-2.0 fold-molar excess of the fresh dimethyldioxirane solution in acetone, in the 
presence of an equivalent mg amount of NaHCO3. After total consumption of the CP-PAH, 
the reaction was filtered and the solvent removed under reduced pressure and the crude 
reaction was dissolved in acetone or dichloromethane, dried over magnesium sulphate and 
filtered. Concentration of the filtrate in vacuo yielded analytically pure samples of the 
epoxides at the cyclopenta five-membered ring in near quantitative yields.  
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Cyclopenta[cd]pyrene-3,4-epoxide (9) 
The spectral data obtained are in agreement with previously published results [32]. δH (d6-
acetone): 8.39 (1H, d, J 7.8), 8.35 (1H, s), 8.31 (1H, dd, J 7.7, J 1.1), 8.22 (2H, AB system, J 7.7), 
8.15 (2H, s), 8.08 (1H, t, J 7.7), 5.19 (2H, AB system, J 2.5); δC (d6-acetone): 138.4, 136.4, 136.2, 
132.1, 131.0, 130.7, 128.5, 128.1 (C-H), 127.1 (C-H), 127.0 (C-H), 126.6 (C-H), 125.8 (C-H), 
124.4 (C-H), 123.9 (C-H), 123.2 (C-H), 122.7, 59.2 (C-H) and 58.7 (C-H); GC-MS: m/z (relative 
intensity) 242 (M+, 80), 214 (100), 187 (12) 107 (30). The GC-MS spectrum corresponds to that 
of 3,4-dihydrocyclopenta[cd]pyren-4-one as has been shown and discussed previously [32].  
Acephenanthrylene-4,5-epoxide (10) 
δH (d6-acetone): 8.72 (1H, dd, J 6.0), 8.56 (1H, d, J 8.3), 8.06 (1H, d, J 7.7), 8.03 (1H, s), 7.82 (1H, 
d, J 6.9), 7.73-7.63 (3H, m), 4.98 (2H, AB system, δA 4.98 δB 4.96, JAB 2.5); δC (d6-acetone): 141.1, 
138.8, 138.4, 134.9, 131.5, 131.2 (C-H), 130.6, 129.4 (C-H), 128.7 (C-H), 128.6 (C-H), 125.5 (C-
H), 124.9 (C-H), 124.6 (C-H), 123.6 (C-H), 59.8 (C-H) and 59.1 (C-H). GC-MS: m/z (relative 
intensity) two distinct peaks are discernible in the GC trace after injection of 10: I: (45%): 218 
(M+, 100), 202 (11), 189 (90), 94 (20) and II: (55%): 218 (M+, 100), 202 (16), 189 (86), 95 (27). 
Under the applied GC-MS conditions epoxide 10 apparently rearranges into the two 
possible ketones, viz. 4,5-dihydro-acephenanthrylen-4-one and 4,5-dihydro-
acephenanthylen-5-one are observed in the spectrum (see also reference [49]).  
Aceanthrylene-1,2-epoxide (11) 
δH (d6-acetone): 8.48 (1H, s), 8.43 (1H, d, J 7.7), 8.17 (1H, d, J 8.5), 7.99 (1H, d, J 8.8), 7.73 (1H, 
d, J 6.3), 7.65-7.47 (3H, m), 7.55 (2H, m), 5.55 (1H, d, J 2.5), 5.12 (1H, d, J 2.5). δC (d6-acetone): 
140.7, 137.3, 136.5, 135.1, 134.3, 130.5 (C-H), 130.4, 127.8 (C-H), 127.4 (C-H), 126.9 (C-H), 
126.3 (C-H), 125.9 (C-H), 124.5 (C-H), 123.0 (C-H), 58.8 (C-H) and 57.3 (C-H). GC-MS m/z 
(relative intensity): 218 (M+, 100), 202 (5), 190 (75), 189 (95), 163 (15), 95 (21), 94 (22). Under 
the applied GC-MS conditions epoxide 11 rearranges into 1,2-dihydro-aceanthrylen-2-one 
[49]. 
Cyclopenta[h,i]chrysene-4,5-epoxide (12) 
δH (d6-acetone): 9.13 (1H, s), 8.99 (1H, d, J 8.5), 8.78 (1H, d, J 9.1), 8.68 (1H, d, J 8.3), 8.16 (2H, 
m), 7.85 (1H, d, J 6.9), 7.80-7.67 (3H, m), 5.12 (1H, d, J 2.5), 5.05 (1H, d, J 2.5). δC (d6-acetone): 
Chapter II 
 68
140.5, 138.9, 137.7, 133.5 (C-H), 132.1, 130.2, 130.0, 129.6 (C-H), 128.8 (C-H), 128.7 (C-H), 
127.9 (C-H), 127.5 (C-H), 124.3 (C-H), 124.1 (C-H), 123.3 (C-H), 122.1 (C-H), 119.3, 119.2, 59.1 
(C-H), 58.8 (C-H).GC-MS m/z (relative intensity) two distinct peaks are discernible in the GC 
trace: I: 75%: 268 (M+ 97), 239 (100), 219 (57), 119 (40), 87 (30) and II: 25%, 268 (M+ 97), 239 
(100), 219 (13), 119 (25). Under the applied GC-MS conditions epoxide 12 apparently 
rearranges into the two possible ketones, viz. 4,5-dihydro-cyclopenta[hi]chrysen-4-one and 
4,5-dihydro-cyclopenta[hi]chrysen-5-one. 
 
II.5.4. Computations 
To obtain estimates of the heats of formation (∆Hfo in kcal/mol) of the compounds 1-4 and 9-
12 and mono hydroxy-carbocation intermediates 9a-12a and 9b-12b shown in Figure 1, semi-
empirical restricted Hartree-Fock (RHF) AM1 calculations (RHF/AM1) [29] were performed 
using the MOPAC 7.0 program using the Eigenvector-following routine (EF) until GNORM 
< 0.05. All geometries were optimised without imposing any geometry constraints. All 
computed minima were characterized by Hessian calculations; in all cases no imaginary 
frequencies were found.  
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II.7. Appendix 
Table A1.  Bacterial mutagenic activitya of cyclopenta[cd]pyrene (1), acephenanthrylene (2), aceanthrylene (3) and cyclopenta[hi]chrysene (4, Figure 1) 
employing the S. typhimurium strain TA98, with and without exogenous metabolic activation mixture (± S9-mix). 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
Conc. 
µg/plate 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
0.0 19 ±   7.2 22.5 ±  2.5 46 ±  5.4 36 ±  3.1 17.5 ±  4.3 6.3 ± 3.5 18.3 ±  4.3 9 ±  5.6 
1.0 180.5 ±   6.5 18.0 ±  2 47.6 ±  2.6 30.3 ±  6.1 27 ± 10.1 13.5 ± 5.9 22.8 ±  1.8 7.8 ±  3.7 
2.0 616.5 ±  10.2 20.5 ±  1 48.6 ±  7.1 42.3 ± 15.7  -b -b  -b -b  -b -b  -b -b 
4.0 1113 ±  80.0   30.5 ±  0.5   50.8 ±  4.4  23.1 ±  5.7 77.3 ±  8.8   9.3 ± 6.4  60.8 ± 12.6   14.3 ±  4 
8.0 2247 ± 450.0 48.0  ± 17 58.8 ±  4.9 32.8 ±  3.9 -b -b  -b -b  -b -b  -b -b 
12.0 2250 ±  90.0   31.0 ±  6   72 ±  5.4  42 ±  4   120.5 ±  4.1    12 ± 4.1   81 ± 16  20.3  ±  5.4 
20.0  2380 ± 220.0 71.0 ± 32 71.7 ± 14.4 48 ±  3  128.2 ±  4.8   15 ± 4.8 69.8 ±  3.7 27.0 ±  7.4 
His  
revertants/ 
nmol (r2) 
63.5                (0.93) ~0.5 (0.55) 0.4 (0.97) 0.2 (0.68) 2.4 (0.99) ~0.2 (0.5) 1.20 (0.90) 0.2 (0.95)
 
a Mutagenic response was determined as described in Materials and methods section [30,31]. Results shown are mean values ± standard deviation (from 
triplicate plates for each dose in two independent experiments), and are given in His revertants per plate, without correction for spontaneous His revertants.   
b Dose not tested 
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Table A2.  Bacterial mutagenic activitya of 3,4-dihydrocyclopenta[cd]pyrene (5), 3,4-dihydroacephenanthrylene (6), 1,2-dihydroaceanthrylene (7) and 4,5-
dihydrocyclopenta[hi]chrysene (8, Figure 1) employing the S. typhimurium strain TA98, with and without an exogenous metabolic activation mixture (± S9-mix). 
 
5 6 7 8
Conc. 
µg/plate +S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
0.0 25 ± 2 15.5 ±  0.5 14 ±  2 9 ± 3 25.5 ± 9.5 15.5 ± 0.5 18.3 ± 5.5 14.5 ± 1.5 
1.0 26.5 ± 35 16.5 ±  0.5  21.5 ± 15 10.5 ± 2 25 ± 2 25.5± 6.5 14.8 ± 4.2 11.0 ± 1 
5.0 41.5 ± 75 17.0 ±  2  71.5 ±  8.5  7 ± 1 18.5 ± 4.5 19 ± 1 11 ± 2.3 9 ± 2 
15.0 37 ± 1 18.0 ±  2 96 ±  1 18 ± 3 22.5 ± 1.5   18.5 ± 2  21.3 ± 5.2   15.5 ± 3 
20.0  65 ± 2 21.0 ±  1   71.5 ±  4.5 6.5 2.5 28.5 ± 6.5 24 ± 1 19.8  ± 7 21 ± 2 
His  
revertants/ 
nmol (r2) 
~ 0.2 -b ~ 0.2 -b 1.1   (0.99) ~ 0.1 -b ~ 0.2 -b ~ 0.2 -b ~ 0.2 -b ~ 0.2 -b 
 
a Mutagenic response was determined as described in Materials and methods section [30,31]. Results shown are mean values ± standard deviation (from 
triplicate plates for each dose in two independent experiments), and are given in His revertants per plate, without correction for spontaneous His revertants. 
b The slope could not be determined.   
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Table A3.  Bacterial mutagenic activitya of cyclopenta[cd]pyrene-3,4-epoxide (9), acephenanthrylene-3,4-epoxide (10), aceanthrylene-1,2-epoxide (11) and 
cyclopenta[hi]chrysene-4,5-epoxide (12, Figure 1) employing the S. typhimurium strain TA98, with and without an exogenous metabolic activation mixture (± S9-
mix). 
 
9 10 11 12
Conc. 
µg/plate +S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
0.0 20.5 ±  7.1 7.5 ±   2.6 20.5 ± 7.1 7.5 ± 2.6 20.8 ± 6b 17.5 ± 7.4b 20.5 ± 7.1 7.5 ±  6.8 
0.1 53.5 ±  4.6 38.3 ±  10.9  23.3 ± 3.9 18.8 ± 6.2 36.5 ± 6.5b  15.5 ± 3.4b 25.5 ± 5.1 10.8 ±  4.2 
0.5 164 ± 35.5 104.8 ±  12.6 23 ± 6.1 23 ± 2.5 28 ± 9.4b  15.7 ± 5.2b 23.5 ± 7.2 17 ± 13.4 
1.5 400 ± 88.4   499 ±  45.0  29.5 ± 8.5  31.5 ± 7.4 30.4 ± 4.7b   20.3 ± 8.6b  30.3 ± 3.3   67 ± 17.9 
2.0 476.7 ± 96.5 513.4 ± 119.8 30.8 ± 3.7 34.5 ± 1.7 28.5 ± 5.5b  17.8 ± 7.9b 62 ± 7.5 107.3 ± 23.4 
His  
revertants/ 
nmol (r2) 
61.8                (0.98) 61.0 (0.93) 1.0 (0.95) 2.5 (0.90) - - - - 2.8 (0.50) 11.3 (0.95)
 
a Mutagenic response was determined as described in Materials and methods section [30,31]. Results shown are mean values ± standard deviation (from 
triplicate plates for each dose in two independent experiments), and are given in His revertants per plate, without correction for spontaneous His revertants.  
b Lack of background lawn, toxicity was observed.  
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Abstract 
Cyclopenta[cd]pyrene (1) and its congeners dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3), 
dicyclopenta[cd,jk]pyrene (4), which were all identified as constituents of combustion 
exhausts, as well as their partially hydrogenated derivatives 3,4-dihydrocyclopenta[cd]- (5), 
1,2,4,5-tetrahydrodicyclopenta[cd,mn]- (6), 5,6,7,8-tetrahydrodicyclopenta[cd,fg]- (7) and 
1,2,6,7-tetrahydrodicyclopenta[cd,jk]pyrene (8), were assayed for mutagenicity in the 
Salmonella typhimurium strain TA98 using different concentrations of microsomal protein in 
the metabolic activation system (S9-mix (S9-fraction from liver of Aroclor-1254 treated rats)): 
2%, 4% and 10% (v/v), respectively). Whereas a positive mutagenic response is found for 1-4 
in the presence of S9-mix, 5-8 exert no mutagenicity either with or without S9-mix. Since for 
1-4 the highest response is observed with S9-mix 2% (v/v) instead of the standard 4% (v/v), a 
one-step activation pathway, i.e. epoxidation of the five-membered ring olefinic bonds, 
appears to be operational. Surprisingly, 3 and, to a lesser extent, 2 also give a positive 
response in the absence of S9-mix. Hence, 2 and 3 are expected to contribute to the direct-
acting mutagenicity of the non-polar fraction of combustion exhausts. Presumably for the 
direct-acting mutagenicity one-electron transfer processes play a role in bioactivation. The 
experimental observations are supported by semi-empirical AM1 calculations on the 
possible ultimate metabolites, i.e. mono-epoxides (2a-4a), cis-di- (2b-4b) and trans-di-
epoxides (2c-4c) and the related mono hydroxy-carbocations (2d-4d and 2e-4e), and the 
radical anions 1.--4.-.  
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III.1. Introduction 
The non-alternant cyclopenta-fused polycyclic aromatic hydrocarbons (CP-PAH) constitute 
a unique sub-class of PAH that possess at least one unsaturated five-membered ring moiety 
annelated to a PAH core. CP-PAH are widespread in our environment since they are 
generated during incomplete combustion processes [1,2]. Although most CP-PAH lack a 
‘bay-region’, viz. the frequently proposed structural feature required for PAH mutagenic 
activation, several CP-PAH possess high (bacterial) mutagenic activity [3-5]. More recently, 
CP-PAH were put forward as prime contributors to explain the total mutagenic activity of 
the non-polar fraction of combustion exhausts [6,7]. A documented example is 
cyclopenta[cd]pyrene (1, Figure 1) [8]. However, despite its high activity, 1 cannot account 
for the total mutagenic activity of the non-polar fractions. Consequently, the identification 
and characterization of other potentially mutagenic CP-PAH present in the non-polar 
fraction is a topical research issue.  
Interesting candidates are the three isomeric dicyclopenta-fused pyrenes, i.e. 
dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3) and dicyclopenta[cd,jk]pyrene (4, Figure 1), 
which after their unequivocal synthesis [9,10], were identified as constituents of the non-
polar fraction of combustion exhausts [11,12]. Hence, the availability of pure 2-4 now 
enables the assessment of their mutagenic response which then can be compared with that 
of 1 [3]. It is noteworthy that 2-4 were further suggested as by-products in the thermal 
treatment of pyrene-contaminated soil [13-15].  
Cyclopenta[cd]pyrene (1) has been extensively studied and possesses a marked 
mutagenic response dependent on metabolism both in bacterial mutagenicity assays [3] and 
in mammalian in vitro assays [16]. Furthermore, 1 has both tumour initiating [17] and 
moderate carcinogenic potential [18]. In the case of 1, epoxidation of the five-membered ring 
olefinic bond (CP-epoxide) [19,20] is postulated as the primary metabolic pathway for its 
bioactivation by cytochrome P450 (cf. Figure 7). Subsequent ring opening of the epoxide 
generates a stable hydroxy-carbocation, which may then react with DNA (adduct formation) 
[21]. This mechanism was substantiated by the isolation of trans-3,4-dihydroxy-3,4-
Dicyclopenta Pyrene Congeners 
dihydrocyclopenta[cd]pyrene as the major metabolite derived from 1 by liver microsomes 
[19] as well as the in vitro formation of DNA and epoxide adducts [22-24].  
Here, we report the mutagenic response of the novel dicyclopenta-fused pyrene 
congeners 2-4 in the Salmonella typhimurium strain TA98 Ames assay both with and without 
exogenous metabolic activation mixture (S9-mix (Aroclor-1254 rat liver S9-fraction and co-
factors)). The strain TA98 allows the detection of frameshift mutagens, and has been 
extensively employed for screening of the mutagenic potency of PAH as recommended in 
the protocol by Ames et.al. [25,26]. 
 
 
1 2 3 4
5 6 7 8
C3
C4 C4 C4 C4
C3 C3 C3
 
Figure 1. Compounds 1-8 that were assayed for mutagenicity in the standard protocol outlined by 
Ames et. al. [25,26]. 
 
 
III.2. Results 
The bacterial mutagenic response of cyclopenta[cd]- (1), dicyclopenta[cd,mn]- (2), 
dicyclopenta[cd,fg]- (3) and dicyclopenta[cd,jk]pyrene (4) and their corresponding partially 
hydrogenated congeners 5-8 (Figure 1), were assessed in the Salmonella typhimurium TA98 
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His reverse mutation assay either in the absence or in the presence of S9-mix with different 
concentrations of S9-fraction in the S9-mix. The dose-response curves for both the direct-
acting (-S9-mix) and metabolic activation dependent mutagenicity (+S9-mix) are shown in 
Figures 2-5 and the specific mutagenic activity of 1-8 is reported in Table 1 (see also 
Appendix Tables A1-A4).  
Under standard metabolic activation conditions (S9-mix 4% (v/v)) the CP-PAH 1-4 
all show a positive mutagenic response. Whereas 1 induces a specific mutagenic activity of 
27.5 His revertants/nmol and 3 and 4 induce a specific mutagenic activity of 23.2 and 14.7 
His revertants/nmol, 2 exhibits the highest response (98.4 His revertants/nmol, Table 1). 
Under these conditions none of the compounds were toxic; no decrease of His revertants 
was found in the whole concentration range. In comparison, the B[a]P induces 30.4 His 
revertants/nmol under similar conditions (Figure 2), which is in line with reported data [27]. 
In contrast to the behaviour of 1-4, the partially hydrogenated derivatives 5-8 do not show 
any positive mutagenic activity under these conditions (Table 1). 
0 5 10 15 20
0
500
1000
1500
2000
2500
3000
3500
4000  1
 2
 3
 4
H
is
 R
ev
er
ta
nt
s/
pl
at
e
µg/plate
0 5 10 15 20
0
50
100
150
200
250
300
350
400
 
 B[a]P
Hi
st
 re
ve
rt
an
ts
/p
la
te
µg/plate
Figure 2. Dose-response curves of cyclopenta[cd]- (1) (▼), dicyclopenta[cd,mn]- (2) (▲), 
dicyclopenta[cd,fg]- (3) (■), and dicyclopenta[cd,jk]pyrene (4) (●). Insert: dose-response curve for B[a]P. 
The standard protocol [25,26] was followed using the S. typhimurium strain TA98 with metabolic 
activation + S9-mix 4% (v/v). 
a Above 8 µg/plate of 2 the number of His revertant colonies markedly increased hampering their 
precise manual counting. No toxicity is observed. 
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Since it was established for cyclopenta[cd]pyrene (1) [3] and, later, confirmed for 
other CP-PAH [4,28] that maximal bacterial mutagenicity is exerted when less microsomal 
protein content in the S9-mix than the standard 4% (v/v) is used, we were prompted to 
study the effect of protein content on the mutagenic response of 2-4. Two additional 
concentrations (S9-mix 2% (v/v) and 10% (v/v)) of microsomal protein in the S9-mix were 
used.  
With S9-mix 2% (v/v) 2 exerts the highest mutagenic response (specific mutagenic 
activity of 163.3 His revertants/nmol), followed by 4 (82.0 His revertants/nmol), 1 (63.5 His 
revertants/nmol) and 3 (48.0 His revertants/nmol, Figure 3 and Table 1). With the exception 
of 1, a decrease in the number of His revertants after maximum mutagenic induction is 
observed. This is caused by cell toxicity. Nevertheless, the presence of less S9-fraction in the 
S9-mix clearly enhances the bacterial mutagenic activity of 1-4 compared with the 
experiment with 4% (v/v) S9-mix. 
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Figure 3. Dose-response curves of cyclopenta[cd]- (1) (▼), dicyclopenta[cd,mn]- (2) (▲), 
dicyclopenta[cd,fg]- (3) (■), and dicyclopenta[cd,jk]pyrene (4) (●). The standard protocol [25,26] was 
followed using the S. typhimurium strain TA98 with metabolic activation + S9-mix 2% (v/v). 
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With S9-mix 10% (v/v) the mutagenic response of 2 is greatly reduced (41.8 His 
revertants/ nmol) and exhibits toxicity at concentrations higher than 8 µg/plate (Figure 4). 
Whereas 1 shows a similar response (28.6 His revertants/nmol), in the case of 3 and 4 (38.5 
and 33.3 His revertants/nmol, respectively) a moderate increase of its mutagenic activity is 
found compared with the experiment with S9-mix 4% (v/v). Notwithstanding, all 
compounds are less active than when S9-mix 2% (v/v) is employed. Furthermore, whereas 1 
is not toxic in the whole concentration range, 3 and 4 show toxicity at concentrations higher 
than 12 µg/plate under these conditions (Figure 4). 
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Figure 4. Dose-response curves of cyclopenta[cd]- (1) (▼), dicyclopenta[cd,mn]- (2) (▲), 
dicyclopenta[cd,fg]- (3) (■), and dicyclopenta[cd,jk]pyrene (4) (●). The standard protocol [25,26] was 
followed using the S. typhimurium strain TA98 with metabolic activation + S9-mix 10% (v/v). 
 
 
In Figure 5, the dose-response curve for mutagenicity without any metabolic 
activation mixture (-S9-mix) is depicted. Whilst 1 is totally inactive, compound 4 is 
marginally mutagen (1.2 His revertants/nmol). Surprisingly, 2 shows weak activity (4.2 His 
revertants/nmol) and 3 a relatively high positive mutagenic response (11.7 His 
revertants/nmol, Table 1).  
 82
Dicyclopenta Pyrene Congeners 
 
 
0 5 10 15 20
0
200
400
600
800
1000  1
 2
 3
 4
H
is
 re
ve
rt
an
ts
/p
la
te
µg/plate
 
 
 
 
 
 
 
 
 
 
Figure 5. Dose-response curves of cyclopenta[cd]- (1) (▼), dicyclopenta[cd,mn]- (2) (▲), 
dicyclopenta[cd,fg]- (3) (■), and dicyclopenta[cd,jk]pyrene (4) (●). The standard protocol [25,26] was 
followed using the S. typhimurium strain TA98 without metabolic activation (-S9-mix); note the different 
scale for His revertants/plate (cf. Figures 2, 3 and 4). 
 
 
III.3. Discussion 
III.3.1. Ames assays 
CP-PAH 1-4 exhibit a metabolic activation dependent positive mutagenic response at all 
concentrations of microsomal protein (S9-fraction) in the exogenous activation mixture (S9-
mix). The results show that mutagenic activity of 2-4 like that of 1 [3] increases markedly 
with the low concentration of S9-fraction in the exogenous S9-mix, viz. S9-mix 2% (v/v) 
(Figure 6). This dependency of the mutagenic response on the amount of S9-fraction present 
in the S9-mix suggests that 1-4 possess similar metabolic activation mechanisms. The low S9-
fraction optimum for maximal mutagenic response is proposed to correlate with a one-step 
metabolic activation pathway, i.e. epoxidation of the five-membered ring olefinic bonds [4]. 
Other PAH, such as B[a]P, are known to be activated via vicinal dihydrodiol-epoxide forms 
at the ‘bay-region’, which is a multi-step activation mechanism. These ‘bay-region’ PAH 
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exert their maximal mutagenic response with a higher microsomal protein content in the S9-
mix [29]. The high activity of CP-PAH at low microsomal protein content (S9-fraction) in the 
S9-mix appears to be a general characteristic [3,4,27,28]. Apparently, at higher 
concentrations of S9-fraction detoxification processes become operative in the case of CP-
PAH, which will then reduce their mutagenic activity.  
 
 
Table 1. Specific mutagenic activitya expressed in His revertants/nmol, of cyclopenta[cd]- (1), 
dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3), and dicyclopenta[cd,jk]pyrene (4, Figure 1) and their 
partially hydrogenated derivatives 5-8 in S. typhimurium strain TA98 without (-S9-mix) and with 
metabolic activation system (+S9-mix) at three different concentration microsome protein levels: 2% 
(v/v) 0.29 mg/plate, 4% (v/v) 0.58 mg/plate and 10% (v/v) 1.45 mg/plate. 
 
Compound 
 
TA98 
- S9-mix 
TA98 
+ S9-mix 2% 
(v/v) 
TA98 
 + S9-mix 4% 
(v/v) 
TA98 
 + S9-mix 10% 
(v/v) 
1 ∼ 0.5 63.5 27.5 28.6 
2 4.2 163.3 98.4 41.8 
3 11.7 48.0 23.2 38.5 
4 1.2 82.0 14.7 33.3 
5 ∼ 0.1 - ∼ 0.3 - 
6 ∼ 0.1 - ∼ 0.2 - 
7 ∼ 0.4 - ∼ 0.3 - 
8 ∼ 0.1 - ∼ 0.2 - 
B[a]P ∼ 0.1 -b 30.4 -b 
 
a The His revertants/nmol values were calculated by least squares regression from the initial ascending 
linear portion of the dose response curve (Figures 2-6). The standard deviation (shown in Figures 2-5 as 
error bars) is include in the calculation of the slopes. The mean number of His revertants and standard 
deviation from each tested dose, as well as the correlation coefficients (r2) from the linear regression are 
shown in the Appendix (Tables A1-A4).  
b In another study in which S. typhimurium strain TA98 was used, the specific mutagenic activity of 
B[a]P was determined at different microsomal protein content in the S9-mix [31]. It was found to 
increase when more protein content in the S9-mix was used. 
 
 
The formation of the epoxides at the externally-fused cyclopenta ring is further 
corroborated by the absence of positive mutagenic response found for the partially 
hydrogenated CP-PAH derivatives 5-8 both in the absence and in the presence of standard 
S9-mix. Hence in the case of 1-4, the presence of cyclopenta-fused etheno moiety is 
mandatory to exert bacterial mutagenicity.  
Dicyclopenta Pyrene Congeners 
 
 
III.3.2. Epoxidation of olefinic bonds; AM1 calculations 
Since both semi-empirical AM1 [30] and ab initio [31-34] calculations as well as available 
single X-ray crystal structures [35,36] of CP-PAH show that the externally-fused five-
membered rings possess (localized) olefinic bonds, it is expected that these bonds will be 
most susceptible to undergo epoxidation by cytochrome P450 epoxidases present in the S9-
mix (Figure 7).  
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Figure 6. Dose-mutagenic response curves at different microsomal content of cyclopenta[cd]- (1, top 
left), dicyclopenta[cd,mn]- (2, top right), dicyclopenta[cd,fg]- (3, bottom left) and 
dicyclopenta[cd,jk]pyrene (4, bottom right, Figure 1). The standard protocol [25,26] was followed using 
the S. typhimurium strain TA98 without metabolic activation -S9-mix (×), with metabolic activation +S9-
mix 2% (v/v) (*), +S9-mix 4% (v/v) (♦), and +S9-mix 10% (v/v) (+). The error bars (standard deviation) 
are not shown. 
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Thus, the cis-di- (2b-4b) and trans-di-epoxide derivatives (2c-4c) are the proposed 
ultimate mutagenic species (Figure 7). After conversion of an epoxide functionality into a 
mono hydroxy-carbocation intermediate (2d-4d, vide infra) by epoxide ring opening, the 
carbocation may react with DNA (adduct formation) and subsequently cause mutagenicity 
[37]. To gain insight into the stabilities of 1-4 and their derivatives, i.e. the mono-epoxides 
(1a-4a), the cis-di- (2b-4b) and trans-di-epoxides (2c-4c), as well as the possible mono 
hydroxy-carbocations with a formal positive charge at C3 (1d-4d) or at C4 (1e-4e) (Figure 7), 
their heats of formation (∆Hfo in kcal/mol) were calculated using the semi-empirical AM1 
method (Table 2 and see Materials and methods) [30]. Since 2-4 and their corresponding 
derivatives are constitutional isomers, a comparison of ∆Hfo values of related species will 
directly reflect their relative stability. The results show that with the exception of the mono 
hydroxy-carbocations (2e-4e), which formally contain a positive charge at position C4, the 
stability order for all related compounds is 3 (3a-3d) > 4 (4a-4d) > 2 (2a-2d) (see Figure 7). 
The mono hydroxy-carbocations containing the formal positive charge at position C3 (1d-
4d) are found to be more stable than those with a formal positive charge at position C4 (1e-
4e). This is readily explained by the fact that 1d-4d represent analogues of a stabilized 
benzylic carbocation.  
To obtain an estimate of the propensity of 1-4 towards epoxidation of the olefinic 
bonds the energy differences (∆E in kcal/mol) between the mono-epoxides (1a-4a), the 
corresponding cis-di- (2b-4b) and trans-di-epoxides (2c-4c) and 1-4, respectively, were 
calculated (Table 2). For the mono-CP-epoxides 1a-4a the ∆E values are close to half the ∆E 
values computed for the related cis-di- (2b-4b) and the trans-di-epoxides (2c-4c). Note that 
2b-4b and 2c-4c, respectively, possess nearly identical ∆Hfo values (∆∆Hfo 0.1-0.4 kcal/mol, 
Figure 7 and Table 2). These results indicate that epoxidation of both olefinic bonds of 2-4 
will occur. The AM1 ∆E values for mono-epoxide (2a-4a) and cis-di- (2b-4b) and the trans-di-
epoxide (2c-4c) formation suggest that epoxidation occurs in the order 2 > 4 > 3. This order is 
also found for the mutagenic response of 2-4 with S9-mix 2% (v/v), i.e. the optimal 
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concentration of protein in the exogenous metabolic activation mixture for maximal 
mutagenic response (Table 1). 
 
 
 
Table 2. Semi-empirical AM1 energy differences (∆E in kcal/mol) of the corresponding mono-epoxides 
(1a-4a), the cis-di- (2b-4b) and trans-di-epoxides (2c-4c), and the two possible mono hydroxy-
carbocations (1d-4d and 1e-4e, see Figure 7).  
 
Compound 
∆E for mono- and di-
epoxidesa 
(kcal/mol) 
∆E for mono hydroxy-carbocations 
(kcal/mol) 
mono- cis-di- trans-di- 
Mono-
epoxideb 
cis-di- 
epoxidec, e 
trans-di-
epoxided,e  
   C3 C4 C3 C4 C3 C4 
1 -18.7 - - 131.5 137.9 - - - - 
2 -20.0 -39.5 -39.7 - - 132.7 140.7 132.8 140.7 
3 -19.0 -37.3 -37.7 - - 135.1 141.6 134.7 141.1 
4 -19.5 -38.6 -38.7 - - 134.9 139.8 134.9 139.8 
 
a Estimate for ∆E(epoxide formation) = ∆Hfo(mono-epoxide (1a-4a), cis-di (2b-4b) or trans-di-epoxides 
(2c-4c)) - ∆Hfo(1-4)). 
b Estimate for ∆E(mono hydroxy-carbocation formation) = ∆Hfo(mono hydroxy-carbocation (1d-1e)) - 
∆Hfo(1a).  
cEstimate for ∆E(mono hydroxy-carbocation formation) = ∆Hfo(mono hydroxy-carbocations (2d-4d or 
2e-4e) derived from the cis-di-epoxides (2b-4b)) - ∆Hfo(cis-di-epoxides (2b-4b) (Figure 7).  
d Estimate for ∆E(mono hydroxy-carbocation formation) = ∆Hfo(mono hydroxy-carbocation (2d-4d or 2e-
4e) derived from the trans-di-epoxides (2c-4c)) - ∆Hfo(trans-di-epoxides (2c-4c)) (Figure 7).  
e Note that the mono hydroxy-carbocations derived from 2b-4b and 2c-4c will possess a different 
stereochemistry.  
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trans-2c, ∆  118.7 (C2)
trans-3c, ∆  114.5 (Cs)
trans-4c, ∆Hfo 115.9 (Ci)
2d, ∆Hfo 251.5 (251.6a)
3d, ∆Hfo 249.2 (250.0a)
4d, ∆Hfo 250.8 (250.9a)
2e, ∆Hfo 259.4 (259.6a)
3e, ∆Hfo 255.6 (256.5a)
4e, ∆Hfo 255.7 (255.8a)
+
+
1d, ∆Hfo 222.2 1e, ∆Hfo 228.6
2, ∆Hfo 158.4 (C2v)
3, ∆Hfo 152.2 (C2v)
4, ∆Hfo 154.6 (C2h)
2a, ∆Hfo 138.4
3a, ∆Hfo 133.2
4a, ∆Hfo 135.1
cis-2b, ∆Hfo 118.9 (Cs)
cis-3b, ∆Hfo 114.9 (Cs)
cis-4b, ∆Hfo 116.0 (C2)
1, ∆Hfo 109.4 (Cs) 1a, ∆Hfo 90.7
 
Figure 7.  AM1 ∆Hfo (in kcal/mol) values for 1-4 and their related mono-epoxides 1a-4a, the cis-di- (2b-4b) and trans-di-epoxides (2c-4c), and the two 
possible mono hydroxy-carbocations with a formal positive charge at either C3 (1d-4d) or C4 (1e-4e).a Between parenthesis the molecular point group is 
reported. 
a Note that the mono hydroxy-carbocations (2d-4d and 2e-4e) derived from the cis-di- (2b-4b) and trans-di-epoxides (2c-4c), respectively, will possess a different 
stereochemistry. Here, 2d-4d and 2e-4e correspond to the mono hydroxy-carbocations obtained from the trans-di-epoxides 2c-4c. The ∆Hfo values between 
parentheses for 2d-4d and 2e-4e correspond to the mono hydroxy-carbocations derived from the cis-di-epoxides (2b-4b), of which the actual optimised AM1 
structures are not shown. 
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III.3.3. Direct mutagenicity of 2 and 3 
As shown in Figure 5, CP-PAH 2 and especially 3 are found to be direct mutagens (2: 130 
His revertants and 3: 400 His revertants/plate at 8 µg/plate, see Appendix); they exhibit 
mutagenic activity in the absence of exogenous metabolic activation mixture. In previous 
work, benz[k]aceanthrylene (B[k]AA) and benz[d]aceanthrylene (B[d]AA) were identified as 
direct-acting mutagens under similar conditions [38] and their positive activity was 
attributed to the facile (spontaneous) formation of their endo-peroxides. In addition, other 
aceanthrylene derivatives were found to possess direct acting mutagenicity in a bacterial 
forward mutation assay [7]. However, neither the benzaceanthrylenes nor the 
aceanthrylenes have been identified as constituents of the non-polar fraction of combustion 
exhausts [8]. Hence, 2 and in particular 3 represent the first two CP-PAH that were recently 
unequivocally identified in the non-polar fraction of combustion exhausts [11,12]. 
The S9-independent bacterial mutagenic activity in the polar fraction of combustion 
exhausts is primarily accounted for by the presence of nitro-PAH [39], which possess an 
extremely high mutagenic activity [40]. For instance, for 1-nitropyrene (1-NP) a direct-acting 
specific mutagenicity of 339 revertants/nmol (tester strain TA98) has been reported [41]. In 
the case of nitro-PAH active metabolites are supposedly obtained by two consecutive one-
electron reduction steps followed by the formation of nitroso derivatives that are 
subsequently further metabolised enzymatically [42]. Hence for nitro-PAH, their first 
reduction potential (E½(0/-1) in V vs. SCE), which is directly proportional to their electron 
affinity (E½(0/-1) ∝ EA), is frequently used as a criterion to explain and predict direct 
positive bacterial mutagenic response [43-46]. 
We have recently shown using both cyclic voltammetry and calculations that non-
alternant CP-PAH containing externally-fused five-membered rings possess a markedly 
enhanced electron affinity, i.e. less negative first electron reduction potentials (E½(0/-1) in V 
vs. SCE) [47-49]. CP-PAH 3 possesses the least negative first reduction potential E½(0/-1) of –
1.02 V (E½(0/-1 in V vs. SCE: 1 –1.56 V, 2 –1.32 V and 4 –1.15 V (Table 3)), which is exactly in 
the range found for some bioactive nitro-PAH exhibiting direct-acting mutagenic behaviour 
[43]. In contrast, the E½(0/-1) values of 2 and 4 represent borderline cases. Thus the 
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propensity of 2-4 to undergo one-electron reduction follows the order 3 > 4 > 2. A similar 
order is found for their second one-electron reduction potential (E½(-1/-2): 3 > 4 > 2) (Table 
3). We propose that the bioactivity of 2 and 3 in the absence of S9-mix is due to their 
propensity to undergo facile one-electron reduction processes. It remains to be established if 
the enzymes responsible for the activation of nitro-PAH [50] are involved in this case. 
Notwithstanding, the search for other CP-PAH in the non-polar fraction of combustion 
exhausts with E½(0/-1) in V vs. SCE values in the range of the nitro-PAH is a timely issue. 
 
 
Table 3. First reduction potential (E½(0/-1 in V vs. SCE) of 1-4 measured using cyclic voltammetry, 
their –εLUMO (AM1) energies and their AM1 EA (in eV) valuesa. 
 
Compound 
 
E1/2(0/-1) 
(V vs. SCE) 
E(-1/-2) 
(V vs. SCE) 
–εLUMOb 
(eV) 
EA  
(eV) 
1 -1.56 -2.22 -1.312 1.70 
2 -1.32 -2.06 -1.540 1.90 
3 -1.02 -1.54 -1.696 2.15 
4 -1.15 -1.63 -1.637 2.03 
 
a Electron affinity (EA) = - (∆Hfo(1.--4.-) - ∆Hfo(1-4)) in eV. For consistency both ∆Hfo(1-4) and ∆Hfo(1.--4.-) 
were calculated at the RHF/AM1 level of theory (∆Hfo(1) 109.4 kcal/mol, ∆Hfo(2) 158.4 kcal/mol, ∆Hfo(3) 
152.2 kcal/mol and ∆Hfo(4) 154.6 kcal/mol, and, ∆Hfo(1.-) 70.2 kcal/mol, ∆Hfo(2.-) 114.5 kcal/mol, ∆Hfo(3.-) 
102.6 kcal/mol and ∆Hfo(4.-) 107.7 kcal/mol, see Materials and methods).  
b RHF/AM1 LUMO energy (in eV) of closed-shell 1-4 following Koopmans theorem [51] (E½(0/-1) ∝ EA 
∝ –εLUMO). 
 
 
III.4. Conclusions 
The dicyclopentafused pyrenes 2-4 that have been identified as constituents of the non-polar 
fraction of combustion exhausts, exhibit a positive dependent on metabolism mutagenic 
response (TA98 +S9-mix). The marked dependency of mutagenic response on the 
concentration of the S9-mix and especially the maximum mutagenic activity at low 
microsomal protein content (S9-mix 2% v/v) indicates that the most plausible metabolic 
activation path for 2-4 is by an one-step epoxidation of the five-membered ring olefinic 
bonds. This is further corroborated by the lack of mutagenic activity of the partially 
hydrogenated derivatives 5-8 with and without S9-mix. The experimental results are 
Dicyclopenta Pyrene Congeners 
 91
supported by semi-empirical AM1 calculations. In line with the ∆Hfo stability order of 2-4 (3 
> 4 > 2) and the ∆E values for the mono-epoxide (2a-4a), and cis-di- (2b-4b) and trans-di-
epoxides (2c-4c), the mutagenicity of 2-4 with S9-mix 2% (v/v) follows the inverse order (2 > 
4 > 3), i.e. the less stable CP-PAH 2 appears to be the most reactive and bioactive. 
Interestingly, CP-PAH 3 and to a lesser extent 2, which were identified as 
constituents in the non-polar fraction of combustion exhausts, were found to possess direct 
mutagenicity in the absence of S9-mix. It is proposed that the direct bioactivity of 3 involves 
one-electron reduction processes similar to those put forward to explain the direct 
mutagenic activity of nitro-PAH.  
 
 
III.5. Materials and methods 
III.5.1. Instrumentation 
To gain insight in the reduction potentials of CP-PAH 1-4 cyclic voltammetry (CV) 
measurements were performed using a EG&G Potentiostat/Galvanostat Model 263 A and 
freshly distilled (from CaH2) acetonitrile (CH3CN, CAS n 75-05-8), containing 0.1 M 
tetrabutylammonium hexafluorophosphate (Bu4N+PF6-, CAS n 3109-63-5) as supporting 
electrolyte at scan rates of 50 and 100 mVs-1 (potential window –2.5 to +3 V). Redox 
potentials were determined relative to an Ag/AgNO3 reference electrode (0.1 M in CH3CN) 
and were referenced to the Standard Calomel Electrode (SCE) by measuring the oxidation 
potential of the redox couple FeCp2/FeCp2·+ (ferrocene/ferrocinium: 0.31 V vs. SCE). 
 
III.5.2. Chemicals 
Benzo[a]pyrene (B[a]P, 98.8%, CAS n 50-32-8) and 1-nitropyrene (1-NP, 99%, CAS n 5522-43-
0) were purchased from Sigma-Aldrich and used without further purification. 
Cyclopenta[cd]- (1, CAS n 27208-37-3), dicyclopenta[cd,mn]- (2, CAS n 96915-04-7), 
dicyclopenta[cd,fg]- (3, CAS n 173678-72-3) and dicyclopenta[cd,jk]pyrene (4, CAS n 98791-
43-6), were synthesized and purified as previously reported [9,10]. The related partially 
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hydrogenated derivatives 3,4-dihydrocyclopenta[cd]- (5, CAS n 25732-74-5), 1,2,4,5-
tetrahydrodicyclopenta[cd,mn]- (6, CAS n 173678-83-6), 5,6,7,8-
tetrahydrodicyclopenta[cd,fg]- (7, CAS n 173678-82-5) and 1,2,6,7-
tetrahydrodicyclopenta[cd,jk]pyrene (8, CAS n 98791-45-8), were prepared by catalytic 
hydrogenation (Pd/C 2 mg, P/H2 1 atm) of 1-4 (20 mg in 15 ml dry THF), respectively, as 
previously reported [9]. Capillary GC, HPLC, GC-MS and, 1H and 13C NMR showed that in 
all cases purity was at least > 98.9%. Caution: CP-PAH must be handled according to NIH 
guidelines for carcinogens. 
Dimethyl sulfoxide (DMSO 99.9%, CAS n 67-68-5) was purchased from Aldrich 
and NADP monosodium salt (98%, CAS n 1184-16-3) and D-glucose-6-phosphate anhydrous 
(G-6-P 99%, CAS n 56-73-5) from Sigma. 
 
III.5.3. Mutagenicity assays 
Mutagenic response was assessed using the Salmonella typhimurium histidine (His) 
auxotropic strain TA98 following the protocol outlined by Ames and Maron [25,26] either in 
the absence or in the presence of a metabolic activation system (S9-mix). The strain TA98 
allows the detection of frameshift mutagens, and has been extensively employed for 
screening of PAH as recommended in the protocol by Ames et.al. [25,26]. The use of a single 
strain is sufficient to demonstrate a mutagenic response [52]. 
The S9-mix consists of rat liver microsome preparations (S9-fraction) and the 
NADPH-generating co-factors (final concentrations: KCl 33 mM, MgCl2 8 mM, G-6-P 5 mM, 
NADP 4 mM and NaH2PO4 (pH 7.4) 100 mM). The S9-fraction was obtained from Aroclor-
1254 treated male rats (U:WU(CPB) Wistar), and the total protein content (29.15 mg/ml) was 
determined using the Lowry method [53]. The EROD method [54] was used to determine 
the activity of the cytochrome P450 isoenzyme P450-1A in the S9-fraction (51.58 
pmol/ml/min/mg protein). 
Compounds 1-8 were dissolved in DMSO (500 µg/ml) and tested at eight different 
concentrations ranging from 0.0 to 20 µg/plate in a constant volume of DMSO (100 µl/plate). 
Compound 2 was tested in the range from 0.0 to 8.0 µg/plate without S9-mix, and 0.0 to 12.0 
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µg/plate with S9-mix. Note that in the assay with S9-mix 4%(v/v) the His revertants could 
not be counted above 8.0 µg/plate (see Results section). All assays were performed in 
triplicate in the absence (-S9-mix) and in the presence of a metabolic activation mixture (S9-
mix) at three microsomal protein levels (S9-mix: 2% (v/v), i.e. 0.29 mg protein/plate, 4% (v/v), 
i.e. 0.58 mg protein/plate and 10% (v/v), i.e. 1.45 mg protein/plate) in at least two 
independent experiments. Spontaneous reversion revertants for TA98 were scored (-S9-mix: 
16 ± 2, +S9-mix: 31 ± 7), as well as positive controls, i. e. 1-NP, 5.0 µg/plate (-S9-mix >1000) 
and B[a]P, 1.0 µg/plate (for example, + S9-mix 4% (v/v) 158.5 ± 10). The positive controls are 
well-established mutagens in the TA98 strain, viz. 1-NP acts as a direct-acting mutagen [40] 
and B[a]P as a dependent on metabolism mutagen [27]. DMSO was used as negative control 
(-S9-mix 29 ± 7, +S9-mix 38 ± 9). The plates were incubated at 37 oC for 48 h and the revertant 
His colonies counted manually. Each dose was tested in triplicate in at least two 
independent experiments. The results obtained are presented in dose-response curves and 
are expressed as mean values of revertant His colonies per dose of test compound without 
correction for spontaneous reversion, and the standard deviation is expressed in error bars 
(see also Appendix Tables A1-A4).  
The following criteria taken from literature [55,56] were used to establish 
mutagenic response: i) three-fold increase in the number of revertants in treated plates as 
compared to the negative control, ii) ascending dose-response behaviour and iii) replication 
of results in at least two independent experiments. The three-fold increase criterion alone is 
considered to be not sufficient to conclude if a compound is mutagen or not [57]. 
The number of His revertants induced per nmol of test compound, i.e. specific 
mutagenic activity (Table 1), was also calculated by least squares regression from the initial 
ascending linear portion of the dose response curve (Figures 2-6). All actual data for each 
tested dose (mean value from six plates ± standard deviation) and the correlation 
coefficients are reported in the Appendix (Tables A1-A4).  
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III.5.4. Computations 
To obtain estimates of the heats of formation (∆Hfo in kcal/mol) of the compounds and 
intermediates shown in Figure 7 as well as the electron affinities (EA in eV, Table 3) of CP-
PAH 1-4, i.e. the conversion of 1-4 into their radical anions 1.--4.-, semi-empirical restricted 
Hartree-Fock (RHF) AM1 calculations (RHF/AM1) were performed using the MOPAC 7.0 
program until GNORM < 0.05 [30]. EA values are calculated according to EA = - (∆Hfo(1.--4.-) 
- (∆Hfo(1-4)) in which the ∆Hfo values represent the calculated heats of formation. The 
structures of the ground state (closed-shell) molecules 1-4 and their (open-shell) radical 
anions 1.--4.- were optimised without imposing any geometry constraints. For the open-shell 
radical anions the structures were initially optimised using the unrestricted Hartree-Fock 
AM1 method (UHF/AM1) followed by a final re-optimisation using RHF/AM1 and the half-
electron approach until GNORM < 0.05 [30]. All computed minima were characterized by 
Hessian calculations; in all cases no imaginary frequencies were found.  
Note that the cis-di-epoxide 4b and the trans-di-epoxide 2c and 3c belong to the C2 
point group and, thus, are formally chiral compounds.  
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III.7. Appendix 
 
Table A1.  Mutagenic activitya of cyclopenta[cd]pyrene (1, Figure 1) using the S. typhimurium strain 
TA98, without (-S9-mix) and with exogenous metabolic activation mixture (+S9-mix, 2% (v/v), i.e. 0.29 
mg protein/plate; standard 4% (v/v), i.e. 0.58 mg protein/plate; 10% (v/v), i.e. 1.46 mg protein/plate). The 
dose response curves are compared in Figure 6. 
 
Concentration 
µg/plate -S9-mix +S9-mix  2% (v/v) 
+S9-mix  
4% (v/v) 
+S9-mix  
10% (v/v) 
0.0 15.5 ±  6.5 19 ±   7.2 22 ±   5.5 23 ±   5.3 
0.5 14 ±  2 64 ±  11.5 57.2 ±  10.1 51.3 ±  21.8 
1.0 18 ±   0.8 180.5 ±   6.5 116 ±  31.6 126 ±  69.9 
2.0 20.5 ±  0.5 616.5 ±  10.2 197.7 ±  60.1 455 ± 363.5 
4.0 50.5 ±  7.5 1113 ±  80 609.2 ± 269.2 819 ±  583.9 
8.0 48 ± 17 2247 ± 450 1356.8 ± 161.8 860 ± 262.7 
12.0 31 ±  6 2250 ±  90 1998.7 ± 307.1 1504 ± 153.9 
20.0 71 ± 31.8 2380 ± 220 2364 ± 228 2720 ± 220 
His 
revertants/nmol 
(r2) 
0.5 (0.55) 63.5 (0.90) 27.5 (0.94) 28.6 (0.98) 
 
a Mutagenic response was determined as described in Materials and methods section [25,26]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background. 
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Table A2. Mutagenic activitya of dicyclopenta[cd,mn]pyrene (2, Figure 1) using the S. typhimurium strain 
TA98, without (-S9-mix) and with exogenous metabolic activation mixture (+S9-mix, 2% (v/v), i.e. 0.29 
mg protein/plate; standard 4% (v/v), i.e. 0.58 mg protein/plate; 10% (v/v), i.e. 1.46 mg protein/plate). The 
dose response curves are compared in Figure 6. 
 
Concentration 
µg/plate -S9-mix +S9-mix  2% (v/v) 
+S9-mix  
4% (v/v) 
+S9-mix  
10% (v/v) 
0.0 15.5 ±  1.6 19 ±   6.5 22 ±   3.6 23 ±   5.3 
0.25 17 ±   3.3 -b -b 59.5 ±   2 58.3 ±   8.4 
0.5 19.7 ±  6.1 233 ±  30.1 184.5 ±   1.5 -b -b 
1.0 38.3 ±   7.8 657 ± 178.8 415 ±  65.1 140 ±  32.2 
2.0 101 ±  6 1180 ± 120 745.2 ± 107.4 279.5 ±  61.4 
4.0 82 ±  1.9 2616 ± 403.9 2510 ± 137.5 760 ±  95.5 
8.0 129 ± 19.6 2340 ± 224.9 3258 ± 698.0 1970 ± 270 
12.0 -b -b 1799 ± 576 -c -c 1191 ± 283 
His 
revertants/nmol (r2) 4.2 (0.91) 163.3 (0.99) 98.4 (0.92) 41.8 (0.93) 
 
a Mutagenic response was determined as described in Materials and methods section [25,26]. Results 
shown are mean values ±  standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background. 
b Dose not tested.  
c At 12 µg/plate of 2 the number of His revertant colonies markedly increased hampering their precise 
manual counting. No toxicity is observed. 
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Table A3. Mutagenic activitya of dicyclopenta[cd,fg]pyrene (3, Figure 1) using the S. typhimurium strain 
TA98, without (-S9-mix) and with exogenous metabolic activation mixture (+S9-mix, 2% (v/v), i.e. 0.29 
mg protein/plate; standard 4% (v/v), i.e. 0.58 mg protein/plate; 10% (v/v), i.e. 1.46 mg protein/plate). The 
dose response curves are compared in Figure 6. 
 
Concentration 
µg/plate -S9-mix +S9-mix  2% (v/v) 
+S9-mix  
4% (v/v) 
+S9-mix  
10% (v/v) 
0.0 15.5 ±   0.5 19 ±   6.5 22 ±  11.2 23 ±   6.4 
0.5 42.3 ±   3.9 91 ±  41.2 55 ±   4.1 74 ±  28.4 
1.0 80 ±   13 213 ± 132.1 119.8 ±  21.6 135 ±  58.8 
2.0 130.6 ±  30.2 399 ± 157.9 162.5 ±  18.9 238 ±  65.6 
4.0 227.6 ±  27.5 823 ± 316.8 366 ±  52.6 442 ± 226.6 
8.0 399.8 ±  64.8 1585 ± 207.1 798.8 ± 158.6 1053 ± 654.8 
12.0 636.2 ± 166 1695 ± 213.7 1292.8 ± 105.3 1925 ± 173.4 
20.0 864 ±  62.9 652 ±  80 1854 ± 175.9 1280 ± 180 
His  
revertants/nmol 
(r2) 
11.7 (0.98) 48.0 (0.99) 23.2 (0.98) 38.5 (0.98) 
 
a Mutagenic response was determined as described in Materials and methods section [25,26]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background. 
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Table A4.  Mutagenic activitya of dicyclopenta[cd,jk]pyrene (4, Figure 1) using the Salmonella 
typhimurium strain TA98, without (-S9-mix) and with exogenous metabolic activation mixture (+S9-mix, 
2% (v/v), i.e. 0.29 mg protein/plate; standard 4% (v/v), i.e. 0.58 mg protein/plate; 10% (v/v), i.e. 1.46 mg 
protein/plate). The dose response curves are compared in Figure 6. 
 
Concentration 
µg/plate -S9-mix +S9-mix  2% (v/v) 
+S9-mix  
4% (v/v) 
+S9-mix  
10% (v/v) 
0.0 15.5 ±  10.6 19 ±   6.5 22 ±   9.6 23 ±   5.3 
0.5 19.7 ±   0.5 217.5 ± 152.5 39.5 ±   5.6 94.5 ±  35.6 
1.0 30.1 ±   8.9 621.3 ± 372.1 63.6 ±  10.7 162.5 ±  52.9 
2.0 41.8 ±  13.6 1261.3 ± 587.5 125.5 ±  46.5 375.8 ± 201.2 
4.0 40.9 ±  10.1 1730 ± 400.1 218.1 ±  43.7 1034 ± 538.9 
8.0 64.4 ±   9.1 2325 ± 398.8 615.5 ± 204.6 -b -b 
12.0 74.9 ±   18.6 2128 ± 386.4 1341 ± 364.2 1353 ± 465.9 
20.0 95.1 ±   18.8 1870 ± 110 2529 ± 654.7 1200 ± 160 
His 
revertants/nmol 
(r2) 
1.2 (0.93) 82.0 (0.95) 14.7 (0.84) 33.3 (0.95) 
 
a Mutagenic response was determined as described in Materials and methods section [25,26]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background.  
b Dose not tested. 
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Abstract 
To rationalize the high bacterial mutagenic response determined for the cyclopenta-fused 
pyrene congeners, viz. cyclopenta[cd]- (1) dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3) 
and dicyclopenta[cd,jk]pyrene (4) in the presence of a metabolic activation mixture (+S9-
mix), their (di-)epoxides at the externally-fused unsaturated five-membered rings were 
previously proposed as the ultimate mutagenic active forms. In the present study, 
cyclopenta[cd]pyrene-3,4-epoxide (5) and the novel dicyclopenta[cd,mn]pyrene-1,2,4,5-di-
epoxide (6), dicyclopenta[cd,fg]pyrene-5,6,7,8-di-epoxide (7) and dicyclopenta[cd,jk]pyrene-
1,2,6,7-di-epoxide (8) are synthesised and subsequently assayed for bacterial mutagenicity in 
the standard microsomal/Histidine reverse assay (Ames-assay, Salmonella typhimurium strain 
TA98). Note that the di-epoxides are obtained as a mixture of presumably their cis- and 
trans- stereoisomers (1H NMR). The direct-acting mutagenic activity and the strong 
cytotoxicity exerted by 5-8 demonstrate that the ultimate mutagenic active forms are the 
proposed (di-)epoxides of 1-4.  
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IV.1 Introduction 
Cyclopenta-fused polycyclic aromatic hydrocarbons (CP-PAH) represent a sub-class of PAH 
and contain at least one externally-fused unsaturated five-membered ring. CP-PAH are 
ubiquitous compounds in our environment, which are formed during incomplete 
combustion of organic matter, viz. the main energy resource in our society [1,2]. CP-PAH 
generally draw attention due to their anomalous physico-chemical properties [3-6], and 
especially in this context their enhanced genotoxic behaviour, i.e. CP-PAH are bacterial and 
cell mutagens, tumourigens and (co-)carcinogens in contrast to their parent PAH [7-12]. 
Therefore, CP-PAH are important contributors to the mutagenicity and 
tumourigenicity associated with combustion exhausts; they pose potential health hazard to 
humans [13,14]. One of the best-studied CP-PAH is cyclopenta[cd]pyrene (1, Figure 1). It has 
been put forward as the main contributor to the total bacterial mutagenic response found for 
the non-polar fraction of combustion exhausts [15]. Furthermore, 1 has also been proposed as 
the primary contributor to the total mutagenicity in airborne particulate matter [16]. 
Notwithstanding, the available amount of 1 cannot generally account for the total mutagenic 
activity encountered. Hence, other still unidentified but biologically active CP-PAH must be 
present. Potential candidates are the three isomeric dicyclopenta-fused pyrene congeners, 
i.e. dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3) and dicyclopenta[cd,jk]pyrene (4, Figure 
1), which were recently synthesized [4,17]. Their availability subsequently enabled their 
unequivocal identification as constituents of the non-polar fraction of combustion exhausts 
[18,19]. Compounds 2-4 have been also suggested more recently as undesired products that 
are formed during the thermal removal of pyrene from contaminated in soils [20]. 
We recently reported the bacterial mutagenic response of 2-4 in the 
microsome/Histidine reversion bacterial mutagenicity assay (Salmonella typhimurium strain 
TA98) [21] according to the standard protocol by Ames et. al. [22,23]. It was found that the 
number and the topology of the cyclopenta moieties along the pyrene perimeter markedly 
affect the mutagenic response of 2-4. Interestingly, 2-4 exert a high dependent on 
metabolism mutagenic activity (+S9-mix). Moreover, unexpectedly 3 and to a lesser extent 2, 
also induced direct-acting mutagenicity (-S9-mix). The importance of the olefinic bonds in 
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the five-membered rings for bioactivation, presumably via di-epoxide formation, was 
determined by assessing the mutagenic response of the corresponding dihydro derivatives 
of 2-4 in which the five-membered rings contain a saturated carbon-carbon bond instead of 
an olefinic carbon-carbon bond. These partially saturated CP-PAH were found to be non-
mutagenic both in the absence or the presence of exogenous metabolic activation mixture 
(±S9-mix) [21]. A typical feature of CP-PAH is the low protein content requirement in the 
exogenous metabolic activation mixture (S9-mix) to exert maximal mutagenic response, 
which is indicative of a one-step metabolic activation pathway [7,8,24], viz. consecutive one-
step epoxidation of the five-membered ring olefinic bonds. This was also observed for 2-4. 
The results suggested that the ultimate mutagenic active forms in the presence of S9-mix are 
the di-epoxides 6-8 (Figure 1). These experimental findings were further substantiated by 
semi-empirical AM1 calculations of the heats of formation of the mono-, cis-di- and trans-di-
epoxides. The calculations revealed that the ease for di-epoxidation of 2-4 followed the 
order in mutagenic potency of 2-4, (2 > 4 > 3), when the optimal microsomal protein 
concentration for maximal mutagenic response was used (S9-mix 2% (v/v)).  
Here we report the synthesis and bacterial mutagenic response (standard protocol 
by Ames et. al., S. typhimurium strain TA98 ±S9-mix 2% (v/v), i.e. 0.29 mg protein/plate) of 
the previously proposed ultimate mutagenic active forms of 2-4, i.e. the di-epoxides 
dicyclopenta[cd,mn]pyrene-1,2,4,5-di-epoxide (6), dicyclopenta[cd,fg]pyrene-5,6,7,8-di-
epoxide (7) and dicyclopenta[cd,jk]pyrene-1,2,6,7-di-epoxide (8). Mono-CP-PAH 1 and its 
corresponding epoxide 5 are also assayed for comparison. The results provide strong 
evidence that the di-epoxides 6, 7 and 8 represent the ultimate mutagenic active forms of 2, 3 
and 4, respectively. 
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Figure 1.  (Di-)cyclopenta-fused pyrene congeners 1-4 and their corresponding (di-)epoxides at the 
cyclopenta moieties 5-8 assayed for mutagenicity following the standard protocol by Ames et. al. (S. 
typhimurium TA98 ±S9-mix) [22,23]. Note that the di-epoxides 6-8 are presumably present as two 
distinct stereoisomer, i.e. the isomeric cis- and trans- di-epoxides; here only the trans-stereoisomers of 6-
8 are shown. The molecular point group for each compound obtained after geometry optimization 
using the semi-empirical AM1 method [25] is shown between parentheses (see also Chapter III, Figure 
7). 
 
 
IV.2.  Results  
Cyclopenta[cd]pyrene-3,4-epoxide (5), dicyclopenta[cd,mn]pyrene-1,2,4,5-di-epoxide (6), 
dicyclopenta[cd,fg]pyrene-5,6,7,8-di-epoxide (7) and dicyclopenta[cd,jk]pyrene-1,2,6,7-di-
epoxide (8) were synthesized from their corresponding CP-PAH 1-4 (Figure 1) by treatment 
with a freshly prepared solution of dimethyldioxirane in acetone as a mild epoxidation 
agent [26] (cf. Materials and methods section: Synthesis). It is noteworthy that 1H NMR 
analysis of the reaction mixture revealed that di-epoxide formation from 2-4 occurs in two 
consecutive steps. 1H NMR also showed that upon conversion of 2-4 into the corresponding 
di-epoxides 6-8, in all cases the two stereoisomers of the di-epoxides are obtained in a close 
to 1:1 ratio. Taking into account the epoxidation mechanism, the two steroisomers 
presumably represent the cis- and trans- di-epoxides of 6, 7 and 8, respectively. 
Unfortunately, all attempts to separate both stereoisomers were hitherto unsuccessful. As a 
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consequence the stereoisomer mixture of the di-epoxides 6-8 were used in the bacterial 
mutagenicity assays. 
The bacterial mutagenic response of 5-8 was determined in the S. typhimurium 
strain TA98 Histidine (His) reverse assay both in the absence (-S9-mix) and in the presence 
of the optimal concentration S9-fraction in the S9-mix for maximal mutagenic response, i.e. 
2% (v/v) 0.29 mg protein/plate. In Figures 2-5 the dose-response curves are shown for the 
direct-acting (-S9-mix) and metabolic activation dependent mutagenicity (+S9-mix) for the 
(di-)epoxides 5-8. The results are compared with those previously found for CP-PAH 1-4 in 
the same dose range (0.0-2.0 µg/plate) and under similar conditions [21]. The specific 
mutagenic activity of 1-8, viz. the number of His revertants/nmol of test compound, is 
reported in Table 1. Note that the bacterial mutagenic response of the CP-PAH 1-4 and their 
(di-)epoxides 5-8 was assayed using the same S. typhimurium T98 frozen permanent and the 
same microsomal protein fraction (S9) for the exogeneous metabolic activation mixture. 
The determination of the mutagenic activity of the (di-)epoxides 5-8 in the 
concentration range employed for their parent CP-PAH 1-4 (0.0-20.0 µg/plate [21]) is 
hampered by the high toxicity observed for the (di-)epoxides as indicated by a lack of the 
background lawn in the plates [23] at concentrations higher than 2.0 µg/plate with and 
without S9-mix (data not shown). Compounds 5-8 are assayed with S9-mix 2% (v/v) (0.29 
mg protein/plate) determined as optimal for maximal response in a previous study for the 
parent CP-PAH 1-4 [21]. It has been established for several CP-PAH that their mutagenic 
response is markedly dependent on the protein concentration in the S9-mix, and that the 
highest mutagenicity is expressed at low concentrations [7,8,24]. It is noteworthy that (di-) 
epoxides 5, 7 and 8 exhibit a positive mutagenic response both with and without exogenous 
metabolic activation mixture (±S9-mix); they act as direct-acting mutagens. In the case of di-
epoxide 6, a high toxicity (±S9-mix) is already found in the low concentration range (vide 
infra). Hence, its mutagenic potency could not be determined. Interestingly, the mutagenic 
activity of the (di-)epoxide derivatives 5, 7 and 8 does not increase with the addition of S9-
mix. 
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CP-PAH 1 is a documented metabolic-dependent potent mutagen (specific 
mutagenic activity of 63.5 His revertants/nmol, Table 1 and Figure 2) and this behaviour is 
re-confirmed in the present study [7]. Its corresponding epoxide 5 exhibits a direct-acting 
specific mutagenic activity of 61.0 His revertants/nmol (Table 1, Figure 2), which accounts 
for the metabolic-dependent mutagenic response of 1. In the presence of S9-mix, epoxide 5 
exerts a similar mutagenic response (specific mutagenic activity 61.8 His revertants/nmol). 
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Figure 2. Dose-response curve of cyclopenta[cd]pyrene (1) (■: +S9-mix 2% (v/v), □: -S9-mix) [21] and its 
corresponding cyclopenta[cd]pyrene-3,4-epoxide (5, Figure 1) ▲: +S9-mix 2% (v/v), △: -S9-mix). The 
standard protocol outlined by Ames et. al. was followed using the S. typhimurium strain TA98 [22,23]. 
 
 
In Figure 3, the dose-response curves of compound 2 are compared to the response 
curves exerted by its di-epoxide derivative 6 (±S9-mix). Note that although the dose-range 
tested is up to 2.0 µg/plate, even in this low concentration region 6 exhibits a high toxicity; 
i.e. lack of background lawn is observed. Hence this hinders the assignment of its mutagenic 
potency. 
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Figure 3. Dose-response curve of dicyclopenta[cd,mn]pyrene (2) (■: +S9-mix 2% (v/v), □: -S9-mix) [21] 
and its corresponding dicyclopenta[cd,mn]pyrene-1,2,4,5-di-epoxide (6, Figure 1) ▲: +S9-mix 2% (v/v), 
△: -S9-mix). The standard protocol outlined by Ames et. al. [22,23] was followed using the S. 
typhimurium strain TA98. 
 
 
In Figure 4, the dose-response curves for compound 3 and its corresponding di-
epoxide 7 are reported. CP-PAH 3 exhibits a high specific mutagenic activity with S9-mix, 
48.0 His revertants/nmol, and it is a direct-acting mutagen, 11.7 His revertants/nmol (Table 
1). Its corresponding di-epoxide 7 exhibits a high direct-acting specific mutagenic response; 
without S9-mix the activity is almost ten-fold higher than for the parent CP-PAH 3 under 
the same conditions (101.1 His revertants/nmol, Table 1). In the presence of S9-mix, 7 also 
exhibits a high specific mutagenic activity (93.3 His revertants/nmol).  
The dose-response curves for the di-epoxide 8 and its parent CP-PAH 4 are shown 
in Figure 5. In the presence of S9-mix, 4 is more mutagenic active than 8 (82.0 and 16.3 His 
revertants/nmol, respectively, Table 1). Without S9-mix, 8 exhibits a high mutagenic 
response in contrast to its parent 4 (-S9-mix, 23.9 His revertants/nmol). 
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Figure 4. Dose-response curve of dicyclopenta[cd,fg]pyrene (3) (■: +S9-mix 2% (v/v), □: -S9-mix) [21] 
and its corresponding dicyclopenta[cd,fg]pyrene-5,6,7,8-di-epoxide (7, Figure 1) (▲: +S9-mix 2% (v/v), 
△: -S9-mix). The standard protocol outlined by Ames et. al. [22,23] was followed using the S. 
typhimurium strain TA98. 
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Figure 5 Dose-response curve of dicyclopenta[cd,jk]pyrene (4) (■: +S9-mix 2% (v/v), □: -S9-mix) [21] 
and its corresponding dicyclopenta[cd,jk]pyrene-1,2,6,7-di-epoxide (8, Figure 1) (▲: +S9-mix 2% (v/v), 
△: -S9-mix). The standard protocol outlined by Ames et. al. [22,23] was followed using the S. 
typhimurium strain TA98. 
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Table 1. Specific mutagenic activitiesa (His revertants/nmol) and mutagenic potencyb of 1-4 [21] and 5-
8. 
 
 
TA98 +S9-mix 2% (v/v) TA98 -S9-mix 
Compound 
His 
revertants/nmol 
Mutagenic 
Potencyb 
His 
revertants/nmol 
Mutagenic 
potencyb 
 1c 63.5  +++ ~0.5  - 
5 61.8  +++ 61.0  +++ 
 2c 163.3  +++ 4.2  + 
6     *,d  *,d *,d  *,d 
 3c 48.0  +++ 11.7  ++ 
7 93.3  +++ 101.1  +++ 
 4c 82.0  +++ 1.2  - 
8 16.3  +++ 23.9  +++ 
 
a Calculated by least squares regression from the initial ascending linear portion of the dose-response 
curves (Figures 2-5).  
b Mutagenic potency: - negative, + weakly positive, ++ positive and +++ highly positive.  
c For 1-4, the dose range 0-20 µg/plate was used [21]. Note that the bacterial mutagenic response of the 
CP-PAH 1-4 and their (di-)epoxides 5-8 was assayed using the same S. typhimurium T98 frozen 
permanent and the same microsomal protein fraction (S9) for the exogeneous metabolic activation 
mixture (see also Chapter III and main text)  
dCould not be determined due to high toxicity, i.e. a lack of background lawn was observed. 
 
 
 
IV.3.  Discussion 
The use of acetone solutions of dimethyldioxirane as epoxidation system has been 
frequently employed in literature for obtaining epoxides of (CP-)PAH in quantitative 
amount, see for example [26]. In the present study, this method gives access to the novel di-
epoxides 6-8. In all cases the di-epoxides are present as a mixture of presumably their cis- 
and trans- stereoisomers. Unfortunately, the separation of these stereoisomers was hitherto 
unsuccessful due to the sensitive character of the di-epoxides. Their detailed chemical 
characterization and preferably the isolation of the distinct stereoisomers is of importance 
for future enzymatic metabolic studies in the formation of ultimate active forms of the series 
of dicyclopenta-fused pyrene congeners 2-4 which were shown to be very biologically active 
(TA98 ±S9-mix) [21]. 
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The (di-)cyclopenta-fused epoxides 5, 7 and 8 are shown to be direct-acting 
mutagens (TA98 ±S9-mix). Hence, their role as ultimate mutagenic active forms of their 
parent compounds 1, 3 and 4, respectively, is confirmed. Di-epoxide 6 derived from 2, 
which was previously found to possess the highest activity of the dicyclopenta-fused pyrene 
series tested (163.5 His revertants/nmol, Table 1), is too toxic under the present experimental 
conditions to determine its mutagenic response. A lack in the background lawn is observed, 
and thus a small number of (revertant) colonies are scored. Thus, since the corresponding 
partially hydrogenated derivative of 2 at the cyclopenta moieties is non-mutagenic with and 
without metabolic activation mixture [21], it is tentative to conclude that epoxide 6 is the 
mutagenic active form of CP-PAH 2. Notwithstanding the mutagenic potency of 6 cannot be 
evaluated under the present conditions due to its high cytotoxicity.   
Compound 7 exhibits a direct-acting specific mutagenic activity of 101.1 His 
revertants/nmol, and represents the most active compound of the epoxides tested in the 
present investigation. The specific mutagenic activity of 7 is more than twice that of its 
parent CP-PAH 3 in the presence of S9-mix (48.0 His revertants/nmol, Table 1). This 
suggests that the formation of the di-epoxide from 3 by the cytochrome P450 is at some 
point limited. Note that compound 3 itself is a direct-acting mutagen (-S9-mix, specific 
mutagenic activity of 11.7 His revertants/nmol) [21]. Hence, 3 represents the first identified 
contributor to the direct-acting mutagenic activity found in the non-polar fraction of 
combustion mixtures [21].  
The metabolic-dependent mutagenic activity of 4 is partially confirmed to occur via 
its di-epoxide 8, since the latter exhibits an independent metabolic specific mutagenic 
activity of 23.9 His revertants/nmol. Probably other metabolic activation paths than the 
epoxidation of the cyclopenta moieties are operative since the parent CP-PAH 4 exerts a 
dependent on metabolism mutagenicity of 82.0 His revertants/nmol. Its corresponding di-
epoxide 8 in the presence of S9-mix exhibits a specific mutagenic activity of only 16.3 His 
revertants/nmol. Since the mutagenic activity for 7 and 8 decreases in the presence of S9-
mix, detoxification processes by the epoxide hydrolase present in the S9-mix are presumably 
operational. 
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The direct-acting mutagenic potency (-S9-mix) of the di-epoxides 6-8 (Table 1) 
follows the order 7 > 8 and 6 being highly toxic, which does not correspond to that 
previously found for their parent CP-PAH 2-4 in the presence of S9-mix 2% (v/v) (2 > 4 > 3 
[21]). Moreover, in this previous study semi-empirical AM1 calculations of the heats of 
formation of the cis- and trans- di-epoxides 6-8 explained the mutagenic potency order 
observed experimentally [21]. The formation of the di-epoxides may not be the major factor 
controlling the mutagenic response dependent on metabolic activation. Other factors can 
contribute, such as the shape of the compounds, i.e. the presence of two distinct cyclopenta-
fused rings in the case of 2-4 as well as the two distinct di-epoxide stereoisomers of 6-8, 
which have to interact with the enzymes present in the S9-mix in order to be metabolized  
 
 
IV.4.  Conclusions 
The synthesis of the novel di-epoxides at the unsaturated cyclopenta ring of 2-4 has been 
achieved and their mutagenic activity determined in the microsomal/His reversion bacterial 
mutagenicity test (standard protocol by Ames et. al., S. typhimurium strain TA98 ±S9-mix). 
All di-epoxides 6-8 act as direct-acting mutagens and impose cytotoxicity. The results 
clearly suggest that the proposed di-epoxides at the externally-fused cyclopenta moiety 6-8 
are the (primary) ultimate mutagenic active forms of the ubiquitous in combustion exhausts 
2-4. Moreover, the data once more demonstrate the effect of the topology of the cyclopenta 
moieties along the PAH perimeter with respect to the bacterial mutagenic activity of 2-4 and 
6-8. It remains to be addressed to what extent the distinct di-epoxide stereoisomers of 6-8 
will exhibit a different mutagenic response. To this end, separation of these steroisomers is a 
prerequisite. Further experiments are in progress. 
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IV.5.  Materials and methods 
IV.5.1.  Test compounds and chemicals 
The (di-)epoxides at the externally-fused five-membered ring(s) cyclopenta[cd]pyrene-3,4-
epoxide (5, CAS n 73473-54-8), dicyclopenta[cd,mn]pyrene-1,2,4,5-di-epoxide (6), 
dicyclopenta[cd,fg]pyrene-5,6,7,8-di-epoxide (7) and dicyclopenta[cd,jk]pyrene-1,2,6,7-di-
epoxide (8) were synthesized and characterized as described in the Synthesis section.  
Benzo[a]pyrene (B[a]P, 98.8%, CAS n 50-32-8) and 1-nitropyrene (1-NP, 99%, CAS n 
5522-43-0) were purchased from Sigma-Aldrich and used without further purification. 
Dimethyl sulfoxide (DMSO, 99.9%, CAS n 67-68-5) was purchased from Aldrich and NADP 
monosodium salt (98%, CAS n 1184-16-3), D-glucose-6-phosphate anhydrous (G-6-P, 99%, 
CAS n 56-73-5) and potassium monopersulphate triple salt (caroate, CAS n 37222-66-5) were 
purchased from Sigma. Caution: CP-PAH and their derivatives must be handled with care 
and according to NIH guidelines for carcinogens. 
 
IV.5.2.  Mutagenicity assays 
Mutagenic response was assessed using the Salmonella typhimurium histidine (His) reverse 
strain TA98 following the protocol by Ames and Maron [22,23]. The tester strain TA98 has 
been extensively used in literature for assaying the mutagenic activity of PAH. It has been 
established that the single use of one tester strain is sufficient to determine positive response 
[27]. The assays were carried out either in the absence or in the presence of an exogenous 
metabolic activation system (±S9-mix). The S9-mix consists of rat liver microsome 
preparations (S9-fraction) obtained from Aroclor-1254 treated male Wistar rats and the 
NADPH-generating co-factors. The total protein content and the activity of the cytochrome 
P450 isoenzyme P450-1A in the S9-fraction were determined as 29.15 mg/ml (Lowry 
method) [28] and 51.58 pmol/ml/min/mg protein (EROD method) [29], respectively. 
The (di-)epoxides derivatives 5-8 were freshly dissolved in p.a. DMSO (500 µg/ml) 
just before each assay and diluted as necessary for testing five different concentrations (0.0, 
0.1, 0.5. 1.5 and 2.0 µg/plate, see Results section). In all experiments triplicate plates were 
employed in the absence (-S9-mix) and in the presence of a metabolic activation mixture 
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(+S9-mix, 2% (v/v) 0.29 mg protein/plate) in at least two independent experiments. Well-
established mutagens for strain TA98 were used as positive controls, i.e. direct-acting 
mutagen 1-NP, 5.0 µg/plate (-S9-mix > 1000) [30] and dependent on metabolic activation 
B[a]P, 6.0 µg/plate (+S9-mix 133.9 ± 20.5) [24]. Negative controls with only DMSO (-S9-mix 
10.2 ± 4.7, +S9-mix 19.8 ± 6.5) and spontaneous His reversion revertants (-S9-mix 13.3 ± 4.7, 
+S9-mix 21.6 ± 6) for TA98 were included in each experiment. After incubation at 37 oC for 
48 h, the His revertant colonies were counted manually. The results obtained are presented 
in dose-response curves of the mean values of revertant His colonies per dose of test 
compound of three different plates from two independent experiments; the spontaneous 
reversion is not subtracted. The standard deviation from each dose tested is shown as error 
bars in the dose-response curves (Figures 2-5). The specific mutagenic activities, i.e. number 
of His revertants induced per nmol of test compound (Table 1) are also calculated by least 
squares regression from the initial ascending portion of the dose-response curves (Figures 2-
5). See the Appendix (Table A1) for actual data (mean His revertants ± standard deviation) 
and correlation coefficients (r2) derivated from the calculation of the specific mutagenic 
activity. The following criteria [31,32] are considered to establish a positive mutagenic 
response: i) three-fold increase in the number of His revertants in plates with test compound 
as compared to the negative control (DMSO), ii) ascending dose-response behaviour and iii) 
replication of results in at least two independent experiments. Note that the generally 
employed criterion of three-fold rule is not sufficient to establish positive response, since the 
negative controls differ from each test strain [33]. Furthermore, it should be noted that the 
bacterial mutagenic response of the CP-PAH 1-4 and their (di-)epoxides 5-8 was assayed 
using the same S. typhimurium T98 frozen permanent and the same microsomal protein 
fraction (S9) for the exogeneous metabolic activation mixture. 
 
IV.5.3.  Synthesis 
Solvents were dried and purified using standard protocols. Commercial reagents were used 
as received. (Flash) Column chromatography was performed either on Merk kieselgel 60 
silica (230-400 ASTM) or neutral aluminium oxide W200. Thin layer chromatography (TLC) 
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was carried out using TLC aluminium sheets (aluminium oxide 60 F254 neutral (type E) and 
TLC silica gel 60 F254). 1H NMR spectra were recorded on a Bruker AC 300 or a Varian Unity 
Inova Spectrometer operating at 300.13 MHz at 25 oC (solvents d6-acetone or CDCl3). 
Chemical shifts values are reported in ppm and are referenced to TMS. J values are given in 
Hz. For the 1H NMR spectrum multiplicity is denoted as follows: s = singlet, d = doublet, t = 
triplet, dd = double doublet and m = multiplet. To distinguish the coupling patterns of the 
two distinct cis- and trans- stereoisomers of the diepoxides of 2-4, a Gaussian enhancement 
was performed with LB = -1 and GB = 50%. GC-MS analysis of 6-8 was thwartened due to 
decomposition of 6-8 in de GC injector.  
Caution: CP-PAH and their corresponding (di-)epoxides must be handled 
according to NIH guidelines for carcinogens due to their potential genotoxicity. 
Dimethyldioxirane is a volatile peroxide and must be synthesized and handled with 
precaution [34,35]. 
 
Synthesis of (di-)epoxides 5-8 
The epoxidation of the externally-fused unsaturated five-membered rings was carried out 
using a solution of dimethyldioxirane in acetone as oxidation agent, which was prepared 
following a literature procedure [34,35]. This method has been used previously for the 
synthesis of arene-oxides of (CP-)PAH, see for example [26,36]. Usually, 50-70 ml of 0.07-
0.10 M dimethyldioxirane solutions in acetone were obtained. The dimethyldioxirane 
content was determined by the oxidation of methyl phenyl sulphide and monitoring the 
formation of its methyl phenyl sulphoxide by capillary GC [34,35].  
General procedure. The epoxidation was carried out in a 25 ml round-bottom flask at 
room temperature in the dark using ca. 0.05-0.1 mmol of the appropriate CP-PAH precursor, 
with either 2.5 mol equivalent (for 1) or 5 mol equivalent (for 2-4) of the freshly prepared 
dimethyldioxirane solution in acetone, in the presence of an equimolar amount of NaHCO3. 
When the reaction mixture turned colourless, the total conversion of the CP-PAH was 
determined (1H NMR). The reaction mixture was rapidly filtered and the filtrate was 
immediately concentrated in vacuo. The residue was dissolved in either dry acetone or 
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CH2Cl2, dried over MgSO4 and filtered. Concentration of the filtrate yielded analytically 
pure samples of the desired (di-)epoxides 5-8 which were stored at -20 oC to prevent 
decomposition. The di-epoxides could be unequivocally characterized on the basis of their 
1H NMR spectra. Gaussian enhancement of the 1H NMR spectra revealed that in all cases 
each di-epoxide was present as a mixture of two distinct stereoisomers in a close to 1:1 ratio 
(cf. Appendix). Unfortunately, all attempts so far to separate these stereoisomers were 
unsuccessful. 
Prior to each bacterial mutagenicity assay the structural integrity of the (di-) 
epoxides 5-8 was assessed by 1H NMR spectroscopy. 
Cyclopenta[cd]pyrene 3,4-epoxide (5) 
All spectral properties of 5 were in accordance with those previously published reported 
data (see also Chapter II ) [26]. 
Dicyclopenta[cd,mn]pyrene-1,2,4,5-di-epoxide (6) 
Presumably, the trans- and the cis- isomers of 6 are obtained. 
52%: δΗ (d6-acetone): 8.38 (2H, d, J 7.7), 8.35 (1H, s), 8.29 (2H, s), 8.11 (1H, t, J 7.4), 5.17 (4H, 
AB system, δA 5.19 and δB 5.18 JAB 2.2). 
48%: δΗ (d6-acetone): 8.38 (2H, d, J 7.7), 8.34 (1H, s), 8.30 (2H, s), 8.11 (1H, t, J 7.4), 5.16 (4H, 
AB system, δA 5.19 and δB 5.18 JAB 2.2). 
Dicyclopenta[cd,fg]pyrene-5,6,7,8-di-epoxide (7)  
Presumably, the trans- and the cis- isomers of 7 are obtained. 
53%: δΗ (d6-acetone): 8.17 (4H, AB system, δA 8.18 and δB 8.16 JAB 7.8), 8.07 (2H, s), 5.31 (2H, 
d, J 2.2), 5.16 (2H, d, J 2.2). 
47%: δΗ (d6-acetone): 8.16 (4H, AB system, δA 8.18 and δB 8.14 JAB 7.7), 8.06 (2H, s), 5.37 (2H, 
d, J 2.5), 5.17 (2H, d, J 2.5). 
Dicyclopenta[cd,jk]pyrene-1,2,6,7-di-epoxide (8)  
Presumably, the trans- and the cis- isomers of 8 are obtained.  
60%: δΗ (d6-acetone): 8.30 (s, 2H), 8.25 (AB system, δA 8.28 and δB 8.22 JAB 7.7, 4H), 5.14 (AB 
system, δA 5.16 and δB 5.14 JAB 2.4, 4H). 
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40%: δΗ (d6-acetone): 8.31 (s, 2H), 8.25 (AB system, δA 8.29 and δB 8.22 JAB 7.7, 4H), 5.16 (AB 
system, δA 5.17 and δB 5.15 JAB 3.0, 4H). 
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IV.7. Appendix 
 
Table A1.  Mutagenic activitya of cyclopenta[cd]pyrene-3,4-epoxide (5), dicyclopenta[cd,mn]pyrene-1,2,4,5-di-epoxide (6), dicyclopenta[cd,fg]pyrene-5,6,7,8-di-
epoxide (7) and dicyclopenta[cd,jk]pyrene-1,2,6,7-di-epoxide (8, Figure 1) using the S. typhimurium strain TA98, with and without exogenous metabolic 
activation mixture (±S9-mix) following standard protocols [22,23]. 
 
5 6 7 8
 
Conc. 
µg/plate 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
+S9-mix 
2% (v/v) 
-S9-mix 
+S9-mix  
2% (v/v) 
-S9-mix 
0.0 20.5 ±  7.1 7.5±   2.6 26.3 ± 3.1b  22.8 ± 6.8b 26.3 
± 
  3.1 22.8 
± 
  6.8  26.3 
± 
 3.1 22.8 ±  6.8 
0.1 53.5 ±  4.6 38.3 ±  10.9 24.3 ± 3.1b    16.8 ± 3.4b 61.3
± 
 17.4 49.3 
± 
  6.3  30.3 
± 
 6.5 26.0 ±  4.2 
0.5 164 ± 35.5 104.8 ±  12.6 27.5 ± 3.4b     26.5 ± 3.4b 209
± 
110.0 139
± 
  21.3 57.8 
± 
 6.8 68.3 ± 13.4 
1.5 400 ± 88.4 499.1 ±  45 25.1 ± 1.0b  23.1 ± 5.0b     497
± 
161.6 424
± 
 102.5 112 55.1
± 
116 47.1 
 ± 
2.0 477 ± 96.5 513.3 ± 119.8 26.3 ± 5.8b      32.8 ± 1.8b 691
± 
161.9 836  49.1 
± 
 126 
± 
36.8 193 25.1 
 ± 
His 
revertants/ 
nmol (r2) 
61.8                (0.98) 61.0 (0.93) - - - - 93.2 (0.99) 101 (0.95) 16.3 (0.98) 23.9 (0.98)
 
a Mutagenic response was determined as described in Materials and methods section [22,23]. Results shown are mean values ± standard deviation (from 
triplicate plates for each dose in two independent experiments), and are given in His revertants per plate, without correction for spontaneous His revertants.  
b Lack of background lawn, toxicity was observed. 
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Abstract 
The mutagenic response of well-characterized Flash Vacuum Thermolysis (FVT) 
pyrolysates that contain cyclopenta[cd]pyrene (1) and 1-ethynylpyrene (1b) (pyrolysate I), 
the dicyclopenta-pyrene congeners dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3), and 
dicyclopenta[cd,jk]pyrene (4) and their related bis-ethynyl- (2b-4b) and mono-cyclopenta-
ethynylpyrene (2a-4a) analogues (pyrolysates II-IV, respectively), or cyclopenta[cd]- (1) and 
the three dicyclopentapyrenes (2-4) (pyrolysate V), respectively, was assessed using the 
standard protocol outlined by Ames et. al. (Salmonella typhimurium strain TA98 ± S9-mix 4% 
(v/v)). It is shown that the mutagenic activity of the pyrolysates deviates from the weighed 
sum of the activity of the individual pyrolysate constituents. Hence, FVT pyrolysates are 
proposed as model mixtures, i.e. partial combustion exhaust mimics, to establish and 
evaluate the interactions (additive, synergistic or antagonistic effects) that may occur 
among the constituents and affect the global mutagenic response. 
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V.1.  Introduction 
Polycyclic aromatic hydrocarbons (PAH) are ubiquitous environmental pollutants that are 
invariably generated during incomplete combustion of fossil fuels [1-3]. A distinct sub-class 
comprises the non-alternant cyclopenta-fused PAH (CP-PAH), which contain at least one 
unsaturated five-membered ring peripherally annelated to the core of an alternant PAH.  
It has been shown that many CP-PAH possess markedly enhanced biological 
activity in bacterial mutagenicity assays in comparison with their parent PAH lacking the 
peripheral pentagon(s) [4-6]. In fact, CP-PAH are considered as potent contributors to the 
burden of mutagenic activity associated with environmental pollution [7]. For instance, 
cyclopenta[cd]pyrene (1, Scheme 1) is primarily an important contributor for the overall 
bacterial mutagenic S9-dependent activity of the non-polar fraction in combustion mixtures 
[8]. Notwithstanding, the amount of 1 can only account for less than half of the observed 
activity. Therefore, other (still unidentified) (CP)-PAH have to contribute to the total 
genotoxicity potency of the non-polar fraction of exhausts.  
Potential candidates are the three isomeric dicyclopenta-fused congeners of pyrene, 
i.e. dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3) and dicyclopenta[cd,jk]pyrene (4, 
Scheme 1), which were recently synthesized via the Flash Vacuum Thermolysis (FVT) [9,10] 
method. Subsequently, 2-4 were indeed unambiguously identified as constituents of the 
non-polar fraction of combustion exhausts [11-13].  
The availability of pure 2-4 has prompted us to assess their individual bacterial 
mutagenic activity following the protocol by Ames et. al. (Salmonella typhimurium, TA98) 
both in the presence and in the absence of an exogenous metabolic activation mixture (± S9-
mix) [14]. Remarkably, 2-4 exert a high mutagenic dependent on metabolism response, 
which is found to be markedly dependent on the dicyclopenta topology. Even more 
surprisingly, 3 and to a lesser extent 2, also exhibit direct-acting mutagenicity.  
In combustion processes ethynyl-substituted PAH (E-PAH) are considered to be 
the penultimate precursors for CP-PAH. E-PAH formation under these conditions is 
generally rationalized by invoking either C2 or C2H2 (ethyne) accretion to alternant PAH 
radicals [15-17]. Ample evidence for the conversion of E-PAH into CP-PAH under high 
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temperature conditions in the gas phase has been obtained using FVT [18,19]. In fact, E-PAH 
themselves have been identified in combustion exhausts [13,20]. An interesting feature of 
the FVT method is that the pyrolysate product composition is temperature dependent. In 
this respect, FVT pyrolysates represent partial mimics of combustion exhausts. 
As a consequence of the continuous human exposure to complex environmental 
(CP)-PAH mixtures, it is paramount to elucidate possible interactions (synergistic vs. 
antagonistic effects) of especially the persistent components in these mixtures. Note that 
standard methodology for human health risk assessment commonly assumes that additive 
interactions are operational among the constituents of a complex mixture [21]. 
This renders the mutagenicity assay of FVT-pyrolysates a timely issue. It has been 
shown that the total mutagenic potency of a PAH mixture, such as that found in both the 
polar and non-polar fractions of combustion exhausts, does not only depend on its 
composition, but also on the occurrence of synergetic or antagonistic interactions (non-
additivity) among the constituents [22,23]. For example, various E-PAH have been proposed 
as inhibitors of certain P450 isoenzymes that are present in the exogenous microsomal 
activation mixture (S9-mix) required for the metabolic activation of well-established 
procarcinogens [24,25]. 
Here, we report results on the mutagenic response of five different FVT-
pyrolysates (I-V) in the standard bacterial mutagenicity assay outlined by Ames et. al. using 
the Salmonella typhimurium strain TA98 with and without standard metabolic activation 
mixture (S9-mix, 4% (v/v)). The pyrolysates were obtained by FVT of the appropriate 
precursors of 1-4, i.e. 1-chloroethenylpyrene (1c) and the three isomeric (bis-)1-
chloroethenylpyrenes (2c-4c), respectively [9,10]. The contribution of 1-4 in the presence of 
their corresponding E-PAH (1b-4b) and the related mono-cyclopenta-ethynyl-substituted 
PAH (CP-E-PAH) intermediates (2a-4a) to the global mutagenic activity found for 
pyrolysates I-V is discussed (Scheme 1). The results demonstrate that the global mutagenic 
activity is indeed affected by the presence of the E-PAH and CP-E-PAH. 
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V.2.  Results and Discussion 
V.2.1. FVT-pyrolysates 
Pyrolysates I-IV were obtained using the FVT method [9,10]. The (bis)1-
chloroethenylpyrenes 1c-4c, which were used as FVT precursors, represent ‘masked’ E-
PAH. In the temperature range 450-500 oC in the gas phase they readily eliminate HCl 
giving in situ access to their related E-PAH (Scheme 1). It should be noted that sublimation 
of solid E-PAH into the hot zone of the furnace is often impeded due to the occurrence of 
solid-state oligomerization-polymerization processes [26,27]. 
An additional attractive aspect of the FVT approach is the temperature dependence 
of the pyrolysate product composition [9]. For pyrolysates I-IV the chosen temperature was 
such that the pyrolysates possess a similar composition (GC and 1H NMR, Scheme 1). 
Pyrolysates I-IV primarily contain the appropriate (di-)CP-PAH congener (1-4) (more than 
75%), their E-PAH derivatives (1b-4b) (ca. 10%) (precursors of CP-PAH in effluents) and the 
CP-E-PAH 2a-4a i.e. intermediates containing only one-CP moiety (ca. 15%). The presence of 
the latter intermediates is in line with previous observations that CP-formation occurs 
stepwise [9]. 
Pyrolysate V was obtained by subjecting a mixture of the (bis)1-chloroethenyl-
pyrenes 1c-4c (1c 1%, 2c 16%, 3c 50%, 4c 33%) to FVT at 1000 oC. Product analysis of this 
pyrolysate (1 28%, 2 14%, 3 30% and 4 28%) revealed that its composition deviates from that 
of the precursors mixture (Scheme 1). The results indicate that especially 3 undergoes C2 
extrusion furnishing additional 1. This phenomenon has been noted before [9,27]. 
 
V.2.2.  Mutagenic activity: Ames-assay TA98 with (S9-mix, 4% (v/v)) and 
without S9-mix 
The dose-response mutagenicity curves for the pyrolysates I-V are shown in Figures 1-5. For 
pyrolysates I-IV, the dose-response curve of pure 1-4 obtained also under FVT conditions is 
included [14]. For further comparison of the mutagenic potency of pyrolysates I-V, their 
dose-response curves both in the presence and in the absence of S9-mix 4% (v/v) are 
reported in Figure 6. 
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Scheme 1.  FVT of the mono- (1c) and bis-1-chloroethenyl-substituted pyrenes 2c-4c at the indicated 
temperatures. The product composition of the pyrolysates I-V is reported in mol% of the total (see 
Materials and methods section).  
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The specific mutagenic activity (His revertants/nmol) of 1-4 [14], pyrolysates I-V 
and 1:1 mixture of 4 and 4b are calculated from the initial ascending linear portion of the 
dose-response curves (Table 1, Figures 1-5 cf. also Appendix for the actual data obtained per 
test-dose and the correlation coefficients (r2)). The expected specific mutagenic activity 
(calculated from the contribution of 1-4) of pyrolysates I-V and the 1:1 mixture of 4 and 4b 
obtained by addition of the contributions of the pyrolysate components is reported in Table 
1. 
The mutagenic potency of pyrolysate I (5.5 His revertants/nmol) is markedly lower 
than that calculated taking into account both the specific mutagenic activity and the relative 
amount of 1 (24.2 His revertants/nmol) (Figure 1 and Table 1). Although pyrolysate I 
consists of 1 for 88%, its mutagenic activity is reduced ca. five-fold in the presence of the E-
PAH precursor (1b, 12%). In fact, this is not entirely surprising since 1-ethynylpyrene (1b) 
has been postulated as a suicide inhibitor of several cytochrome P450 isoenzymes [24,25] 
that selectively deactivate particular cytochrome P450 dependent activities such as the 
conversion of 1 into its ultimate active mutagenic form, viz. cyclopenta[cd]pyrene-3,4-
epoxide. Furthermore, 1b has also been found to inhibit the total metabolism of the well-
established carcinogen benzo[a]pyrene (B[a]P) when induced rat liver microsomes were 
used [28]. Hence, the metabolic inhibition of cytochrome P450 by 1b in pyrolysate I is here 
confirmed, i.e. the small amount of 1b (12%, Scheme 1) almost fully suppresses the high 
mutagenic dependent on metabolism potency of 1. In the absence of the exogenous 
activation mixture (-S9-mix), no positive mutagenic response was observed for either 
pyrolysate I or pure 1. 
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Table 1.  Specific mutagenic activitya expressed in His revertants/nmol of cyclopenta[cd]- (1), 
dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- (3), and dicyclopenta[cd,jk]pyrene (4) [14], the pyrolysates 
I-V (Scheme 1) and the 1:1 mixture of 4 and 4b (see Results and discussion) using Salmonella 
typhimurium strain TA98 with (+S9-mix 4% (v/v) and without (-S9-mix) metabolic activation system 
[29,30]. 
 
Compound TA98 
-S9-mix 
TA98 
+S9-mix 4% (v/v) 
1 ∼ 0.5  27.5  
2 4.2  98.4  
3 11.7  23.2  
4 1.2  14.7  
Pyrolysate I ∼ 0.3 (0.4) b  5.5 (24.2) b  
Pyrolysate II 1.9 (3.5) b  63.8 (73.8) b  
Pyrolysate III 2.2 (9.6) b  8.6 (19.0) b  
Pyrolysate IV 6.9 (1.0) b  40.8 (14.4) b  
Pyrolysate V 2.1 (4.6) b  88.2 (32.6) b  
1:1 Mixture of 4 and 4b ∼ 0.6 (0.6) b  17.5 (7.4) b  
 
a His revertants/nmol was calculated by least squares regression from the initial ascending linear 
portion of the dose response curve (Figures 1-4). For correlation coefficients (r2) see Appendix (Tables 
A1-A5).  
b Between parentheses the expected specific mutagenic activity calculated from the weighed 
contributions of the major components cyclopenta[cd]- (1), dicyclopenta[cd,mn]- (2), dicyclopenta[cd,fg]- 
(3), and dicyclopenta[cd,jk]pyrene (4, Scheme 1), respectively. Note that the bacterial mutagenic 
response of the CP-PAH 1-4 and their corresponding pyrolysates I-V was assayed using the same S. 
typhimurium T98 frozen permanent and the same microsomal protein fraction (S9) for the exogeneous 
metabolic activation mixture (see also Chapter III and main text). 
 
Pyrolysate II exhibits a high mutagenic activity (63.8 His revertants/nmol). 
Notwithstanding, the specific activity (73.8 His revertants/nmol) expected on the basis of the 
amount of 2 present (75%, Scheme 1) is again reduced due to the presence of its ethynyl 
derivatives 2a and 2b (Figure 2 and Table 1). Thus, possible inhibition of the cytochrome 
P450 activity due to the presence of the E-PAH derivatives is apparently operational. 
Pyrolysate II also shows a direct-acting mutagenicity (1.9 His revertants/nmol) that is fully 
accounted for by the amount of 2 in pyrolysate II (75%, Scheme 1 and Table 1). 
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Figure 1.  Comparison of the mutagenicity dose-response curves of pure cyclopenta[cd]pyrene (1) 
(■: +S9-mix, □: -S9-mix [14]) and pyrolysate I: 1 and 1b (Scheme 1) (▲: +S9-mix, △: -S9-mix). The assays 
were carried out following the standard Ames-assay protocol [29,30] with TA98 ± S9-mix 4% (v/v). The 
deviation standard is shown as error bars. For actual data and correlation coefficients see in the 
Appendix Table A1. 
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Figure 2.  Comparison of the mutagenicity dose-response curves of pure dicyclopenta[cd,mn]pyrene 
(2) (■: +S9-mix, □: -S9-mix [14]) a and pyrolysate II: 2, 2a and 2b (▲: +S9-mix, △: -S9-mix) (Scheme 1). 
The assays were carried out following the standard Ames-assay protocol [29,30] with TA98 ± S9-mix 4% 
(v/v)a. The deviation standard is shown as error bars. For actual data and correlation coefficients see in 
the Appendix Table A5. a Above 8 µg/plate of 2 the number of His revertant colonies markedly 
increased hampering their precise manual counting. No toxicity is observed. 
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Pyrolysate III shows a markedly decreased mutagenic activity in comparison to that 
expected for a similar amount of pure 3 (8.6 vs. 19.0 His revertants/nmol, Figure 3 and Table 
1). Interestingly, E-PAH 3b, which was synthesized as described in the Materials and 
methods section, was found to be inactive both in the presence and in the absence of S9-mix 
(data not shown). Hence in this case also, an inhibition by the E-PAH derivatives in 
pyrolysate III is proposed since the presence of 3a (11%) and 3b (7%) reduces two-fold the 
mutagenic potency of 3 in the presence of metabolic activation mixture. In a previous 
investigation, 3 was found to be a direct-acting mutagen [14]. However, pyrolysate III exerts 
considerably lower mutagenic activity than the calculated due to the amount of 3 (Scheme 1 
and Table 1). In this case, an antagonistic effect between 3, 3a and 3b is proposed. For 
pyrolysates I-III, the inhibition of enzymatic activation with +S9-mix 4% (v/v) due to the 
presence of E-PAH congeners is confirmed experimentally. 
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Figure 3.  Comparison of the mutagenicity dose-response curves of pure dicyclopenta[cd,fg]pyrene 
(3) (■: +S9-mix, □: -S9-mix [14]) and pyrolysate III: 3, 3a and 3b (Scheme 1) (▲: +S9-mix, △: -S9-mix). 
The assays were carried out following the standard Ames-assay protocol [29,30] with TA98 ± S9-mix 4% 
(v/v). The deviation standard is shown as error bars. For actual data and correlation coefficients see in 
the Appendix Table A3. 
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Pyrolysate IV, however, shows a three-fold higher response than expected on the 
basis of the available amount of pure 4 (Figure 4 and Table 1) with +S9-mix 4% (v/v). 
Furthermore, it shows toxicity at concentrations higher than 8 µg/plate. The enhanced 
mutagenic activity of pyrolysate IV may be due to the presence of 4a and 4b or is indicative 
of the occurrence of synergistic processes among the pyrolysate constituents. Since a 1:1 
mixture of 4 and its bis-ethynyl counterpart 4b (see synthesis in Materials and methods 
section), exerts a mutagenic response that is mainly accounted for by the amount of pure 4 
(Figure 4, Tables 1 and 2), 4a appears to be highly active. Note that pure 4b exerted no 
positive response under the same conditions (data not shown). In addition, 4a may be also 
responsible for the direct-acting response found for pyrolysate V (4.6 His revertants/nmol, 
Tables 1 and 2). Pure 4 [14] and 4b exert no mutagenic response without metabolic 
activation (-S9-mix).  
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Figure 4.  Comparison of the mutagenicity dose-response curves of pure dicyclopenta[cd,jk]pyrene 
(4) (■: +S9-mix, □: -S9-mix [14]), pyrolysate IV: 4, 4a and 4b (Scheme 1) (▲: +S9-mix, △: -S9-mix) and a 
1:1 mixture of 4 and 4b (●: +S9-mix, ○: -S9-mix). The assays were carried out following the standard 
Ames-assay protocol [29,30] with TA98 ± S9-mix 4% (v/v). The deviation standard is shown as error 
bars. For actual data see and correlation coefficients in the Appendix Table A4. 
 
 136
FVT-Pyrolysates as Combustion Exhaust Mimics 
 
To establish if also synergistic vs. antagonistic interactions between compounds 1-4 
can occur that will affect their mutagenic potency in combustion exhausts, pyrolysate V 
(Scheme 1) was assayed for mutagenicity in the Ames-test. In the presence of S9-mix 4% 
(v/v), its mutagenic potency is almost three-fold higher than the expected when the 
individual contributions of 1-4 are calculated (expected specific mutagenic activity 32.6 vs. 
88.0 His revertants/nmol found, Figure 5 and Table 1). Enhanced synergistic interactions 
may be operational under these conditions. In the absence of S9-mix, the activity found is 
slightly lower than that expected (antagonistic processes) and can be totally accounted for 
by the amount of 3 (CP-PAH with high S9 independent mutagenic response, Figure 4 and 
Table 1) present [14]. Note that pyrolysate V also shows toxicity at concentrations higher 
than 15 µg/plate in the presence of S9-mix 4% (v/v). 
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Figure 5.  Mutagenicity dose-response curves of pyrolysate V: 1, 2, 3 and 4 (Scheme 1) (▲: +S9-mix, 
△: -S9-mix). The assay was carried out following the standard Ames-assay protocol [29,30] with TA98 ± 
S9–mix 4% (v/v). The deviation standard is shown as error bars. For actual data and correlation 
coefficients see in the Appendix Table A5. 
 
In Figure 6, the mutagenic response of pyrolysates I-V with (+S9-mix 4% (v/v), (i)) 
and without (- S9-mix, (ii)) exogenous activation mixture are compared. Pyrolysate V exerts 
the highest dependent on metabolism activity followed by pyrolysate II, IV, III and I (see 
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also Table 1). The decrease in mutagenic activity can be accounted for the presence of E-
PAH derivatives that are known to act as suicide inhibitors of several cytochrome P450 
isoenzymes [24]. This inhibition effect is observed in pyrolysates I and III. Thus, compounds 
1b, 3a and 3b are presumably good substrates for the P450 enzymes present in the S9-mix. 
In the absence of S9-mix (Figure 6, (ii)), pyrolysate IV shows a high positive response that 
has to be attributed to the presence of 4a. The direct-acting mutagenic activity of pyrolysate 
V can be exclusively accounted for the presence of 2 and 3. 
(i) TA98 + S9-mix 4% (v/v)
0
1000
2000
3000
4000
0.00 5.00 10.00 15.00 20.00
µg/plate
H
is
 re
ve
rt
an
ts
/p
la
te
Pyrolysate I
Pyrolysate II
Pyrolysate III
Pyrolysate IV
Pyrolysate V
(ii) TA98 - S9-mix
0
100
200
300
400
500
0.00 5.00 10.00 15.00 20.00
µg/plate
H
is
 re
ve
rt
an
ts
/p
la
te
 
Figure 6.  Comparison of (i) the dependent on metabolism (+S9-mix) and (ii) the direct-acting (-S9-
mix) mutagenicity dose-response curves of pyrolysates I-V. The assay was carried out following the 
standard Ames-assay protocol [30] with TA98 ± S9-mix 4% (v/v). The deviation standard (error bars) is 
not shown. 
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V.3.  Conclusions 
Appropriate FVT pyrolysates that represent partial combustion exhaust mimics, are 
interesting mixture samples to gain insight in the possible occurrence of synergistic vs. 
antagonistic interactions between their constituents that can affect the total mixture 
mutagenic response. In fact, our results strongly indicate that the global mutagenicity of 
combustion exhausts cannot be simply calculated on the basis of the independent 
mutagenicity contributions of the (limited identified) individual components because of 
interactions between the constituents. For the pyrolysates I-IV it is found that in particular 
the intermediates (E-PAH and CP-E-PAH) formed during the stepwise formation of CP-
PAH may affect the bacterial mutagenic response with and without metabolic activation. 
Various E-PAH are found to be inhibitors of the cytochrome P450 enzymes present in the 
exogenous metabolic activation mixture S9-mix. In addition, the CP-E-PAH intermediates 
can exert mutagenic activity both in the presence and in the absence of S9-mix. Hence, the 
synthesis of pure CP-E-PAH and the evaluation of their mutagenic response represent 
worthwhile research targets. 
 
 
V.4.   Materials and methods 
V.4.1.   Synthesis 
All reactions were carried out under a N2 atmosphere. Solvents were dried and purified 
using standard procedures. Commercial reagents were used as received. 1H and 13C NMR 
spectra were recorded either on a Bruker AC 300 or a Varian Unity Inova Spectrometer 
operating at 300.13 MHz (1H) and 75.47 MHz (13C), respectively, at 25 oC; either CDCl3 or 
CD2Cl2 were used as solvents. Chemical shift (δ) values are in ppm with TMS as internal 
standard. J values are in Hz (multiplicity: s = singlet, d = doublet and m = multiplet). 
Capillary GC chromatograms were obtained using a Varian GC 3350 or GC 3400: 
capillary column (DB 5, length 30 m, ID 0.3 mm and 1 µm film thickness), temperature 
program (initial temperature 200 or 250 oC, isothermal for 10 min, heating to 280 oC at 10 oC 
min-1), injector temperature 300 oC, detector temperature 300 oC, and He as carrier gas. GC-
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MS spectra were measured on a ATI Unicam Automass System 2 quadrople mass 
spectrometer: capillary column (J & W Scientific DB-11bms column, length 30 m, ID 0.25 mm 
and 0.25 mm film thickness), temperature program (initial temperature 200 or 250 oC, 
isothermal for 10 min, heating to 280 oC at 10 oC min-1) injector temperature 300 oC, detector 
temperature 300 oC, and He as carrier gas. Mass Spectrometry (MS): EI (70 eV). 
 
Synthesis of 1,8-bisethynyl- (3b) and 1,6-bisethynylpyrene (4b) 
The (bis-1-chloroethenyl)-PAH 3c and 4c were prepared as described previously [9,10]. 
General procedure. To a cooled suspension (-40 oC) of sodium (0.12 g, 5.0 mmol) 
dissolved in liquid ammonia (45 ml) either (1,8-bis-1-chloroethenyl)- (3c, 0.51 g, 1.6 mmol) or 
(1,6-bis-1-chloroethenyl)pyrene (4c, 0.45 g, 1.4 mmol) dissolved in dry THF (20 ml) was 
slowly added drop wise. After stirring for an additional 8 h at –35 oC, the temperature of the 
reaction mixture was slowly raised to room temperature. The ammonia was evaporated and 
1 M H2SO4 (150 ml) was added. Subsequently, the reaction mixture was extracted with 
CH2Cl2 (4 × 60 ml). The combined organic fractions were dried over MgSO4, filtered and 
concentrated under low-pressure. In the case of 3b, the residue was purified by flash 
chromatography (silica, eluent CH2Cl2). 1,8-Bisethynylpyrene (3b), yield 0.20 g (0.8 mmol, 
50%), dark-orange solid, m.p. 168 oC (dec.). δΗ (CD2Cl2): 8.61 (2H, s), 8.14 (2H, d, J 7.9), 8.10 
(2H, d, J 7.9), 8.04 (2H, s) and 3.65 (2H, s). δC (CD2Cl2): 132.5, 131.9, 130.8, 129.3, 128.8, 126.6, 
125.5, 117.6, 83.5 and 82.5. MS (m/z) 250 (M·+). 1,6-Bisethynylpyrene (4b), yield 0.20 g (0.8 
mmol, 57%), dark-yellow solid m.p. 149 oC (dec.). δΗ (CD2Cl2): 8.62 (2H, d, J 9.1), 8.20-8.14 
(6H, m), 3.70 (2H, s) δC (CD2Cl2): 132.8, 131.7, 130.9, 128.7, 126.5, 125.5, 124.2, 117.6, 83.4 and 
82.5. MS (m/z) 250 (M·+). 
 
V.4.2.  Flash Vacuum Thermolysis (FVT)  
In the FVT experiments a Thermolyne 21100 tube furnace with an unpacked quartz tube 
(length 40 cm, ID 2.5 cm) was used at p ≤ 0.01 mmHg in the temperature range 500-1200 oC 
[31]. In a typical FVT experiment an appropriate precursor is sublimed into the hot zone 
(residence time ms range) where it gains thermal energy by collision(s) with the furnace 
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wall [32]. After thermal excitation rearrangement and/or decomposition reactions may occur 
[26,33-35]. The products (pyrolysate), which deposit either just behind the hot zone of the 
furnace or in the liquid N2 trap, are recovered from both the tube and the trap using dry 
CH2Cl2 (ca. 5 ml). The pyrolysate product composition is determined using 1H NMR 
spectroscopy, capillary GC and GC-MS. All analytical methods gave nearly identical results. 
 
V.4.3.  Mutagenicity Assays: Ames-assay 
Mutagenic response was measured using the Salmonella typhimurium histidine (His) 
auxotropic strain TA98 with and without an exogenous metabolic activation system (S9-
mix) according to the Maron and Ames protocol [30]. The S9-mix consists of rat liver 
microsome preparations (S9-fraction) and NADPH-generating cofactors. The S9-fraction 
was obtained from Aroclor-1254 treated male Wistar rats and its total protein content was 
determined by the Lowry method (29.15 mg/ml) [36]. The activity of the cytochrome P450 
isoenzyme P450-1A was measured using the EROD method (51.58 pmol/ml/min/mg 
protein) [37]. 
For the Ames-assays the pyrolysates I-V (Scheme 1) were dissolved in DMSO (4-5 
ml, 500 µg/ml) and assayed at five different concentrations (0.0-20.0 µg/plate) in triplicate 
plates in two independent experiments both in the presence (S9-mix 4% (v/v) 0.58 mg 
protein/plate) and in the absence of S9-mix. Spontaneous reversion revertants for TA98 (-S9-
mix 16 ± 2, +S9-mix 31 ± 7) and the positive controls, i.e. 1-nitropyrene, 5.0 µg/plate (-S9-mix 
>1000) and benzo[a]pyrene (B[a]P), 1.0 µg/plate (+S9-mix 150.5 ± 4) were scored. DMSO was 
used as a negative control (-S9-mix 17 ± 2, +S9-mix 28 ± 3). The plates were incubated at 37 
oC for 48 h and the revertant His colonies counted manually. The results are reported in 
dose-response curves and expressed as mean values of revertant His colonies per dose of 
test compound; they are not corrected for spontaneous reversion. The standard deviation is 
shown as error bars. 
The following criteria taken from literature [38,39] are used to assign positive 
mutagenicity: i) three-fold increase in the number of revertants in treated plates as 
compared to the negative control, ii) ascending dose-response behaviour and iii) replication 
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of results in at least two independent experiments. Note that in general the single three-fold 
rule (i) is not sufficient to characterize a positive mutagenic response [40]. The specific 
mutagenic activity, i.e. number of His revertants per nmol of test compound, are calculated 
by linear regression squares from the initial ascending linear portion of the dose-response 
curves. The actual data (mean His revertants ± standard deviation) for each dose tested and 
the correlation coefficients derived from the calculation of the specific mutagenic activity (r2) 
are reported in the Appendix (Tables A1-A5). Furthermore, it should be noted that the 
bacterial mutagenic response of the CP-PAH 1-4 and their (di-)epoxides 5-8 was assayed 
using the same S. typhimurium T98 frozen permanent and the same microsomal protein 
fraction (S9) for the exogeneous metabolic activation mixture. 
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V.6. Appendix. 
 
Table A1. Mutagenic activitya of cyclopenta[cd]pyrene (1) [14] and its corresponding pyrolysate I 
(Scheme 1) using the S. typhimurium strain TA98, without (-S9-mix) and with standard exogenous 
metabolic activation mixture (+S9-mix, 4% (v/v), i.e. 0.58 mg protein/plate). The dose response curves 
are compared in Figure 1. 
 
Cyclopenta[cd]pyrene (1) Pyrolysate I 
Concentration 
µg/plate 
-S9-mix 
 +S9-mix  
4% (v/v) 
-S9-mix 
+S9-mix  
4% (v/v) 
0.0 15.5 ±  6.5 22 ±   5.5 22.5 ± 6.5 28 ±    1 
0.5 14 ±  2 57.2 ±  10.1 16.5 ± 5.5 66 ±   5.5 
1.0 18 ±   0.8 116 ±  31.6 -c -c -c -c 
2.0 20.5 ±  0.5 197.7 ±  60.1 -c -c -c -c 
4.0 (5.0)b 50.5 ±  7.5 609.2 ± 269.2 29 ± 1 312 ±  12 
8.0 48 ± 17 1356.8 ± 161.8 -c -c -c -c 
12.0 (15.0)b 31 ±  6 1998.7 ± 307.1 38.5 ± 2.5 272 ±  20 
20.0 71 ± 31.8 2364 ± 228 47.0 ± 8 341 ±  30 
His revertants/ 
nmol (r2) 
0.5 (0.55) 27.5 (0.94) ~ 0.05 - 5.04 (0.84) 
 
a Mutagenic response was determined as described in the Materials and methods section [29,30]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background.  
b Test-dose corresponding to pyrolysate I between brackets.  
c Dose not tested. 
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Table A2. Mutagenic activitya of dicyclopenta[cd,mn]pyrene (2) [14] and its corresponding 
pyrolysate II (Scheme 1) using the S. typhimurium strain TA98, without (-S9-mix) and with standard 
exogenous metabolic activation mixture (+S9-mix, 4% (v/v), i.e. 0.58 mg protein/plate). The dose 
response curves are compared in Figure 2. 
 
Dicyclopenta[cd,mn]pyrene (2) Pyrolysate II 
Concentration 
µg/plate 
-S9-mix 
 +S9-mix  
4% (v/v) -S9-mix 
+S9-mix  
4% (v/v) 
0.0 15.5 ±  1.6 22 ±   3.6 17 ±  1.6 28 ±   3 
0.25 17 ±   3.3 59.5 ±   2 -c -c -c -c 
0.5 19.7 ±  6.1 184.5 ±   1.5 29 ±  3.3 118.5 ±   2 
1.0 38.3 ±   7.8 415 ±  65.1 43.5 ±  8.5 469 ±  27 
2.0 101 ±  6 745.2 ± 107.4 36 ±  6 1132 ±  88 
4.0 82 ±  1.9 2510 ± 137.5 144 ±  9 1364 ± 236 
8.0 129 ± 19.6 3258 ± 698.0 143.5 ±  9.5 2324 ± 250 
12.0 -b -b -c -c 116.5 ±  1.6 3110.5 ±  19.5 
20.0 -b -b -c -c 202 ± 24 3033 ±   38.5 
His revertants/ 
nmol (r2) 4.2 (0.91) 98.4 (0.92) 1.9 (0.98) 63.8 (0.98) 
 
a Mutagenic response was determined as described in the Materials and methods section [29,30]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background.  
b At 12 µg/plate of 2 the number of His revertant colonies markedly increased hampering their precise 
manual counting. No toxicity is observed.  
c Dose not tested 
FVT-Pyrolysates as Combustion Exhaust Mimics 
 
 147
Table A3. Mutagenic activitya of dicyclopenta[cd,fg]pyrene (3) [14] and its corresponding FVT-
pyrolysate (Pyrolysate III, Scheme 1) using the S. typhimurium strain TA98, without (-S9-mix) and with 
standard exogenous metabolic activation mixture (+S9-mix, 4% (v/v), i.e. 0.58 mg protein/plate). The 
dose response curves are compared in Figure 3. 
 
Dicyclopenta[cd,fg]pyrene (3) Pyrolysate III 
Concentration 
µg/plate 
-S9-mix 
 +S9-mix  
4% (v/v) -S9-mix 
+S9-mix  
4% (v/v) 
0.0 15.5 ±   0.5 22 ±  11.2 17 ±  2 28 ±  3 
0.5 42.3 ±   3.9 55 ±   4.1 25 ±  1 30 ±  4 
1.0 80 ±   13 119.8 ±  21.6 38 ±  5 46 ±  5 
2.0 130.6 ±  30.2 162.5 ±  18.9 45.5 ±  5.5 82.5 ±  8.5 
4.0 227.6 ±  27.5 366 ±  52.6 73 ± 11 92 ±  2 
8.0 399.8 ±  64.8 798.8 ± 158.6 90.5 ±  1.6 275 ±  7 
12.0 636.2 ± 166 1292.8 ± 105.3 74.5 ±  8.5 414 ±  2 
20.0 864 ±  62.9 1854 ± 175.9 98 ± 15 460 ± 24 
His 
revertants/ 
nmol (r2) 
11.7 (0.98) 23.2 (0.98) 8.55 (0.97) 2.21 (0.99) 
 
a Mutagenic response was determined as described in the Materials and methods section [29,30]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background. 
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Table A4. Mutagenic activitya of dicyclopenta[cd,jk]pyrene (4) [14], its corresponding pyrolysate IV (Scheme 1) and the 1:1 mixture 4b-4 using the S. 
typhimurium strain TA98, without (-S9-mix) and with standard exogenous metabolic activation mixture (+S9-mix, 4% (v/v), i.e. 0.58 mg protein/plate). The dose 
response curves are compared in Figure 4. 
 
Dicyclopenta[cd,jk]pyrene (4) Pyrolysate IV Mixture 1:1 
Concentration 
µg/plate -S9-mix 
 
+S9-mix 
4% (v/v) 
 
-S9-mix 
 
 
+S9-mix 
4% (v/v) 
-S9-mix 
 
+S9-mix 
4% (v/v) 
0.0 15.5 ± 10.6 22 ±   9.6 17 ±  2 28 ±   3 16 ±  1.6 25 ±  2 
0.5 19.7 ±  0.5 39.5 ±   5.6 32 ±  1 35 ±   4 13 ±  2 33 ±  9 
1.0 30.1 ±  8.9 63.6 ±  10.7 52.5 ±  9.5 167 ±  69 22 ±  5 33 ±  1.5 
2.0 41.8 ± 13.6 125.5 ±  46.5 80 ±  2 327 ±  82 21 ±  1.5 130 ±  2 
4.0 40.9 ± 10.1 218.1 ±  43.7 131 ±  3.5 770 ± 167 31 ±  4 279 ± 69 
8.0 64.4 ±  9.1 615.5 ± 204.6 170 ± 31 1702 ± 218 33 ±  1 632 ±  8 
12.0 74.9 ± 18.6 1341 ± 364.2 264 ± 30 1536 ±  80 34 ±  5.5 728 ± 40 
20.0 95.1 ± 18.8 2529 ± 654.7 430 ± 50 1411 ±  67 57 ±  3.5 786 ± 18 
His revertants/ 
nmol (r2) 1.2            (0.93) 14.7 (0.84) 6.9 (0.98) 40.8 (0.98) 0.6 (0.98) 17.5 (0.90)
 
a Mutagenic response was determined as described in the Materials and methods section [29,30]. Results shown are mean values ± standard deviation (from 
triplicate plates for each dose in two independent experiments), and are given in His revertants per plate, without correction for background.  
b Dose not tested. 
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Table A5. Mutagenic activitya of FVT-pyrolysate V (Scheme 1) using the S.typhimurium strain TA98, 
without (-S9-mix) and with standard exogenous metabolic activation mixture (+S9-mix, 4% (v/v), i.e. 
0.58 mg protein/plate). The dose response curves are compared in Figure 5. 
 
Pyrolysate V 
Concentration 
µg/plate 
-S9-mix 
+S9-mix  
4% (v/v) 
0.0 23 ±  6.5 28 ±   1.6 
1.0 33 ±  1.5 309 ±  31 
5.0 66 ±  1.5 2960 ± 280 
15.0 147 ± 12.5 3330 ± 330 
20.0  131 ±  2.5 2160 ± 120 
His 
revertants/nmol 
(r2) 
2.1 (0.99) 88.2 (0.88) 
 
a Mutagenic response was determined as described in the Materials and methods section [29,30]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background.  
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Abstract 
The bacterial mutagenicity in the standard microsomal/Histidine reverse assay (Ames-assay, 
S. typhimurium strain TA98) of cyclopenta[cd]fluoranthene (1) and 3-ethynylfluoranthene (2), 
which were both recently identified in combustion exhausts, is compared to that exerted by 
fluoranthene (3), viz. one of the most abundant PAH in combustion exhausts. The mutagenic 
activity found for 1 is modest in comparison to other active CP-PAH. Unexpectedly, the 3-
ethynyl derivative 2 exerted a positive mutagenic response with and without metabolic 
activation mixture. Furthermore, the synthesis and the bacterial mutagenic activity of 
cyclopenta[cd]fluoranthene-3,4-epoxide (6) is reported in order to evaluate its role as the 
ultimate mutagenic active form of 1. It is shown that epoxide 6 exerts a direct-acting 
mutagenic activity. In addition, an pyrolysate containing a mixture of 1 (85%), 2 (2%) and 3 
(13%) obtained by FVT at 1050 oC using 3-(1-chloroethenyl)fluoranthene (2a) as precursor is 
also tested.  
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VI.1.  Introduction 
The genotoxicity associated with combustion exhausts is commonly attributed to the 
presence of polycyclic aromatic hydrocarbons (PAH). PAH are formed during incomplete 
combustion and thus, are widely distributed throughout our environment [1,2]. For 
instance, fluoranthene (3, Figure 1) represents one of the most abundant constituents of 
combustion exhausts and its concentration is greater than that of the most studied PAH 
benzo[a]pyrene (B[a]P) [3]. Among the plethora of PAH that are formed during incomplete 
combustion, the total genotoxicity is in general determined by summing the individual 
contributions of the 16 PAH recommended by the US-EPA which in general is then referred 
to the potency of B[a]P [4]. However, the total genotoxicity of the combustion exhausts 
cannot entirely be accounted by these PAH. Both the contribution of other bioactive PAH 
present in combustion effluents that are on the US-EPA list and presumably still 
unidentified compounds are of importance too. Hence, the search for and identification of 
other genotoxic PAH is a timely issue [5].  
 Among the PAH accessible under combustion conditions, cyclopenta-fused PAH 
(CP-PAH) represent a special sub-class. These non-alternant PAH, which possess at least 
one externally-annelated unsaturated five-membered ring, are readily accessible via 
accretion of C2 or C2H2 (ethyne) to PAH radicals, furnishing ethynyl-substituted PAH (E-
PAH) [6-10]. The facile conversion of suitable E-PAH into CP-PAH under high temperature 
conditions in the gas phase has been extensively investigated in our group using Flash 
Vacuum Thermolysis (FVT) [11,12]. FVT does not only allow the synthesis of pure CP-PAH, 
which are difficult to access using classical ‘wet chemical’ synthesis, but also provide 
mixtures (pyrolysates) that resemble partial mimics of combustion exhausts [13]. The 
proposed role of E-PAH as penultimate precursors for CP-PAH is supported by their 
identification in combustion exhausts [14-16].  
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Figure 1. Pyrolysate (product mixture) obtained by FVT (p < 0.01 mmHg, T = 1050 oC) consisting of 
cyclopenta[cd]fluoranthene (1, 85%), 3-ethynylfluoranthene (2, 2%) and fluoranthene (3, 13%), partially 
hydrogenated derivatives 3-ethylfluoranthene (4), 3,4-dihydrocyclopenta[cd]fluoranthene (5) and 
cyclopenta[cd]fluoranthene-3,4-epoxide (6) that are assayed for bacterial mutagenic response following 
the standard protocol by Ames et. al. (S. typhimurium strain TA98) [17,18]. 
 
 
 CP-PAH are also of great interest because they generally exhibit unusual physico-
chemical properties [19] and more important, they possess enhanced genotoxic properties 
when compared to their parent PAH lacking the cyclopenta moiety. For example, one of the 
most studied CP-PAH, cyclopenta[cd]pyrene is a bacterial and cell mutagen, tumour 
promoter and (co-)carcinogen [20-24]. In contrast, its parent PAH pyrene is biologically 
inactive [25]. Moreover, cyclopenta[cd]pyrene and fluoranthene (3, Figure 1) were 
previously proposed to represent the main contributors to the total dependent on 
metabolism mutagenic activity found in the non-polar fraction of combustion exhausts 
using a forward mutation assay [3]. Nevertheless, the amount of cyclopenta[cd]pyrene and 3 
could not account for the total mutagenic response of the non-polar fraction. Hence, still 
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unidentified compounds have to contribute to the total genotoxic potency. Recently, we 
have assayed the bacterial mutagenic response of the three possible dicyclopenta-fused 
congeners of cyclopenta[cd]pyrene [26], which were identified as constituents of the non-
polar fraction of combustion exhausts [15,27]. It was found that all the dicyclopenta pyrene 
congeners contribute to the burden of mutagenic activity. Interestingly, they exert a higher 
activity than cyclopenta[cd]pyrene [28]. This prompted us to study the mutagenic potency of 
other novel CP-PAH that were recently identified in combustion exhausts besides with the 
previously studied dicyclopenta-fused pyrenes [15,16], i.e. in particular, 
cyclopenta[cd]fluoranthene (1, Figure 1). 
 Here, we report the mutagenic activity of the cyclopenta-fused congener of 
fluoranthene (3), i.e. cyclopenta[cd]fluoranthene (1) and 3-ethynylfluoranthene (2, Figure 1), 
which is the anticipated thermal precursor of 1 under combustion conditions. Assessment of 
the bacterial mutagenic response of 2 is also of interest from another perspective. Various E-
PAH have been identified to act as inhibitors of some isoenzymes of cytochrome P450 that 
are responsible for the oxidative metabolic activation of PAH, viz. epoxide formation [29-31]. 
Furthermore, an FVT-pyrolysate containing 1-3 (Figure 1), which can be considered as a 
partial mimic of combustion exhausts, is also assayed for mutagenic activity. Note that in a 
previous investigation we found that the presence of E-PAH in the FVT-pyrolysates may 
greatly affect the global mutagenic response [13]. The importance of the unsaturated 
cyclopentano moiety and the ethynyl group in 1 and 2, respectively, to exhibit mutagenic 
response is validated by testing the partially hydrogenated derivatives 3,4-
dihydrocyclopenta[cd]fluoranthene (4) and 3-ethylfluoranthene (5). Since it is frequently 
proposed that the ultimate mutagenic active forms of CP-PAH are the epoxides at the 
externally-fused five-membered ring, which are obtained by a one-step oxidation process by 
cytochrome P450 present in exogenous activation mixture (S9-mix) [22,32], the mono-
epoxide derivative of 1, i.e. cyclopenta[cd]fluoranthene-3,4-epoxide (6), was also synthesized 
and assayed for mutagenicity.  
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VI.2.  Results  
The mutagenic response of cyclopenta[cd]fluoranthene (1), 3-ethynylfluoranthene (2), 
fluoranthene (3), the pyrolysate containing 1 (85%), 2 (2%) and 3 (13%), 3,4-
dihydrocyclopenta[cd]fluoranthene (4), 3-ethylfluoranthene (5) and 
cyclopenta[cd]fluoranthene-3,4-epoxide (6, Figure 1), is determined in the 
Salmonella/microsome test following standard protocols (Ames-assay, S. typhimurium strain 
TA98 ± S9-mix, standard 4% and 2% (v/v), i.e. 0.58 and 0.29 mg protein/plate, respectively) 
[17,18]. Mutagenic activity is shown in dose-response curves in Figures 2-6. The specific 
mutagenic activity of each compound is calculated, i.e. the number of His revertants 
produced per nmol of test compound, and the data are reported in Table 1. The actual 
results are reported in the Appendix (Tables A1-A3). 
In Figure 2 the mutagenic activity of 1 in the absence (-S9-mix) and in the presence 
of both standard S9-mix 4% (v/v) as well as with a low-protein content S9-mix 2% (v/v) is 
presented. Although the activity at both protein concentrations is positive, it is moderate 
(specific mutagenic activity 0.8 and 0.7 His revertants/nmol, respectively (Table 1)). Without 
metabolic activation mixture (-S9-mix) 1 is non-mutagenic. The dependent on metabolism 
mutagenic potency of 1 appears to be effectively independent on the protein content in the 
activation mixture (S9-mix 2% or 4% (v/v)). Thus, the low protein content (S9-mix 2% (v/v)) 
was chosen in further experiments. 
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Figure 2.  Dose-response curves of cyclopenta[cd]fluoranthene (1) following the protocol outlined by 
Ames et. al. (S. typhimurium strain TA98) [17,18] in the presence of S9-mix 2% (v/v) (■) or standard S9-
mix 4% (v/v) (▲), and in the absence of exogenous metabolic activation mixture (□: -S9-mix).  
 
Unexpectedly 3-ethynylfluoranthene (2) is both a dependent on metabolism (+S9-
mix) and direct-acting mutagen (-S9-mix) with specific mutagenic activities of 1.4 and 1.5 
His revertants/nmol, respectively (Figure 3 and Table 1). In contrast, fluoranthene (3) does 
not exhibit mutagenic activity both with and without S9-mix under our experimental 
conditions (S. typhimurium strain TA98). The importance of the unsaturated five-membered 
ring containing the olefinic bond in the case of 1 and the ethynyl moiety in 2 for exerting 
mutagenic activity is supported by the mutagenic activity of their corresponding partially 
hydrogenated derivatives, i.e. compounds 4 and 5, respectively. Compounds 4 and 5 are 
found to be non-mutagens (Figure 4). 
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Figure 3. Dose-response curves of 3-ethynylfluoranthene (2, ▲: +S9-mix 2% (v/v), △: -S9-mix) and 
fluoranthene (3, ■: +S9-mix 2% (v/v), □: -S9-mix) following the protocol outlined by Ames et. al. (S. 
typhimurium strain TA98) [17,18], with and without S9-mix 2% (v/v).  
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Figure 4. Dose-response curves of the hydrogenated derivatives 3,4-dihydrocyclopenta[cd]fluoranthene 
(4, ▲: +S9-mix 2% (v/v), △: -S9-mix) and 3-ethylfluoranthene (5, ■: +S9-mix 2% (v/v), □: -S9-mix) 
following the protocol outlined by Ames et. al. (S. typhimurium strain TA98) [17,18], with and without 
S9-mix 2% (v/v).  
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An FVT-pyrolysate containing 1: 85%, 2: 2% and 3: 13%, was also tested and found 
to exert a dependent on metabolism specific mutagenic activity higher (0.9 His 
revertants/nmol) than when pure 2 is assayed. The mixture exhibits a weak direct-acting 
specific mutagenic response (0.5 His revertants/nmol, Figure 5 and Table 1).  
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Figure 5.  Dose-response curves of the FVT-pyrolysate containing cyclopenta[cd]fluoranthene (1), 3-
ethynylfluoranthene (2) and fluoranthene (3) (Figure 1) following the protocol outlined by Ames et. al. 
(S. typhimurium strain TA98) [17,18] in the presence of S9-mix 2% (v/v) (■) and in the absence of 
exogenous metabolic activation mixture (□: -S9-mix). 
 
 
Since it is documented that in most cases the ultimate mutagenic active forms of 
CP-PAH are the epoxides at the cyclopentano ring [33], the dose-response curves of epoxide 
6 and its parent compound 1 are compared in the dose-range from 0.0 until 2.0 µg/plate 
(Figure 6). A low concentration test-range is used because higher test concentrations are 
hampered due to the toxicity of 6 under the experimental conditions (data not shown).  
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Figure 6. Comparison of the dose-response curves of cyclopenta[cd]fluoranthene (1, ■: +S9-mix 2% 
(v/v), □: -S9-mix) and cyclopenta[cd]fluoranthene-3,4-epoxide (6, ▲: +S9-mix 2% (v/v), △: -S9-mix) 
following the protocol outlined by Ames et. al. (S. typhimurium strain TA98) [17,18], with and without 
S9-mix 2% (v/v). 
 
 
VI.3.  Discussion 
In comparison to other CP-PAH, 1 does not exhibit a high specific mutagenic activity with 
S9-mix (specific mutagenic activity of 0.7 His revertants/nmol, Table 1). For instance, under 
the same experimental conditions we found for cyclopenta[cd]pyrene a specific mutagenic 
activity of 64.6 His revertants/nmol (see Chapter II) [28]. Nevertheless, the olefinic bond in 
the five-membered ring appears to be a prerequisite for 1 to exert its moderate mutagenic 
response; its corresponding dihydro derivative 4 is non-mutagenic. It is noteworthy that 
epoxide 6 is a direct-acting mutagen (-S9-mix, specific mutagenic activity of 4.1 His 
revertants/nmol). This supports the supposition that epoxidation of the five-membered ring 
olefinic bond is still the main activation pathway. Since the mutagenic potency of 6 is 
reduced in the presence of S9-mix (specific mutagenic activity of 1.6 vs. 4.1 His 
revertants/nmol, Table 1), detoxification processes of 6 by the P450 enzymes are presumably 
operational.  
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Table 1.  Specific mutagenic activitiesa (His revertants/nmol) and mutagenic potencyb of 1-6 (Figure 1) 
and the FVT-pyrolysate obtained in the synthesis of 1. 
 
 
TA98 +S9-mix 2% (v/v) TA98 -S9-mix 
Compound 
His 
revertants/nmol 
Mutagenic 
potencyb 
His  
revertants/nmol 
Mutagenic 
potencyb 
1 0.7 (0.8)c  +/- 0.1  - 
2 1.4  + 1.5  + 
3 ~0.05 (~0.05) c  - ~0.05  - 
4 ~0.05  - ~0.05  - 
5 ~0.05  - ~0.05  - 
6 1.6  + 4.1  + 
FVT-
pyrolysate 0.9 (0.9)
c  +/- 0.5  - 
 
a Calculated by least squares regression from ascending linear portion of dose-response curves (Figures 
3-6). For 1-5, the dose range 0.0-20.0 µg/plate was used.  
b Mutagenic potency: - negative; + weakly positive.  
c With standard S9-mix 4% (v/v). 
 
 
Surprisingly, the ethynyl derivative of 3, i.e. 3-ethynylfluoranthene (2) exhibits a 
positive response both with and without S9-mix. In general ethynyl-substituted PAH are 
known to inhibit the activity of several cytochrome P450 isoenzymes that participate in the 
metabolic formation of the ultimate mutagenic active forms [29,30]. The genotoxicity of 2 
reported here, indicates that the general rule that E-PAH act as suicide inhibitors is 
apparently not valid for all E-PAH. Other (still untested) E-PAH present in combustion 
exhausts [14-16] thus can also contribute to the total bioactivity found. In this study we have 
demonstrated that a small amount of 2 (2%) greatly influences the total mutagenic activity 
found in the FVT-pyrolysate of 1. The necessity of the triple bond for positive mutagenic 
response is confirmed since its ethyl-PAH derivative 5 acts as a non-mutagen.  
Fluoranthene (3) does not exhibit mutagenic activity in the presence and absence of 
a metabolic activation mixture (± S9-mix 2% (v/v)) under our conditions. However, 3 has 
been reported previously to act as a bacterial mutagen in the conventional and in the ‘taped-
plate’ (for volatile compounds) Ames-assay [34]. In the latter study, however, a considerably 
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higher microsomal protein content in the activation mixture (S9-mix 10% (v/v)) was used. 
For other unsubstituted PAH, such as phenanthrene, variations in the exogenous metabolic 
activation mixture were also found to greatly affect its mutagenic response [35]. In a 
forward mutation assay (S. typhimurium strain TM677), 3 exhibit mutagenic activity [3]. 
Under these conditions the ultimate mutagenic active metabolites have been isolated and 
identified as the diol-epoxides [36,37]. This disagreement in mutagenic response has 
presumably to be attributed, on one hand, to the use of more protein content in the S9-mix  
[34] and, on the other hand, to the different bacterial strains employed for the determination 
of the mutagenic activity response [3]. 
 
 
VI.4.  Conclusions 
The mutagenic activity of cyclopenta[cd]fluoranthene (1), a recently identified constituent of 
combustion exhausts, was evaluated and shown to possess a positive mutagenic response 
that depends on metabolic activation (+S9-mix). Its mutagenic response, however, is not as 
high as that found for other bioactive mono-CP-PAH (see Chapter II). Its precursor under 
FVT and presumably also combustion conditions, viz. 3-ethynylfluoranthene (2), as well as 
the parent compound fluoranthene (3) were also assayed for mutagenicity. Whereas 3 is a 
non-mutagen under our conditions, unexpectedly, E-PAH 2 exerts a positive mutagenic 
activity with and without S9-mix. The positive mutagenic response exerted by 2 both in the 
presence and in the absence of the metabolic activation system, suggests the possibility that 
other E-PAH may also contribute to the burden of genotoxicity associated with combustion 
exhausts, viz. more importantly the generalization that E-PAH act as inhibitors of some 
isoenzymes present in the cytochrome P450 (S9-mix), presumably cannot be maintained. 
The partially hydrogenated derivative at the cyclopenta moiety 3,4-
dihydrocyclopenta[cd]fluoranthene (4) is found to be non-mutagenic pointing to the 
importance of the double bond at the five-membered ring for a positive mutagenic response.  
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Moreover, the epoxide cyclopenta[cd]fluoranthene-3,4-epoxide (6) was synthesized 
and biologically evaluated. Presumably, epoxide 6 is the ultimate mutagenic active form of 
the CP-PAH 1. 
 
 
VI.5. Materials and methods 
VI.5.1.  Test compounds and chemicals 
Cyclopenta[cd]fluoranthene (1, CAS n 193-54-4), 3-ethynylfluoranthene (2, CAS n 173066-87-
0), 3,4-dihydrocyclopenta[cd]fluoranthene (4), 3-ethylfluoranthene (5, CAS n 20496-16-6), 
cyclopenta[cd]fluoranthene-3,4-epoxide (6) were synthesized as described in the Synthesis 
section. Fluoranthene (3, 98%, CAS n 206-44-0) was purchased from Aldrich and purified by 
recrystallization from ethanol (20 mg/ml). The purity of all test compounds was at least > 
98.9%. Benzo[a]pyrene (B[a]P, 98.8%, CAS n 50-32-8) and 1-nitropyrene (1-NP, 99%, CAS n 
5522-43-0) were purchased from Sigma-Aldrich and used without further purification. 
Dimethyl sulfoxide (DMSO, 99.9%, CAS n 67-68-5) was purchased from Aldrich and NADP 
monosodium salt (98%, CAS n 1184-16-3), D-glucose-6-phosphate anhydrous (G-6-P, 99%, 
CAS n 56-73-5) and potassium monopersulphate triple salt (caroate, CAS n 37222-66-5) were 
purchased by from Sigma. Caution: CP-PAH and its derivatives must be handled according 
to NIH guidelines for carcinogens. 
 
VI.5.2.  Bacterial mutagenicity assays 
Mutagenic response was determined with the microsomal/Histidine (His) reversion assay 
(Salmonella typhimurium strain TA98) following the protocol by Ames and Maron [17,18] 
both in the absence and in the presence of an exogenous metabolic activation system (± S9-
mix). The S9-mix consists of rat liver microsome preparations (S9-fraction) obtained from 
Aroclor-1254 treated male Wistar rats and the NADPH-generating co-factors using standard 
procedures [18]. The total protein content and the activity of the cytochrome P450 
isoenzyme P450-1A were determined as 29.15 mg/ml (Lowry method) [38] and 51.58 
pmol/ml/min/mg protein (EROD method) [39], respectively. 
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Compounds 1-5 were dissolved in DMSO (500 µg/ml) and tested at five different 
concentrations (0.0, 1.0, 5.0, 15.0 and 20.0 µg/plate) in a constant volume of 100 µl/plate of 
DMSO. Compound 6 was tested until 2.0 µg/plate due to the high cytotoxicity at high 
concentrations (see Results). In each assay three plates were employed both in the absence (-
S9-mix) and in the presence of a metabolic activation mixture (+S9-mix, standard 4% (v/v) 
and 2% (v/v), 0.58 and 0.29 mg protein/plate, respectively) for every concentration dose in at 
least two independent occasions. Positive controls, i.e. 1-NP, 5.0 µg/plate (-S9-mix >1000) 
and B[a]P, 6.0 µg/plate (for example +S9-mix 2% (v/v) 133.9 ± 20.5), negative controls, i.e. 
DMSO (-S9-mix 10.2 ± 4.7, +S9-mix 19.8 ± 6.5) and spontaneous reversion His revertants (-S9-
mix 13.3 ± 4.7, +S9-mix 21.6 ± 6) for TA98 were included in each experiment. The plates were 
incubated at 37 oC for 48 h and the His revertants counted manually. The results obtained in 
the bacterial mutagenicity test are presented in dose-response curves and are expressed as 
mean values of His revertants per dose of test compound of three different plates from two 
independent experiments with no correction for spontaneous His revertants. The standard 
deviation (from six plates) is expressed as error bars (see also in the Appendix Tables A1-A3 
for actual data).  
The following criteria for positive mutagenic activity are used to establish a 
positive response [40,41]: i) three-fold increase of His revertants in plates with test 
compound as compared to the negative control (DMSO), ii) ascending dose-response 
behaviour and iii) replication of results in at least two independent experiments. The three 
criteria were used because employing the three-fold rule alone is not considered to be 
sufficient for establishing an unambiguous positive mutagenic response [42]. The specific 
mutagenic activities, i.e. number of His revertants induced per nmol of test compound, are 
calculated by least squares regression from the initial ascending portion of the dose-
response curves (Table 1). In the Appendix (Tables A1-A3) the actual data (mean His 
revertants ± standard deviation) and the correlation coefficients (r2) derivated from the 
calculation of the specific mutagenic activities are depicted. 
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VI.5.3.  Synthesis 
All reactions except the epoxidation were carried out under a N2 atmosphere. Solvents were 
dried and purified using standard protocols. Commercial reagents were used as received if 
not otherwise indicated. (Flash) Column chromatography was performed either on Merk 
kieselgel 60 silica (230-400 ASTM) or neutral aluminium oxide W200. Thin layer 
chromatography (TLC) was carried out using TLC aluminium sheets (aluminium oxide 60 
F254 neutral (type E) or TLC silica gel 60 F254). Melting points are uncorrected. 1H and 13C 
NMR spectra were recorded on a Bruker AC 300 or a Varian Unity Inova Spectrometer 
operating at 300.13 MHz and 75.47 MHz, respectively, at 25 oC; either d6-acetone, CD2Cl2 or 
CDCl3 were used as solvents. Chemical shift values are reported in ppm and are referenced 
to TMS. J values are given in Hz (multiplicity: s = singlet, d = doublet, t = triplet, dd = double 
doublet and m = multiplet). Capillary GC chromatograms were measured in a Varian GC 
3350 or GC 3400: capillary column DB 5 (length 30 m, ID 0.3 mm and 1 µm film thickness), 
temperature program (Ti = 200 or 250 oC, isothermal for 10 min, heating to 280 oC at 10 oC 
min-1), injector and detector temperature 300 oC and He as carrier gas. GC-MS spectra were 
measured on a ATI Unicam Automass System 2 quadrople mass spectrometer: J & W 
Scientific DB-15ms capillary column (length 30 m, ID 0.25 mm and 0.25 mm film thickness), 
temperature program (Ti = 200 or 250 oC, isothermal for 10 min, heating to 280 oC at 10 oC 
min-1), injector and detector temperature 300 oC and He as carrier gas. Mass Spectrometer 
(MS): EI 70 eV. Caution: CP-PAH and derivatives have to be handled according to NIH 
guidelines for carcinogens due to their potential genotoxicity. Dimethyldioxirane is a 
volatile peroxide and must be synthesized and used with precaution. 
 
FVT-pyrolysate and cyclopenta[cd]fluoranthene (1)  
Cyclopenta[cd]fluoranthene (1) and its corresponding FVT-pyrolysate (mixture of 1 + 2 + 3) 
were synthesized employing Flash Vacuum Thermolysis (FVT) as described previously [43]. 
A commercial Thermolyne 21100 tube furnace containing an unpacked quartz tube (40 cm 
long, diameter 2.5 cm) was used at T = 1050 oC, p < 0.01 mmHg. The pyrolysate, which 
deposited behind the hot zone was recovered from the tube with dry CH2Cl2 (ca. 3 ml), and 
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subjected to spectral analysis before further purification. The FVT-pyrolysate consisted of 
cyclopenta[cd]fluoranthene (1, 85%), 3-ethynylfluoranthene (2, 2%), and fluoranthene (3, 
13%); the mass recovery is ca. 85%. The presence of 3 is explained by invoking C2 extrusion 
under the high temperature conditions used [26,44] (Figure 1).  
Compound 1 was isolated from the pyrolysate after flash chromatography using n-
hexane as eluent. After removal of the solvent in vacuo the solid residue was recrystallized 
from ethanol (15 mg/ml) at T= - 20 oC. Pure 1 was isolated as (large) red needles and its 1H 
and 13C NMR spectra were in accordance with previously published results [43].  
The pyrolysate, which resembles part of a combustion exhaust, was assayed for 
mutagenicity without further purification (see the Results and Discussion sections).  
 
Independent synthesis of 3-ethynylfluoranthene (2) 
3-(1-Chloroethenyl)fluoranthene (2a) was prepared as described previously [43]. To a cooled 
suspension (– 40 oC) of Na (0.25 g, 0.01 mmol) dissolved in 45 ml of liquid ammonia, a 
solution of 2a, (0.5033 g, 1.92 mmol) in dry THF (20 ml) was slowly added drop wise. After 
stirring for 8 h at – 35 oC the temperature of the reaction mixture was slowly raised to room 
temperature. The ammonia was evaporated and 1 M H2SO4 (150 ml) was added. 
Subsequently, the reaction mixture was extracted with CH2Cl2 (4 × 60 ml). The combined 
organic fractions were dried over MgSO4, filtered and concentrated in vacuo that gave pure 
3-ethynylfluoranthene (2), yield 0.425 g (1.88 mmol, 98%), dark-orange solid. δΗ (CD2Cl2): 
8.14 (1H, d, J 8.3), 7.96 (1H, d J 6.9), 7.91-7.87 (4H, m, also contains AA’ part of AA’XX’ 
system), 7.70 (1H, dd, J 8.3, J 6.9), 7.43 (2H, m, XX’ part of AA’XX’ system) and 3.59 (1H, s). 
δC (CD2Cl2): 140.0, 139.1, 138.1, 137.5, 133.4, 132.4, 130.9, 129.2, 128.5, 128.1, 125.3, 122.2, 122.0, 
121.1, 119.8, 119.5, 82.7, 81.5. m/z (MS): 226 (M·+) (100), 198 (8), 113 (27). 
 
Fluoranthene (3)  
Commercial fluoranthene (3) was purified by recrystallization from ethanol (20 mg/ml). 
Pure fluoranthene (3) was isolated as large white needles. δΗ (CDCl3): 7.96 (2H, d, J 6.9), 7.85-
7.79 (2H, m, AA’ part of AA’XX’ system), 7.81 (2H, d, J 8.2), 7.61-7.56 (2H, dd, J 8.2 J 6.9) and 
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7.38-7.32 (2H, m, XX’ part of AA’XX’ system). δC (CDCl3): 139.5, 137.0, 132.4, 130.0, 128.0, 
127.6, 126.7, 121.6 and 120.1. GC-MS m/z (relative intensity): 202 (M·+) (100), 101 (12).  
 
3,4-Dihydrocyclopenta[cd]fluoranthene (4) and 3-ethylfluoranthene (5) 
3,4-Dihydrocyclopenta[cd]fluoranthene (4) and 3-ethylfluoranthene (4) were obtained by 
catalytic hydrogenation of cyclopenta[cd]fluoranthene (1) and 3-ethynylfluoranthene (2), 
respectively, (ca. 10 mmol) with hydrogen (pH2/1 atm) and Pd on activated carbon (2 mg) in 
dry THF (15 ml) at room temperature. The reaction was finished when the intense colour of 
the reactant solution disappeared (2-3 h). The reaction mixture was filtered over Celite 
followed by concentration of the filtrate in vacuo giving pure 4 and 5 as colourless solids. 
3,4-Dihydrocyclopenta[cd]fluoranthene (4)  
White solid, m.p. 148-150 oC. δΗ (CDCl3): 7.99-7.93 (2H, m, AA’ part of AA’XX’ system), 7.47 
(2H, d, J 6.9), 7.40-7.38 (2H, m, XX’ part of AA’XX’ system) and 3.54 (4H, s). δC (CDCl3): 
145.9, 140.2, 139.5, 132.7, 131.1, 126.8, 122.1, 122.0, 120.5 and 32.4. GC-MS: m/z (relative 
intensity) 228 (M·+) (100), 113 (35).  
3-Ethylfluoranthene (5)  
Pale beige solid. m.p. 75 oC. δΗ (CDCl3): 8.02 (1H, d, J 8.3), 7.95 (1H, d, J 6.9), 7.91-7.86 (2H, m, 
AA’ part of a AA’XX’ system), 7.67-7.61 (2H, m), 7.45 (1H, d, J 6.9), 7.37-7.34 (2H, m, XX’ part 
of AA’XX’ system), 3.23 (2H, q, J 7.5) and 1.46 (3H, t, J 7.5). δC (CDCl3): 141.7, 139.4, 139.4, 
137.4, 135.1, 132.8, 129.1, 127.5, 127.4, 127.0, 126.5, 123.5, 121.4, 121.1, 120.3, 119.7, 25.3 and 
16.1. GC-MS: m/z (relative intensity) 230 (M·+) (50), 215 (100). 
 
Cyclopenta[cd]fluoranthene-3,4-epoxide (6) 
Epoxidation of 1 was carried out using a freshly prepared solution of dimethyldioxirane in 
acetone. The dimethyldioxirane solution was prepared by dissolving solid caroate (triple 
salt of potassium monopersulphate) in a cold solution of NaHCO3 in acetone/water 
following literature procedures [45,46]. Usually, 50-70 ml of 0.07-0.10 M dimethyldioxirane 
solutions in acetone were obtained. The dimethyldioxirane content was assayed by 
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oxidation of methyl phenyl sulphide and monitoring its sulphoxide formation by GC. The 
dimethyldioxirane solutions were stored at –20 oC over 3 Å activated mol sieves prior to use. 
To as suspension of cyclopenta[cd]fluoranthene (1, 7.4 mg, 0.0327 mmol) and 
sodium bicarbonate (20 mg) in 3 ml dry acetone, 2 ml of a dimethyldioxirane solution (0.071 
M) was added and the reaction mixture was stirred at room temperature in the dark for 8 h. 
After total consumption of the CP-PAH (GC), the reaction mixture was filtered and the 
solvent removed in vacuo. The residue was dissolved in dry CH2Cl2, dried over MgSO4 and  
the solution filtered. Concentration of the filtrate in vacuo gave a beige waxy solid (7 mg, 
88.5%) that was identified as the analytically pure epoxide 6. δΗ (d6-acetone): 7.96-7.94 (2H, 
m, AA’ part of AA’XX’ system), 7.82 (4H, AB system, δA 7.90 and δB 7.74, JAB 7.0), 7.40-7.37 
(2H, m, XX’ part of AA’XX’ system), 4.88 (2H, s). δC (d6-acetone): 141.5, 140.5, 137.3, 136.9, 
132.8, 128.9, 125.2, 123.7, 122.0, 59.2. GC-MS: m/z (relative intensity) 242 (M·+, 60), 214 (100), 
213 (75) 121 (12), 187 (12), 107 (15). Presumably, epoxide 6 rearranges to 3,4-
dihydrocyclopenta[cd]fluoranthen-3-one under the GC-MS conditions [47] (see also Chapter 
II). 
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VI.7. Appendix 
 
Table A1.  Bacterial mutagenic activitya of cyclopenta[cd]fluoranthene (1, Figure 1) using the S. 
typhimurium strain TA98, without (-S9-mix) and with exogenous metabolic activation mixture (+S9-mix, 
2% (v/v), i.e. 0.29 mg protein/plate; standard 4% (v/v), i.e. 0.58 mg protein/plate). 
 
Concentration 
µg/plate -S9-mix +S9-mix 2% (v/v) 
+S9-mix 
4% (v/v) 
0.0 9 ±  5.6 18.3 ± 4.3 40.3 ± 11.2 
1.0 11.8 ±  6.3 20.3 ± 2.7 41.3 ±  7.8 
5.0 11.3 ±  7 41 ± 7.8 52.8 ± 20.5 
15.0 14.5 ±  4.5 56.5 ± 9.8 66.6 ± 13.1 
20.0 23.3 ± 13.2 69.3 ± 8.7 98.5 ±  5.5 
His 
revertants/nmol 
(r2) 
~ 0.05 (0.72) 0.6 (0.96) 0.7 (0.98) 
 
a Mutagenic response was determined as described in Materials and methods section [17,18]. Results 
shown are mean values ± standard deviation (from triplicate plates for each dose in two independent 
experiments), and are given in His revertants per plate, without correction for background. 
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Table A2. Bacterial mutagenic activitya of 3-ethynylfluoranthene (2), fluoranthene (3) and the pyrolysate consisting of cyclopenta[cd]fluoranthene (1) (85%), 2 
(2%) and 3 (13%) (Figure 1), employing the S. typhimurium strain TA98, with and without exogenous metabolic activation mixture (± S9-mix). 
 
2 3 Pyrolysate
 
Concentration 
µg/plate 
+S9-mix 
2% (v/v) 
-S9-mix 
+S9-mix 
4% (v/v) 
-S9-mix 
+S9-mix 
2% (v/v) 
-S9-mix 
0.0 25.5 ±  6.80 15.5 ±  7.50 16.5 ± 4.50 12 ± 1 26 ±  6.80 20 ± 7.50 
1.0 59 ± 19.60 30 ±  5.40 27.5 ± 0.50 23.5 ± 2.5 34 ± 10.50 29 ± 4.40 
5.0 65 ± 10.80 62 ±  6.40 29 ± 2.00 21 ± 5 62 ±  8.60 38 ± 0.80 
15.0 100 ± 22.30 124 ±  4.30 24 ± 5.00 19 ± 1.0 84 ±  7.90 54 ± 8.50 
20.0 175.5 ± 17.80 150 ± 15.10 15.5 ± 1.5 20 ± 1 80 ± 11.70 63 ± 9.70 
His revertants/ 
nmol (r2) 1.4          (0.98) 1.5 (0.99) -
 b - b - - b b 0.9 (0.92) 0.5 (0.92)
 
a Mutagenic response was determined as described in Materials and methods section [17,18]. Results shown are mean values ± standard deviation (from 
triplicate plates for each dose in two independent experiments), and are given in His revertants per plate, without correction for spontaneous His revertants.  
b Could not be determined.  
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Table A3. Bacterial mutagenic activitya of 3,4-dihydrocyclopenta[cd]fluoranthene (4), 3-ethylfluoranthene (5) and cyclopenta[cd]fluoranthene-3,4-epoxide (6, 
Figure 1), employing the S. typhimurium strain TA98, with and without exogenous metabolic activation mixture (±S9-mix). 
 
4 5 6
Concentration 
µg/plate +S9-mix 
2% (v/v) 
-S9-mix 
+S9-mix 
4% (v/v) 
-S9-mix 
Concentration 
µg/plate +S9-mix 
2% (v/v) 
-S9-mix 
0.0 25.5 ± 6.8 20 ± 7.5 25.5 ± 6.8 20 ± 7.5 0.0 21.8 ± 4.7 7.5 ±  2.6 
1.0 20 ± 3.4 24.3 ± 2.6 23.5 ± 3.0 25.8 ± 5.4 0.1 15.5 ± 8.2 13.8 ±  3.4 
5.0 25.8 ± 5.3 27 ± 5.3 22 ± 8.8 20 ± 1.4 0.5 17.3 ± 4.1 21.3 ±  7.3 
15.0 28.8 ± 4.0 30 ± 5.0 26 ± 3.8 17.5 ± 1.1 1.5 24.5 ± 5.4 25.5 ± 14.5 
20.0 27.5 ± 4.4 29 ± 4.6 29.5 ± 4.8 24.8 ± 2.7 2.0 35.5 ± 5.6 43 ±  7.4 
His  
revertants/nmol 
(r2) 
- b - b       - - b b - - b b - - b  b 
His revertants/ 
nmol (r2) 1.6 (0.63) 4.1 (0.92)
 
a Mutagenic response was determined as described in Materials and methods section [17,18]. Results shown are mean values ± standard deviation (from 
triplicate plates for each dose in two independent experiments), and are given in His revertants per plate, without correction for spontaneous His revertants. 
b Could not be determined.  
 
 
Chapter VI 
 176
 
 
 
 
 
 
 
 
 
 
  
Chapter VII.   
 
 
Complete  1H and 13C NMR Assignments of the 
Three Isomeric Dicyclopenta-Fused Pyrenes 
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Abstract 
Complete 1H and 13C NMR assignment of the (di-)cyclopenta-fused pyrene congeners, 
cyclopenta[cd]- (2), dicyclopenta[cd,fg]- (3), dicyclopenta[cd,jk]- (4) and 
dicyclopenta[cd,mn]pyrene (5) is achieved using two-dimensional (2D) NMR techniques. 
The experimental results are compared with computed ab initio CTOCD-PZ2 chemical shifts. 
A satisfactory agreement between the experimental and computed ab initio data is found. 
Substituent-Induced Chemical Shifts in the pyrene (1) parent system due to annelation of 
cyclopenta moieties is discussed. It is shown that for CP-PAH  2-5 the number as well as the 
topology of the cyclopenta fusion affect the electronic structure. 
Total 1H and 13C NMR Assignments  
VII.1. Introduction 
The (di-)cyclopenta-fused congeners of pyrene (1), viz. cyclopenta[cd]- (2) [1], 
dicyclopenta[cd,fg]- (3), dicyclopenta[cd,jk]- (4) and dicyclopenta[cd,mn]pyrene (5) [2,3], are 
representatives of a sub-class of the polycyclic aromatic hydrocarbons (PAH) known as 
cyclopenta-fused PAH (CP-PAH), which are of interest in both applied and fundamental 
science.  
From an applied viewpoint, the availability of 1-5 as pure reference compounds 
has enabled their unequivocal identification as constituents of the non-polar fraction of 
combustion exhausts obtained by combustion of organic matter, viz. fossil fuels [4-6]. 
Furthermore, CP-PAH 2-5 have been proposed as undesired side-products can be formed 
during the thermal treatment of pyrene-contaminated soil [7]. This is of relevance since 
(CP)-PAH may exhibit mutagenic and even carcinogenic properties [8], which would render 
2-5 of human health concern [9-15]. In fact, the bacterial mutagenicity response of the series 
2-5 was recently assayed employing the standard Ames-assay (Salmonella typhimurium strain 
TA98 either in the presence or absence of metabolic activation (±S9-mix)). The novel 3-5 
were all found to be highly active metabolic-dependent mutagens. Unexpectedly, CP-PAH 3 
and, to a lesser extent, 5 were also found to act as direct-acting mutagens in the absence of 
metabolic activation [16].  
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Figure 1. Pyrene (1), cyclopenta[cd]- (2), dicyclopenta[cd,fg]- (3), dicyclopenta[cd,jk]- (4) and 
dicyclopenta[cd,mn]pyrene (5). The applied carbon atom-numbering scheme facilitates the comparison 
of CP-PAH 1-5. 
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From a fundamental perspective, the non-alternant character of 2-5 [17] can 
produce unusual physico-chemical properties, such as high electron affinities (low one-
electron reduction potentials) [18-20], characteristic upfield-shifted 1H NMR chemical shifts 
[2,3,21], together with photophysical properties, such as UV/Vis spectra that are strongly 
modulated by the number and topology of the cyclopenta moieties [2,18] and anomalous 
fluorescence [22]. In addition, compounds 3-5 have been proposed to play a key role in 
fullerene formation under flame conditions [6,23-25]. Therefore, CP-PAH are interesting 
probes to assess both the energy and magnetic criteria of aromaticity in π-conjugated 
polycyclic systems. For the series 1-5 it has been shown that both the number and topology 
of annelated cyclopenta moieties have remarkable effects on the global and local aromaticity 
of the parent PAH system [26-28]. 
However, hitherto the total 1H and 13C NMR assignments of compounds 3-5 have 
not been reported yet. This is the subject of this chapter. Compounds 3-5 were studied using 
two-dimensional (2D) NMR techniques, such as Nuclear Overhauser Effect Spectroscopy 
(NOESY), Heteronuclear Chemical Shift Correlation (HETCOR) and Long-Range (L-R) 
HETCOR.  
 
 
VII.2.  Results and Discussion 
In this section, the total assignment of 1H and 13C NMR chemical shifts for compounds 1-5 is 
described. Although in the case of 2 both its 1H and 13C NMR assignments have been 
reported previously [29,30], there is still some ambiguity with respect to the assignment of 
some of the quaternary C atoms (C14 and C17). Hence, 2 was also re-investigated. 
Subsequently, a comparison of the experimental assignments with computed ab initio 
CTOCD-PZ2 chemical shifts is carried out and conclusions are drawn concerning the effect 
of cyclopenta annelation to a pyrene perimeter on the 1H and 13C chemical shifts 
(Substituent-Induced Chemical Shifts, SCS; ∆δ with either 1 or 2 as the reference compound 
for the series 2-5 and 3-5, respectively).  
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The total 1H and 13C NMR assignment of compounds 1-5 was achieved by means of 
2D NMR techniques. NOESY allows the assignment of proton signals by evaluation of 
through-space dipolar interactions, HETCOR enables the identification of carbon atoms 
bearing a hydrogen atom, and LR-HETCOR will assist in the assignment of quaternary 
carbon atoms by reflecting one to three bond C-H couplings (1JC-H-3JC-H). In this study, 
different long-range C-H coupling constants (range 4-10 Hz) were used in order to visualize 
the different correlations since not all expected three-bond and/or two-bond C-H couplings 
could be observed in a single experiment. In some cases, the long-range C-H interactions are 
not detected because their nJC-H values deviate markedly from the applied long-range 
coupling constants in the LR-HETCOR experiment (4, 6, 8 or 10 Hz). It is known that 3JC-H 
falls normally in the range 4-10 Hz and, 2JC-H and 4JC-H are typically less than 4 and 2 Hz, 
respectively [31].  
 
VII.2.1.  Experimental NMR spectra 
Cyclopenta[cd]pyrene (2) 
The total 1H and 13C NMR assignments (see Figure 2 for the 1D 13C NMR spectra of 1 and 2) 
of 2 was first published by Jans et. al. [29]. However in a subsequent study by others [30], the 
original 13C assignment of 2 was re-examined using a partially 13C-labelled 2. The 
assignment of the 13C resonances of C2, C7, C14, C16 and C17 was questioned (see also 
Figure 1). This ambiguity, prompted us to also to re-investigate 2. 
Since all 1H NMR resonances of 2 have been unequivocally assigned [29,32] (Table 
1), all tertiary C atoms attached to a hydrogen can be readily determined using the HETCOR 
spectrum. The 13C resonances at δ 133.48 and δ 130.52 show a cross-peak with δ 7.47 (H3) 
and δ 8.38 (H8), respectively, thus they must originate from C3 and C8, respectively. 
Following similar reasoning the 13C resonances positioned at δ 128.54 corresponds to C10, δ 
127.81 to C4, δ 126.94 to C9, δ 126.93 to C12, δ 126.57 to C13, δ 126.48 to C6,  δ 124.34 to C1 
and  δ 122.68 to C15. 
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Figure 2. 1D 13C NMR spectra of pyrene (1, top) and cyclopenta[cd]pyrene (2, bottom). 
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Table 1. Schematic representation of the cross-peaks observed in the HETCOR and LR-HETCOR spectra of cyclopenta[cd]pyrene (2)a. HETCOR cross-peaks 
(1JC-H coupling constant 160 Hz) are shown as HT. Independent LR-HETCOR gave the cross-peaks indicated as a-d. Long-range nJC-H coupling constants of 4 Hz 
(a), 6 Hz (b), 8 Hz (c) and 10 Hz (d) were used respectively. 
 
H8 H6 H10 H1 H15 H12 H9 H13 H3 H4
  8.38 (d, 3J 7.7) 8.36 (s) 8.28 (d, 3J 7.6) 8.12 (m) 8.08 (m) 8.03 (m) 8.00 (m) 7.98 (m) 7.47 (d, 3J 5.10) 7.27 (d, 3J 5.10)
C17      b,c,d      120.69
C16            122.23 a d c c,d
C15             122.68 HT
C1            124.34 HT b
C6            126.48 HT c,d
C13            126.57 c HT
C12            126.93 a HT
C9            126.94 HT
C18            127.34 d d
C4            127.81 a,d HT
C10            128.54 b HT d
C11            130.18 b d
C8            130.52 HT a,d c
C14       d  b   130.87
C7            131.90 a,c b,d
C3            133.48 HT a
C2            135.58 d c,d
C5            139.07 a d a
 
a See Figure 1 for the structure of 2 and its atom numbering In Figure 2 the 1D 13C NMR spectrum of 2 is shown. Quaternary carbon atoms are typeset in 
boldface and the multiciplicity of the 1H chemical shifts are indicated between brackets. 
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Independent LR-HETCOR experiments in which different long-range nJC-H 
coupling constants were used (see Table 1 and Experimental section) enabled the 
assignment of all quaternary C atoms of 2. Under the applied experimental conditions, two- 
(2JC-H) and three-bond (3JC-H) long-range coupling constants are most likely to be observed 
[33]. In the following discussion, only interactions between hydrogens and quaternary C 
atoms will be considered. The hydrogens H6, H4 and H3 (Figure 1) show a cross-peak with 
the 13C resonance at δ 139.07, which can only correspond to either C5 or C18. The 13C 
resonance at δ 135.58 shows cross-peaks with hydrogens H1 and H4, implying that this 13C 
signal originates from either C2 or C18. The hydrogens H3 and H4 also show a cross-peak 
with the 13C resonance at δ 127.34, which can correspond to either C5, C2 or C18. To 
distinguish between the latter three C atoms, the experimental 1D proton-decoupled 13C 
NMR spectrum of 2 is examined (Figure 2). It is found that the 13C resonance at δ 127.34 
possesses the lowest intensity. This suggests that the δ 127.34 resonance belongs to C18, 
which is located inside the pyrene perimeter and, thus, more distant from the hydrogen 
containing perimeter carbon atoms. Due to the increased distance, its relaxation will be 
slower leading to a reduced intensity [34]. If the assignment of C18 is correct, this implies 
that the 13C resonances at δ 139.07 and δ 135.58 belong to C5 and C2, respectively. The cross-
peaks found between the 13C signal at δ 130.87 and the hydrogens H12 and H13, indicate 
that this 13C resonance must originate from either C14 or C11. Fortunately, the 13C signal 
located at δ 131.90 can only correspond to C7; it exhibits only cross-peaks with H6 and H9. 
In analogy, the 13C resonance at δ 122.23 shows interactions with H6, H8, H10 and H13, 
which means that it can only arise from C16. With the identification of C16, the 13C 
resonance at δ 130.18 can be assigned to C11, due to its cross-peaks with H10 and H12. The 
previous assignments now permit the unequivocal identification of C14 as the 13C signal at δ 
130.87. By elimination, the 13C resonance at δ 120.69 then corresponds to C17. The 1H and the 
13C assignments of 2 are summarized in Table 1. Hence, the remaining ambiguous 
assignment of C14/C17 by Vollhardt et. al. is now resolved [30]. 
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Dicyclopenta[cd,fg]pyrene (3) 
In line with its C2v symmetry the 1H and 13C NMR spectra of dicyclopenta[cd,fg]pyrene (3, 
C20H10) can contain five and ten distinct resonances, respectively (Figure 3). In its 1H NMR 
spectrum, the singlet at δ 7.45 (2H) can be unequivocally assigned to hydrogen H13. 
Furthermore, a clear-cut distinction between the vicinal hydrogens H1 and H15, and, H3 and 
H4 is possible due to their different vicinal 3JH-H coupling constants. The vicinal 3JH-H coupling 
constant from the externally fused cyclopenta-rings has a typical value (ca. 5 Hz) for olefinic 
bonds incorporated in a five-membered ring. The 1H total assignment is accomplished by a 
NOESY experiment. The observation of a cross-peak between the doublet at δ 7.63 (2H, 3JH-H 
7.60), and the doublet at δ 7.03 (2H, 3JH-H 5.30) reveals that the former corresponds to H1 and 
the latter to H3, respectively. Consequently, the other two doublets at δ 7.72 (2H, 3JH-H 7.60) 
and δ 6.79 (2H, 3JH-H 5.30) belong to the hydrogens H15 and H4, respectively. 
 
 
Figure 3.  1D 13C NMR spectrum of dicyclopenta[cd,fg]pyrene (3).  
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Since all 1H NMR resonances of 3 have now been identified, all tertiary C atoms 
can be unambiguously determined by HETCOR. The 13C resonances positioned at δ 137.31, 
δ 127.88, δ 127.07, δ 127.03 and δ 123.45 correspond to C3, C4, C15, C13 and C1, respectively 
(Table 2). 
Independent LR-HETCOR experiments with different long-range nJC-H coupling 
constants (see Table 2 and Experimental section for further details) enabled the assignment 
of all quaternary C atoms. Only interactions between the quaternary carbon atoms and the 
hydrogens will be considered in the following discussion. Hydrogen H1 shows two cross-
peaks with the 13C resonances at δ 130.62 and δ 131.23, which may then correspond to either 
C14, C18 (three-bond (3JC-H) coupling) or C2 (two-bond (2JC-H) coupling). Hydrogen H13 
shows two cross-peaks with the 13C resonances at δ 130.62 and δ 120.91, which can thus arise 
from either C14 (two-bond (2JC-H) coupling) or C17 (three-bond (3JC-H) coupling). Since the δ 
130.62 resonance was also found to interact with hydrogen H1, it can only correspond to 
C14. Consequently, the δ 120.91 signal has to be associated with C17. Hydrogen H15 shows 
cross-peaks with δ 120.91 (C17) and δ 140.24, which can originate from C2 (three-bond (3JC-H) 
coupling) and C14 (two-bond (2JC-H) coupling). Since C14 (δ 130.62) has already been 
assigned, the 13C resonance at δ 140.24 has to correspond to C2. Consequently, the δ 131.23 
13C signal belongs to C18. By elimination, the 13C resonance at δ 137.94 then corresponds to 
C5. This is confirmed by the observation of cross-peaks of δ 137.94 with H3 (three-bond (3JC-
H) coupling) and H4 (two-bond (2JC-H) coupling). As illustrative examples a HETCOR and a 
LR-HETCOR spectrum of 3 are shown in Figure 3; the total 1H and 13C NMR assignments of 
3 are summarized in Table 2. 
 
Dicyclopenta[cd,jk]pyrene (4) 
In the case of dicyclopenta[cd,jk]pyrene (4), which possesses C2h symmetry, its 1H and 13C 
NMR spectra can contain five and ten distinct resonances, respectively. The total 1H 
assignment is accomplished by a NOESY experiment. The cross-peak between the singlet at 
δ 7.50 (2H), which corresponds to H13, and the doublet at δ 6.62 (2H, J 5.21) indicates that 
the latter arises from H4 (cf. the characteristic 3JH-H coupling constant (ca. 5 Hz) for the 
olefinic vicinal hydrogens in a five-membered ring). Another interaction is observed 
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between the doublet at δ 7.47 (2H, 3JH-H 7.69) and the doublet at δ 6.71 (2H, 3JH-H 5.21). Thus, 
this suggests that H1 corresponds to δ 7.47 and H3 to δ 6.71. Since all 1H NMR signals of 4 
have been now identified, all tertiary C atoms of 4 can be unequivocally assigned using 
HETCOR (Figure 4, Table 3). Hence, δ 133.49 corresponds to C3, δ 131.63 to C4, δ 129.63 to 
C15, δ 125.72 to C13 and δ 122.40 to C1. 
 
 
Table 2. Schematic representation of the cross-peaks observed in the HETCOR and LR-HETCOR 
spectra of dicyclopenta[cd,fg]pyrene (3)a. HETCOR cross-peaks are indicated as HT. LR-HETCOR 
experiments gave the cross-peaks shown as a, b and c, using long-range coupling constants nJC-H of 6 Hz 
(a), 8 Hz (b), 10 Hz (c).  
 
  H15 H1 H13 H3 H4 
  
7.72  
(d, 3J 7.60) 
7.63  
(d, 3J 7.60) 
7.45 (s) 
7.03 
 (d, 3J 5.30)
6.49 
 (d, 3J 5.30) 
C17 120.91 a, b  a   
C1 123.45 c HT  b a 
C13 127.03 b b HT   
C15 127.07 HT  b   
C4 127.88    b HT 
C14 130.62  a,b a,b,c   
C18 131.23  a,b,c    
C3 137.31    HT a 
C5 137.94    c c 
C2 140.24 a    b,c 
 
a See Figure 1 for the structure of 3 and its atom numbering. In Figure 3 the 1D 13C NMR spectrum of 3 is 
shown. Quaternary carbon atoms are typeset in boldface and the multiciplicity of the 1H chemical shifts 
are indicated between brackets. 
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Figure 4.  HETCOR (1JC-C 160 Hz, top) and LR-HETCOR (1JC-C 160 Hz and nJC-H 8 Hz, bottom) spectra of 
dicyclopenta[cd,fg]pyrene (3, see Figure 1 and Table 2 for the 1H and 13C NMR chemical shift 
assignments). 
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Figure 5.   1D 13C NMR spectrum of dicyclopenta[cd,jk]pyrene (3).  
 
 
LR-HETCOR experiments in which different long-range C-H coupling constants 
were used (See Table 3 and Experimental section for further details) in order to enable  the 
assignment of all quaternary C atoms. Again, only interactions between the quaternary 
carbon atoms and the protons will be considered in the discussion. Hydrogen H1 shows two 
cross-peaks with the 13C resonances at δ 130.66 and δ 132.07, which can arise from C14, C18 
(three-bond (3JC-H) coupling) and C2 (two-bond (2JC-H) coupling). Hydrogen H15 exhibits 
interactions with the 13C resonances at δ 141.00 and δ 121.44, which may then correspond to 
C2 and C17 (three-bond (3JC-H) coupling) or C14 (two-bond (2JC-H) coupling). The 13C 
resonance at δ 141.00 gives another cross-peak with H4. Hence, we assign δ 141.00 to C2 
(three-bond (3JC-H) coupling), while C14 and C17 would present a four- (4JC-H) and a five-
bond (5JC-H) coupling with H4, respectively, which is unlikely to be observed under the 
applied experimental conditions [33]. Since the cross-peaks for H1 with δ 130.66 and δ 132.07 
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can now only arise from C14 and C18, this leaves δ 121.44 for C17. By elimination, it is now 
possible to relate 13C signal δ 140.42 to C5. These assignments are supported by the 
behaviour of H13, which exhibits two cross-peaks with δ 121.44 (C17), and δ 130.66, which 
can arise from the interaction with C18 (three-bond (3JC-H) coupling) or C14 (two-bond (2JC-H) 
coupling). The final assignment for C14 and C18 is achieved by comparing their intensities 
in the 1D 13C spectrum (Figure 5). The intensity of the 13C signal at δ 132.07 is stronger than 
that at δ 130.66. This strongly suggests that the δ 132.07 and δ 130.66 13C resonances have to 
originate from C14 and from C18, respectively, since the latter carbon atom is more distant 
from the pyrene perimeter [34]. The total 1H and 13C NMR assignments for 4 are compiled in 
Table 3.  
 
 
Table 3. Schematic representation of the cross-peaks observed in the HETCOR and LR-HETCOR 
spectra of dicyclopenta[cd,jk]pyrene (4)a. HETCOR cross-peaks are indicated as HT. LR-HETCOR 
experiments gave the cross-peaks shown as a, b, c, and d using C-H long-range coupling constants nJC-H 
of 4 Hz (a), 6 Hz (b), 8 Hz (c) and 10 Hz (d).  
 
  H15 H13 H1 H3 H4 
  
7.71  
(d, 3J 7.69) 
7.50 (s) 
7.47 
 (d, 3J 7.69)
6.71  
(d, 3J 5.21) 
6.62 
 (d, 3J 5.21) 
C17 121.44 b,c,d b,c    
C1 122.40 b,c  HT   
C13 125.72 a,b HT    
C15 129.63 HT a,b,c c,d   
C18 130.66  c,d b   
C4 131.63     HT 
C14 132.07   b,c   
C3 133.49  c  HT a 
C5 140.42      
C2 141.00 a,b    a 
 
aSee Figure 1 for the structure of 4 and its atom numbering. In Figure 5 the 1D 13C NMR spectrum of 4 is 
shown. Quaternary carbon atoms are typeset in boldface and the multiciplicity of the 1H chemical shifts 
are indicated between brackets. 
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Dicyclopenta[cd,mn]pyrene (5) 
Dicyclopenta[cd,mn]pyrene (5) has 10 hydrogen and 20 carbon atoms, but due to its C2v 
symmetry, only 6 and 12 distinct signals can be observed in its 1H and 13C NMR spectrum 
(Figure 6), respectively. Various 1H resonances are readily assigned. The triplet at δ 8.08 (1H, 
3JH-H 7.65) has to correspond to hydrogen H9. The singlets at δ 8.15 (1H) and δ 8.37 (2H) 
originate from H1 and H6 and the doublet at δ 8.53 (2H, 3JH-H 7.80) to H8. The doublets at δ 
7.51 (2H, 3JH-H 5.10) and δ 7.26 (2H, 3JH-H 5.10) corresponds to H3 and H4, respectively (cf. the 
typical vicinal 3JH-H value (ca. 5 Hz) for an olefinic bond in a five-membered ring). A NOESY 
spectrum of 4 reveals that cross-peaks between the singlet at δ 8.37 (H6) and the doublet at δ 
7.26, on one hand, and the singlet at δ 8.15 (H1) and the doublet at δ 7.51, on the other hand, 
are discernible.  As the total 1H assignment is achieved, all the tertiary C atoms of 4 can be 
assigned using HETCOR (Table 2). Thus, the 13C resonances located at δ 135.03, δ 132.76, δ 
127.04, δ 126.53, δ 125.80 and δ 118.78 correspond to C3, C8, C9, C4 C6 and C1, respectively. 
 
 
Figure 6.  1D 13C NMR spectrum of dicyclopenta[cd,mn]pyrene (5).  
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Independent LR-HETCOR experiments using different long-range nJC-H coupling 
constants allow the assignments of the quaternary C atoms (see Table 4 and Experimental 
section for details). Again, only interactions that arisen from quaternary carbon atoms and 
protons will be considered. For hydrogen H9 two cross-peaks are observed with the 13C 
resonances at δ 120.10 and δ 127.96, which can correspond to C7 and C16. Note, however, 
that for C16 the interaction with H9 has to be a four-bond, long-range nJC-H coupling. 
Hydrogen H6 correlates with the 13C signals positioned at δ 127.96, δ 131.52 and δ 138.56; the 
possible assignments for these cross-peaks are C7 and C5 (two-bond (2JC-H) coupling) or C18 
and C16 (three-bond (3JC-H) coupling). The 13C resonances at δ 131.52 and δ 138.56 can only 
correspond to C5 and C18, since the 13C signal at δ 127.96 has already been assigned to either 
C7 or C16. H3 correlates with δ 131.52 and δ 135.63 so that these signals can be assigned to 
C2, C5 and C18. Since δ 131.52 and δ 138.56 belong to either C5 or C18, the 13C resonance at δ 
135.63 has to originate from C2. In the 1D 13C NMR spectrum of 5, the signal at δ 138.56 is 
slightly more intense than that at δ 131.52 (Figure 6). Hence, the δ 138.56 resonance most 
likely corresponds to C5, since the more distant a carbon atom is situated from a molecular 
perimeter, the weaker its signal will be [34]. That leaves δ 131.52 for C18. In addition, the 13C 
signal at δ 127.96 is more intense that the one position at δ 120.10, which allows their 
assignment to C7 and C16, respectively. By elimination the 13C resonance at δ 114.71 has 
then to be assigned to C17. The total 1H and 13C assignments of 5 are summarized in Table 4.  
 
VII.2.2. Computed 13C chemical shifts of 1-5 
In previous work [28] we have assigned the 1H NMR resonances of (CP)-PAH 1-5 using 
theoretical 1H chemical shifts computed with the PZ2 (paramagnetic zero) variant [35] of the 
all electron ab initio continuous-transformation-of-origin-of-current-density (CTOCD) 
method, all with the 6-31G** basis as implemented in the Exeter version of SYSMO [36] (see 
Experimental: Computations). Although the computed 1H NMR chemical shifts of 1-5 were 
found to deviate by ca. 0.5 ppm from their experimental values, they satisfactorily followed 
the trends observed in the experimental 1H NMR spectra of 1-5. These observations 
prompted us to compute the 13C NMR chemical shifts of 1-5 using the same CTOCD-PZ2 
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method (see Table 5). For 13C NMR chemical shifts, which span a considerably wider range 
in ppm, the deviations between the computed and experimental values, which are most 
significant for the carbon atoms of the cyclopenta moieties (range 2.1-4.5 ppm), are still 
sufficiently small (for all carbon atoms: range 0.0-4.6 ppm, cf. ∆δ values in Table 5) to make 
the computations a material aid for 13C chemical shift assignments in π-conjugated 
polycyclics. To an extent this is a fortunate consequence of the combination of basis set (6-
31G**) and the CTOCD method, as the results for 13C shifts in the 6-31G** basis can be closer 
to experiment than ‘accurate’ Hartree-Fock limiting results [37]. 
 
 
Table 4.  Schematic representation of the cross-peaks observed in the HETCOR and LR-HETCOR 
spectra of dicyclopenta[cd,mn]pyrene (5)a. HETCOR cross-peaks are indicated as HT. LR-HETCOR 
experiments gave the cross-peaks shown as a, b and c, using long-range coupling constants nJC-H of 10 
Hz (a); 4 Hz  (b) and 10 Hz (c).  
 
  H8 H6 H1 H9 H3 H4 
  
8.53  
(d, 3J 7.80) 8.37 (s) 8.15 (s) 
8.08  
(t, 3J 7.65) 
7.51  
(d, 3J 5.10) 
7.26  
(d, 3J 5.10) 
C17 114.71        
C1 118.78   HT    
C16 120.10    b   
C6 125.80 b HT     
C4 126.53      HT 
C9 127.04  a  HT   
C7 127.96  c  b   
C18 131.52  a   a a 
C8 132.76 HT b     
C3 135.03     HT c 
C2 135.63     b c 
C5 138.56  b    b 
 
a See Figure 1 for the structure of 5 and its atom numbering. In Figure 6 the 1D 13C NMR spectrum of 5 is 
shown. Quaternary carbon atoms are typeset in boldface and the multiciplicity of the 1H chemical shifts 
are indicated between brackets. 
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In the case of 1-5 the computed 13C chemical shifts can be used for the verification 
of the assignments of especially those 13C resonances for which intensity considerations had 
to be taken into account (vide supra). As shown by the results in Table 5, our experimental 
assignments in which the intensity of certain 13C signals was considered are corroborated 
and validated by the corresponding computed 13C chemical shifts.  
A comparison of the absolute carbon nuclear shield constants (σav) of 1-5 and their 
out-of-plane (σout) and mean in-plane (σin) components reveal that all carbon sites possess a 
large diamagnetic, σout component and approximately cancelling in-plane principal 
components that leave a relatively small, usually paramagnetic, mean in-plane σin value 
(Table 5). Similar behaviour has been observed for other (CP)-PAH [38].  
 
 
Table 5. CTOCD-PZ2/6-31G**//RHF/6-31G computed ab initio absolute carbon nuclear shielding 
constants (σav in ppm) of pyrene (1), cyclopenta[cd]- (2), dicyclopenta[cd,fg]- (3), dicyclopenta[cd,jk]- (4) 
and dicyclopenta[cd,mn]pyrene (5) (See Figure 1 for their generalized atom numbering). σ (out) is the 
component of the absolute shielding out-of-plane of the ring, σ (in) is the mean shielding in-plane, and 
σav the overall mean value. The corresponding δ values (expressed in ppm) were obtained by the rule 
σav × 106 + δ = 185.6 (see Experimental: computations). 
 
Compound Nucleus σ (out) σ (in) σav δ calc δ exp ∆δ a 
1 C1 191.9 -7.5 58.9 126.7 125.78 0.9 
 C2 177.9 0.8 59.8 125.8 124.87 0.9 
 C5 167.4 2.7 57.6 128.0 127.32 0.7 
 C17 200.5 -11.6 59.1 126.5 124.61 1.9 
 C18 194.6 -16.8 53.7 131.9 131.08 0.8 
2 C1 186.8 -2.5 60.6 125.0 124.34 0.7 
 C2 163.7 -7.3 49.7 135.9 135.58 0.3 
 C3 149.6 -1.7 48.7 136.9 133.48 3.4 
 C4 152.9 6.5 55.3 130.3 127.81 2.5 
 C5 154.9 -5.8 47.8 137.8 139.07 -1.3 
 C6 164.3 3.0 56.7 128.9 126.48 2.4 
 C7 190.9 -15.2 53.5 132.1 131.90 0.2 
 C8 177.4 -6.9 54.5 131.1 130.52 0.6 
 C9 189.9 -5.2 59.8 125.8 126.94 -1.1 
 C10 178.9 -5.0 56.3 129.3 128.54 0.8 
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 C11 195.7 -15.0 55.2 130.4 130.18 0.2 
 C12 167.9 2.1 57.4 128.2 126.93 1.3 
 C13 170.6 2.1 58.3 127.3 126.57 0.7 
 C14 193.4 -16.9 53.2 132.4 130.87 1.5 
 C15 176.5 3.5 61.1 124.5 122.68 1.8 
 C16 201.0 -9.3 60.8 124.8 122.23 2.6 
 C17 203.5 -5.5 64.1 121.5 120.69 0.8 
 C18 180.2 -4.0 57.4 128.2 127.34 0.9 
3 C1 185.3 -1.0 61.1 124.5 123.45  1.0 
 C2 160.5 -12.2 45.4 140.2 140.24  0.0 
 C3 145.1 -4.3 45.5 140.1 137.31  2.8 
 C4 153.3 6.8 45.5 130.0 127.88  2.1 
 C5 146.1 -3.0 46.7 138.9 137.95  1.0 
 C13 168.6 2.1 57.6 128.0 127.03  1.0 
 C14 192.4 -15.0 54.1 131.5 130.62  0.9 
 C15 177.4 -1.2 58.3 127.3 127.07  0.2 
 C17 197.9 -3.2 63.8 121.8 120.91  0.9 
 C18 169.0 -3.0 54.3 131.3 131.23  0.0 
4 C1 185.2 0.8 62.3 123.3 122.40 0.9 
 C2 160.1 -12.7 44.9 140.7 141.00 -0.3 
 C3 146.5 0.7 49.3 136.3 133.49 2.8 
 C4 149.4 2.3 51.3 134.2 131.63 2.6 
 C5 147.8 -4.5 46.3 139.3 140.42 -1.1 
 C13 167.0 2.9 57.6 128.0 125.72 2.3 
 C14 186.7 -13.7 53.1 132.5 132.07 0.4 
 C15 176.3 -4.6 55.7 129.9 129.63 0.3 
 C17 198.1 -3.6 63.6 122.0 121.45 0.6 
 C18 173.4 -2.5 56.2 129.4 130.66 -1.3 
5 C1 183.3 1.6 62.2 123.4 118.78 4.6 
 C2 159.8 -3.5 50.9 134.7 135.63 -0.9 
 C3 148.6 -5.1 46.1 139.5 135.03 4.5 
 C4 152.1 9.0 56.7 128.9 126.53 2.4 
 C5 158.6 -7.6 47.8 137.8 138.56 -0.8 
 C6 165.2 2.4 56.6 129.0 125.80 3.2 
 C7 191.0 -14.1 54.3 131.3 127.96 3.3 
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 C8 178.5 -11.8 51.6 134.0 132.76 1.2 
 C9 187.7 -3.7 60.1 125.5 127.04 -1.5 
 C16 204.0 -8.8 62.1 123.5 120.10 3.4 
 C17 209.1 2.3 71.3 114.3 114.71 -0.4 
 C18 178.2 -7.6 47.8 129.8 131.52 1.7 
a ∆δ = δcalc  - δexp. 
 
VII.2.3.  Substituent-Induced Chemical Shifts (SCS; 13C ∆δ) 
To establish to what extent mono- and di-cyclopenta annelation influences the 13C NMR 
chemical shifts of related carbon positions Substituent-Induced Chemical Shifts (SCS; 13C ∆δ 
in ppm) were calculated using the experimental and computed ab initio CTOCD-PZ2 13C 
chemical shifts. The 13C chemical shifts of either pyrene (1) or cyclopenta[cd]pyrene (2), were 
taken as a reference for the calculation of SCS ∆δexp and ∆δcalc values for CP-PAH 2-5 (∆δexp(1) 
vs. ∆δcalc(1)) and 3-5 (∆δexp(2) vs. ∆δcalc(2)), respectively (Table 6). A survey of the ∆δexp/calc(1) 
and ∆δexp/calc(2) values shows that the pyrene ipso carbon atoms (C2 and C5, see Figure 1) to 
which the cyclopenta moieties are attached possess ∆δexp/calc(1) values of 10-16 ppm (∆δexp(1)) 
and 9-15 ppm ((∆δcalc(1))) for CP-PAH 2-5 when pyrene (1) is taken as the reference 
compound. In line with the satisfactory agreement between the experimental (δexp) and 
computed (δcalc) 13C chemical shifts for 1-5 (Table 5), 13C ∆δexp and 13C ∆δcalc values for both 
series are comparable (Table 6). The ipso Substituent-Induced Chemical Shifts (∆δ(1)exp/calc for 
C2 and C5 (and symmetry equivalent positions) fall in the range expected for alkyl 
substitution of a benzenoid system [39]; a deshielding of 10 to 15 ppm is found. However, 
the non-zero ∆δ(1) values found for more distant C atoms (for example: C8, C10, C15, C17 
and C18 ( see Table 6 and Figure 1)) indicate that cyclopenta annelation influences the whole 
electronic structure of the CP-PAH 2-5. 
The related ∆δexp/calc(2) values, calculated using cyclopenta[cd]pyrene (2) as a 
reference, shows that the ipso carbon atoms of 3 and 4 behave differently than those from 5 
(Table 6). Whereas the ipso carbon atom C2 (Figure 1) of 3 and 4 are deshielded by ca. 4-5 
ppm (∆δexp/calc(2)), the other ipso carbon C5 is slightly shielded in 3 (∆δexp(2) -1.13 ppm) but 
deshielded in 4 (∆δexp(2) 1.35 ppm). The corresponding ∆δcalc(2) values are ca. 1 ppm for C5 in 
both 3 and 4. In contrast, the related ∆δexp(2) values for 5 are 0.05 (C2) and -0.51 (C5) (for 
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comparison: ∆δcalc(2) -1.20 (C2) and 0.00 (C5)). This demonstrates that, for the dicyclopenta-
fused pyrene congeners 3-5, the topology of the two annelated cyclopenta moieties affects 
their whole electronic structure (see also reference [20]) This is substantiated by the 
∆δexp/calc(2) values found for more distant carbon atoms (for example: C8, C10, C15, C17 and 
C18) in the series 3-5 (Table 6 and Figure 1).  
 
 
VII.3. Conclusions 
The total 1H and 13C NMR assignment for the non-alternant (di-)cyclopenta-fused congeners 
of pyrene 3-5 is achieved. The assignments are corroborated by a comparison of the 
experimental results with those computed using the all electron ab initio CTOCD-PZ2 
method. A comparison of the Substituent-Induced Chemical Shifts ∆δexp/calc calculated using 
either the experimental or theoretical 13C chemical shifts of 1-5 taking either pyrene (1) or 
cyclopenta[cd]pyrene (2) as a reference reveals that the number and topology of the 
annelated cyclopenta moieties markedly affects their electronic structure. 
 
 
VII.4. Experimental  
CP-PAH 2-5 were synthesised using Flash Vacuum Thermolysis (FVT). The corresponding 
(1-choroethenyl)-substituted PAH precursors were prepared as described previously [2]. 
Pure CP-PAH 2-5 were isolated from the pyrolysates by recrystallization from n-hexane. 
Caution: CP-PAH 2-5 have to be handled care according to the NIH guidelines for 
carcinogens. 
 
 
Chapter VII 
 198
   
Table 6. CTOCD-PZ2 ab initio (∆δcalc.) and experimental (∆δexp) 13C Substituent–Induced Chemical Shifts (∆δ(1); relative to pyrene (1) and ∆δ(2); relative to 
cyclopenta[cd]pyrene (2)) for cyclopenta[cd]- (2), dicyclopenta[cd,fg]- (3), dicyclopenta[cd,jk]- (4) and dicyclopenta[cd,mn]pyrene (5, Figure 1).  
 
 2 3 4 5
 ∆δ(1) ∆δ(1) ∆δ(2)  ∆δ(1) ∆δ(2)   ∆δ(1) ∆δ(2)  
               Calc. Exp. Calc. Exp. Calc. Exp. Calc. Exp. Calc. Exp. Calc. Exp. Calc. Exp.
C1 -1.70 -1.44 -2.20 -2.33 -0.50 -0.89 -3.40 -3.38 -1.70 -1.94 -3.30 -7.01 -1.60 -5.57
C2  10.10 10.71 14.40 15.37  4.30  4.66 14.90 16.13  4.80  5.41 8.90 10.76 -1.20  0.05 
C3 *          * * *  3.20  3.83 * * -0.60  0.01 * *  2.60  1.55 
C4 *            * * * -0.30  0.06 * *  3.90  3.82 * * -1.40 -1.28
C5   9.80 11.75 10.90 10.63  1.10 -1.13 11.30 13.10  1.50  1.35 9.80 11.24  0.00 -0.51 
C6   0.90 -0.84 aC5 aC5 aC5 aC5 aC13 aC13 aC13 aC13     1.00 -1.52  0.10 -0.69
C7   0.20  0.82 aC18 aC18 aC18 aC18 aC14 aC14 aC14 aC14     -0.60 -3.52 -0.80 -4.34
C8   5.30  5.65 aC2 aC2 aC2 aC2 aC15 aC15 aC15 aC15 8.20 7.89  2.90  2.24 
C9  -0.90  1.16 aC1 aC1 aC1 aC1 aC1 aC1 aC1 aC1     -1.20 1.26 -0.30  0.10
C10   3.50  3.67 aC15 aC15 aC15 aC15 aC2 aC2 aC2 aC2 aC8 aC8 aC8 aC8 
C11    -1.50 -0.90 aC14 aC14 aC14 aC14 aC18 aC18 aC18 aC18 aC7 aC7 aC7 aC7 
C12   0.20 -0.39 aC13 aC13 aC13 aC13 aC5 aC5 aC5 aC5 aC6 aC6 aC6 aC6 
C13  -0.70 -0.75  0.00 -0.29  0.70  0.46  0.00 -1.60  0.70 -0.85 aC5 aC5 aC5 aC5 
C14   0.50 -0.21 -0.40 -0.46 -0.90 -0.25  0.60  0.99  0.10  1.20 aC18 aC18 aC18 aC18 
C15  -1.30 -2.19  1.50  2.20  2.80  4.39  4.10  4.76  5.40  6.95 aC2 aC2 aC2 aC2 
C16         -1.70 -2.38 aC17 aC17 aC17 aC17 aC17 aC17 aC17 aC17 -3.00 -4.52 -1.30 -2.14
C17  -5.00 -3.92 -4.50 -3.70  0.50  0.22  4.80 -3.17  0.30  0.75 -12.20 -9.90 -7.20 -5.98 
C18  -3.70 -3.74 -2.50  0.15  1.20  3.89 -1.90 -0.42  1.80  3.32 -2.10 0.44  1.60  4.18 
 
a Equivalent position due to molecular symmetry. 
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VII.4.1. NMR Spectroscopy 
1H and 13C NMR spectra were recorded at 25 oC on a Varian Unity Inova Spectrometer 
operating at 300.13 MHz and 75.47 MHz, respectively. 2D NMR experiments were also 
performed on the Varian Unity Inova Spectrometer. In all experiments, saturated CDCl3 
solutions of the (CP)-PAH 1-5 were used. 1H and 13C NMR chemical shifts are reported in 
ppm using residual CHCl3 (δ 7.26 ppm) and CDCl3 (δ 77.00 ppm), respectively, as an 
internal standard.  
Prior to the (LR-)HETCOR experiments, the proton coupled C-H 13C spectra of CP-
PAH 2-5 were collected in order to gain insight into the magnitude of 1JC-H coupling 
constants. The 1H decay time (T1) was also determined in order to optimise the relaxation 
delay in the 2D NMR experiments. NOESY: The relaxation delay was set approximately at 
T1 for each compound, mixing time 0.75 s, acquisition time 1.3 s, 2D width 700 Hz, number 
of increments 64. The recording time of the NOESY spectra was in the range 12-20 h. 
HETCOR and LR-HETCOR: In the HETCOR and LR-HETCOR experiments, a 1JC-H = 160 
Hz coupling constant was used. The relaxation delay was set as 1 s (HETCOR) and as either 
1 s or 4 s (LR-HETCOR) in order to obtain the two- (2JC-H) and three-bond (3JC-H) C-H 
coupling constants. HETCOR and LR-HETCOR experiments were recorded with a proton 
and carbon sweep width of 500-600 Hz and 2500-3000 Hz, respectively. The number of 
increments was 32. Recording times were approximately 24 h for the HETCOR spectra and 
60-72 h for the LR-HETCOR spectra.  
 
VII. 4.2. Computations 
The absolute carbon nuclear shielding constants (σav in ppm), their out-of-plane (σout in ppm) 
and mean in-plane (σin in ppm) components of (CP)-PAH 1-5 were computed by using the 
PZ2 (paramagnetic zero) variant [35] of the all electron ab initio continuous transformation of 
origin of current density (CTOCD) method, all with the 6-31G** basis using the Exeter 
version of SYSMO [36]. The σav values were converted into δ values by the rule σav ×  106 + 
δ = 185.6 [38]. 
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The molecular geometries were optimised at the RHF level in the 6-31G basis 
(RHF/6-31G) using the GAMESS-UK program [40] and were taken from a previous study 
[28]. All optimised geometries (1 (D2h), 2 (Cs), 3 (C2v), 4 (C2h) and 5 (C2v) were characterized 
as genuine minima by Hessian calculations. 
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Summary  
 
The synthesis by Flash Vacuum Thermolysis (FVT) of a series of (multiple) cyclopenta-fused 
polycyclic aromatic hydrocarbons (CP-PAH) that represent important recurring constituents 
of exhausts obtained during incomplete combustion of organic matter is described. The 
availability of novel CP-PAH in pure form provides the opportunity to systematically assess 
their mutagenic activity in the well-documented Histidine (His) reverse bacterial 
mutagenicity assay (Ames-assay) employing the bacteria Salmonella typhimurium strain 
TA98. The Ames-assay is one of the most extensively applied bacterial mutagenicity tests 
and it is commonly applied for general screening purposes. Besides CP-PAH, the 
corresponding dihydro-CP-PAH are also prepared and assayed for bacterial mutagenicity. 
The results show that for most CP-PAH the olefinic bond at the externally-fused five-
membered ring is indeed mandatory for CP-PAH to exert a positive bacterial mutagenic 
response. The formation of epoxides at the unsaturated cyclopenta moiety is proposed as 
the main metabolic activation pathway for positive response. Therefore, the corresponding 
epoxides at the cyclopenta moiety are also synthesized and their mutagenic activity has 
been evaluated. The results demonstrate that these epoxides are indeed the ultimate 
mutagenic active forms of the parent CP-PAH. Additional support is obtained by semi-
empirical AM1 calculations. FVT-pyrolysates are as well evaluated since they are 
considered as mimics of parts of combustion effluents. The results show that synergistic and 
antagonistic effects occur among the constituents.  
In Chapter I a general introduction concerning PAH sources, their environmental 
distribution and their general genotoxic properties is presented. Furthermore, the 
identification of CP-PAH in combustion exhausts and their physico-chemical properties is 
also described. A general review concerning FVT as an important method to access new CP-
PAH reference compounds as well as a source for the synthesis of well-defined partial 
combustion exhaust mimics is provided.  
In Chapter II, the bacterial mutagenic response (Ames-assay, S. typhimurium TA98 
±S9-mix) of a series of the mono-CP-PAH cyclopenta[cd]pyrene, acephenanthrylene, 
Summary 
 
 204
aceanthrylene and cyclopenta[hi]chrysene is systematically re-evaluated. Their bacterial 
mutagenic response is compared to that exerted by their analogues in which the olefinic 
bond at the five-membered ring is hydrogenated, viz. the related dihydro-CP-PAH. The 
results show that the olefinic bond at the externally-fused five-membered ring is mandatory 
for the CP-PAH exerting a positive mutagenic response. Furthermore, the epoxides at the 
cyclopenta moiety are synthesised and all of them are shown to exhibit a positive direct-
acting mutagenic activity. This confirms the important role of the CP-arene oxides as the 
ultimate mutagenic active forms when the parent CP-PAH possess positive mutagenic 
activity. The experimental results are supported by semi-empirical AM1 calculations on the 
epoxides at the five-membered ring and the related two mono hydroxy-carbocations 
obtained via epoxide-ring opening. It is shown that the ease of epoxidation and mono 
hydroxy-carbocation formation appears to correlate with the direct-acting mutagenic 
activity.  
In the following three chapters (Chapter III-V), attention is focused on the 
cyclopenta-fused pyrene congeners containing either one or two cyclopenta moieties, viz. 
cyclopenta[cd]-, dicyclopenta[cd,mn]-, dicyclopenta[cd,fg]-, dicyclopenta[cd,jk]pyrene. After 
their successful synthesis by FVT they are all unequivocally identified as constituents of the 
non-polar fraction of combustion exhausts. Moreover, they are proposed as potential 
precursors for the formation of fullerenes under flame conditions.  
Chapter III reports the bacterial mutagenic activity of the cyclopenta[cd]pyrene 
and the three possible isomeric dicyclopenta-fused pyrenes. Different concentrations of 
microsomal protein in the metabolic activation system (S9-mix: 2%, 4% and 10 % (v/v), 
respectively) are used. All dicyclopenta-fused pyrene congeners show a high positive 
mutagenic response with S9-mix, and the maximal response is observed at low protein 
content suggesting a one-step activation pathway, i.e. formation of the epoxides at the 
olefinic bond of the cyclopenta moieties. This is supported by the fact that the hydrogenated 
derivatives at the cyclopenta moieties exerted no bacterial mutagenic activity either with or 
without S9-mix. Surprisingly, two compounds (dicyclopenta[cd,mn]-, and 
dicyclopenta[cd,fg]pyrene) display a direct-acting mutagenic response. As a consequence 
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they are the first two compounds that are identified to contribute to the direct-acting 
mutagenicity previously observed in the non-polar fraction of combustion exhausts. It is 
rationalized that the direct-acting mutagenic response correlates with the low one-electron 
reduction potential of these CP-PAH, which compare favourably with the one-electron 
reduction potentials of the known direct-acting nitro-PAH. The experimental results are 
supported by semi-empirical AM1 calculations on the proposed ultimate metabolites, i.e. 
mono-epoxides, cis-di- and trans-di-epoxides, the related mono hydroxy-carbocations 
derived from the epoxide-ring opening and the radical anions.  
The importance of epoxide formation at the olefinic bonds in the series of 
dicyclopenta-fused pyrene congeners in order to obtain the ultimate mutagenic form in the 
presence of S9-mix is experimentally confirmed in Chapter IV. The novel di-epoxides are 
synthesised, characterised and assessed for bacterial mutagenicity under the same 
conditions. For each di-epoxide, two stereoisomers (cis- and trans-) can be distinguished. 
The bacterial mutagenicity observed indicate that both stereoisomers are active. The direct-
acting mutagenicity and the high toxicity of all di-epoxides demonstrate that they are 
indeed the ultimate mutagenic active forms.  
In Chapter V the mutagenic response of analytically well-characterized FVT-
pyrolysates containing the dicyclopenta-pyrene congeners and their thermal precursors, viz. 
the bis-ethynyl- (E-) and mono-cyclopenta-ethynyl-pyrene (CP-E-) analogues, and a mixture 
of the three dicyclopenta-pyrenes is assessed using the standard protocol outlined by Ames 
et. al. (S. typhimurium strain TA98 ± S9-mix). It is shown that the bacterial mutagenic 
response of the pyrolysates deviates from the predicted by summing up the individual 
activities from each constituent of the FVT-pyrolysate. Hence, FVT-pyrolysates are 
proposed as model mixtures, i.e. partial combustion exhaust mimics, to establish and 
evaluate interactions (additive, synergistic or antagonistic effects) that may occur among the 
constituents and affect the global mutagenic response of real combustion exhausts. For 
example, E-pyrenes are shown to act as inhibitors and CP-E-pyrenes are shown to exert 
direct-acting and metabolic dependent mutagenic activity. 
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Besides the three isomeric dicyclopenta-pyrene congeners, another CP-PAH 
cyclopenta[cd]fluoranthene has recently been also identified in combustion exhausts too. 
Chapter VI reports the bacterial mutagenic activity (Ames-assay) of this CP-PAH. The 
results are compared to that exerted by its parent PAH fluoranthene and its thermal 
precursor 3-ethylfluoranthene. The latter has been also identified in combustion effluents. 
An FVT-pyrolysate which contains all three isomers is also tested. Surprisingly, a positive 
mutagenic response both with and without metabolic activation mixture (S9-mix) is 
determined for the ethynyl and a low activity dependent on metabolism is found for the CP- 
derivative. Moreover, the synthesis and the bacterial mutagenic activity of the (novel) 
epoxide at the five-membered ring are also reported. It is shown that the epoxide is a direct-
acting mutagen that accounts for the modest positive response of 
cyclopenta[cd]fluoranthene. 
Finally, in Chapter VII the total 1H and 13C NMR assignment of the dicyclopenta-
fused pyrene congeners is achieved using two-dimensional NMR techniques. The 
experimental results are compared with computed ab initio CTOCD-PZ2 1H and 13C NMR 
chemical shifts. In general, a satisfactory agreement between the experimental and the 
computed ab initio results is found. The accuracy of the applied ab initio method is 
demonstrated. Substituent-Induced Chemical Shifts in the pyrene parent system due to 
cyclopenta-fused substitution are evaluated and discussed.  
Outlook and Perspectives 
 207
Outlook and Perspectives 
Cyclopenta-fused polycyclic aromatic hydrocarbons (CP-PAH) are invariably formed 
during incomplete combustion of fossil fuels, still the main energy source of our society. 
Hence, CP-PAH are recurring exhausts constituents since they have been identified in a 
variety of complex combustion exhausts. Thus, CP-PAH represent ubiquitous pollutants 
widely distributed throughtout our environment. The formation of CP-PAH in combustion 
exhausts is rationalized by the accretion of C2H2 to PAH radicals under high temperature 
conditions furnishing E-PAH which subsequently may convert to CP-PAH. The bacterial 
mutagenic response of a series of recently identified CP-PAH was assayed in the present 
research and the results confirm the potential genotoxicity of CP-PAH as recurring 
combustion exhaust constituents. In general CP-PAH are shown to exert an enhanced 
mutagenic activity than that exhibited by benzo[a]pyrene (B[a]P), a well-known reference 
compound to assess the total genotoxicity associated with complex combustion exhausts. 
CP-PAH are primary contributors to the global genotoxicity associated with especially the 
non-polar fraction of combustion exhausts. Nevertheless, the CP-PAH class, as other well-
established bioactive PAH derivatives, are still not listed by the US Environmental 
Protection Agency (US-EPA). As a consequence they are not considered as markers to 
estimate the genotoxic potency of combustion exhausts and risk assessment for human 
health. Thus, the generally accepted criteria for the assessment of the potential genotoxicity 
of combustion exhausts (list of 16 PAH by the US-EPA and the application of B[a]P as 
reference compound) should be reconsidered. 
Moreover, due to their non-alternant character CP-PAH possess amongst others 
anomalous physico-chemical properties, such as low one-electron reduction potentials. This 
feature is presumably responsible for the unexpected, direct-acting mutagenic activity found 
for various CP-PAH described in this thesis. The one-electron reduction potentials of these 
CP-PAH representatives are similar to those found for nitro-PAH. Note that the direct-
acting mutagenic response of the polar fraction of combustion exhausts is associated to the 
presence of nitro-PAH. Hence, the search for other CP-PAH with low one-electron reduction 
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potentials that may contribute to the direct-acting mutagenic activity observed in the non-
polar fraction of combustion exhausts will remain a timely issue.  
Series of epoxides at the cyclopenta moiety were synthesized and characterized. 
The direct-acting mutagenic activity exhibited by the epoxides demonstrates their crucial 
role as ultimate mutagenic active forms from their parent CP-PAH. Moreover, even when 
the CP-PAH exerts no mutagenicity, the epoxide may be active.  
The results show that in particular the unequivocal identification of still unknown 
recurring CP-PAH in combustion exhausts, insight in their behaviour and the elucidation of 
their physico-chemical and biological properties will remain important research goals. This 
is further substantiated by our observation that the bacterial mutagenicity response of 
pyrolysates that contain CP-PAH and related (substituted) ethynyl-PAH (E-PAH) deviates 
from that of the summed contributions of the individual constituents. Hence, synergistic vs. 
antagonistic interactions in these ‘simple’ combustion exhaust mimics apparently are 
operational and can now be systematically studied. 
The obvious next step will constitute studies on the metabolites derived from the 
metabolic activation of CP-PAH. This investigation should be useful to support the role of 
the epoxides as the ultimate mutagenic active forms. In this context, the synthesis of diols 
and ketones derived from the epoxides at the five-membered ring followed by the 
assessment of their bacterial mutagenic response with and without metabolic activation will 
be of relavance too. Last but not least, the most active recurring CP-PAH should be subjected as 
soon as possible to further studies in eukaryotic cell systems.  
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Samenvatting  
 
Cyclopenta-gefuseerde polycyclische aromatische koolwaterstoffen (CP-PAK’s) maken 
onderdeel uit van een complex mengsel van polyaromatische koolwaterstoffen, die ontstaan 
bij onvolledige verbranding van organisch materiaal (fossiele brandstoffen). In dit 
proefschrift is beschreven hoe deze CP-PAK’s in zuivere vorm verkregen kunnen worden 
door synthese in de gas fase met behulp van Flits Vacuüm Thermolyse (FVT). Dit maakte 
het mogelijk om de mutagene activiteit van de individuele CP-PAK’s te analyseren. Hierbij 
is gebruik gemaakt van de klassieke Ames-test, de meest gebruikte methode om mutagene 
effecten van stoffen in bacteriën vast te stellen. Door te testen in aan en afwezigheid van een 
extern metaboliserend systeem (S9-mix bestaand uit een levermicrosoom preparaat van 
Aroclor 1254 behandelde ratten en NADPH generende co-factoren) is onderscheid gemaakt 
tussen de direct-mutagene werking van de CP-PAK’s en eventuele oxidatieve metabolieten. 
Door vergelijking van CP-PAK’s en hun gehydrogeneerde derivaten in de Ames-test is 
aangetoond dat de dubbele band in de cyclopenta ring essentieel is voor de mutagene 
activiteit. Als belangrijkste metabole activatieroute wordt de vorming van een epoxide aan 
de onverzadigde cyclopenta ring verondersteld. Om dit te onderbouwen zijn eveneens de 
corresponderende epoxides van de CP-PAK’s gesynthetiseerd, gekarakteriseerd en op hun 
bacteriële mutageniteit getest met behulp van de Ames-test. De resultaten tonen aan dat de 
epoxides inderdaad de uiteindelijke mutageen actieve vorm van de CP-PAK’s zijn. De 
gevonden resultaten worden verder ondersteund door semi-empirische AM1 berekeningen. 
Daarnaast zijn ook pyrolysaten van (CP-)PAK’s verkregen na FVT bestudeerd met de Ames-
test. Deze pyrolysaten worden beschouwd als model systemen voor verbrandingsmengsels. 
 In Hoofdstuk I wordt een introductie geven over de vorming van PAK's, hun 
distributie in ons milieu en hun genotoxische eigenschappen. Vervolgens wordt de 
aanwezigheid van CP-PAK’s in verbrandingsmengsels beschreven en een aantal van hun 
bijzondere fysisch-chemische eigenschappen beschreven. Verder wordt geïllustreerd dat 
pyrolysaten beschouwd kunnen worden als een model voor complexe 
verbrandingsmengsels.  
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In Hoofdstuk II is de bacteriële mutageniteit van een serie mono-CP-PAK’s, 
namelijk cyclopenta[cd]pyreen, acefenanthryleen, aceanthryleen en cyclopenta[hi]chryseen, 
onderzocht in de Ames-test. De respons is vergeleken met die van de gerelateerd mono-CP-
PAK’s, waarin de dubbele binding in de vijfring is gehydrogeneerd. De resultaten tonen aan 
dat de dubbele binding in de extern-gefuseerde vijfring bepalend is voor de positieve 
respons van CP-PAK’s. Vervolgens zijn de epoxide-derivaten van de CP-PAK’s 
gesynthetiseerd en getest. Alle epoxides vertoonden een direct mutagene activiteit die 
onafhankelijk is van metabole activering. Dit ondersteunt hun rol als de ultieme mutageen 
actieve vorm. De experimentele resultaten worden bevestigd door semi-empirische AM1 
berekeningen aan de epoxidatie op de vijfring en de corresponderende mono hydroxy-
carbocation vorming na ring opening. Combinatie van de theoretische en experimentele 
resultaten geeft aan dat de mogelijkheid tot epoxidatie en vorming van hydroxy-
carbocationen correleert met de mate van mutageniteit.  
In de volgende hoofdstukken (Hoofdstuk III-V), wordt aandacht geschonken aan 
een serie (di-)cyclopenta-gefuseerde pyreen derivaten. Deze bevatten één of twee cyclopenta 
eenheden, namelijk cyclopenta[cd]-, dicyclopenta[cd,mn]-, dicyclopenta[cd,fg]- en 
dicyclopenta[cd,jk]pyreen. De dicyclopenta-gefuseerde pyreen derivaten zijn recent 
succesvol gesynthetiseerd met behulp van FVT, en vervolgens geïdentificeerd in de niet-
polaire fractie geïsoleerd uit verbrandingsmengsels. Ze worden ook voorgesteld als 
uitgangsstoffen voor de opbouw van fullerenen onder vlam condities.  
Hoofdstuk III beschrijft de bacteriële mutageniteit van de cyclopentagefuseerde 
pyreen derivaten. Hun activiteit wordt vergeleken met die van de gerelateerde van de 
afgeleide dihydro verbindingen. In deze verbindingen is de dubbele band in de vijfring 
gehydrogeneerd. Alle experimenten werden uitgevoerd met verschillende concentraties S9-
mix (2%, 4% en 10 % (v/v)). Alle dicyclopenta-gefuseerde derivaten geven een hoge 
positieve mutagene response met S9-mix, en de maximale response werd verkregen bij lage 
eiwit concentratie. Dit suggereert dat het bioactiveringsmechanisme uit één stap bestaat, 
namelijk de vorming van het epoxide derivaat aan de dubbele binding van de vijfring. Dit 
wordt bevestigd door het gegeven dat de tetrahydro derivaten geen mutagene activiteit 
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vertonen in aan of afwezigheid van S9-mix. Twee verbindingen te weten, 
dicyclopenta[cd,fg]- en dicyclopenta[cd,mn]pyreen vertoonden opvallend genoeg een directe 
mutagene respons in afwezigheid van S9-mix. Deze twee verbindingen zijn de eerste CP-
PAK’s die zijn geïdentificeerd in verbrandingsmengsels mogelijk bijdragen aan de eerder 
vastgestelde directe mutageniteit van de niet-polaire fractie van verbrandingsmengsels. De 
experimentele resultaten met S9-mix worden ondersteund door semi-empirische AM1 
berekeningen aan de voorgestelde uiteindelijke metabolieten, d.w.z. aan de mono-epoxides, 
cis-di- en trans-di-epoxides en de gerelateerde mono hydroxy-carbocation derivaten. De 
radicaal anionen berekeningen en reductie potentialen kunnen de activiteit zonder S9-mix 
verklaren.  
In Hoofdstuk IV wordt de in hoofdstuk III voorgestelde rol van de 
dicyclopentagefuseerde di-epoxides als uiteindelijke mutagene actieve vorm experimenteel 
bevestigt. De nieuwe di-epoxides zijn gesynthetiseerd, gekarakteriseerd and getest op 
bacteriële mutageniteit. Van elke di-epoxide zijn twee stereo-isomeren (cis- and trans-) 
verkregen en beide vormen lijken actief te zijn. De directe mutageniteit en de grote toxiciteit 
van alle di-epoxides tonen aan dat zij inderdaad de uiteindelijke mutageen actieve vorm 
zijn. 
In Hoofdstuk V is de mutagene respons van goed gekarakteriseerde FVT-
pyrolysaten getest. De FVT-pyrolysaten bestaan uit de dicyclopenta-gefuseerde pyreen 
derivaten en de gerelateerde bis-ethynyl- en mono-cyclopenta-ethynyl-pyreen analogen. 
Het blijkt dat de mutagene activiteit van de pyrolysaten afwijkt van de som van de 
individuele activiteiten van de bestanddelen in de mengsels. Onduidelijk is nog hoe de 
interacties tussen de verschillende bestanddelen van verbrandingsmengsels (additief, 
synergistisch of antagonistisch) tot stand komen en de mutageniteit van het mengsel 
beïnvloeden.  
Naast de dicyclopenta-gefuseerde pyreen derivaten is recent ook 
cyclopenta[cd]fluorantheen geïdentificeerd in verbrandingsmengsels. Daarom wordt in 
Hoofdstuk VI de mutagene activiteit van deze CP-PAK’s bestudeerd en vergeleken met de 
activiteit van de moederverbinding PAK fluorantheen, en zijn precursor onder 
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verbrandingscondities, het 3-ethylfluorantheen. Deze laatste verbinding is ook 
geïdentificeerd in verbrandingsmengsels. Als laatste is ook het pyrolysaat, dat bestaat uit 
alle drie verbindingen getest te weten fluorantheen, 3-ethynylfluorantheen en 
cyclopenta[cd]fluorantheen. Onverwacht werd een positieve mutagene respons gevonden 
met en zonder metabole activatie voor de 3-ethynyl verbinding. Voor 
cyclopenta[cd]fluorantheen werd een lage activiteit gemeten die wel afhankelijk was van 
metabolitische activering met S9-mix. Ook werd in dit hoofdstuk de synthese en mutagene 
activiteit van het epoxide derivaat aan de vijfring van cyclopenta[cd]fluorantheen 
beschreven.  
Ten slotte wordt in Hoofdstuk VII de volledige 1H en 13C NMR toekenningen van 
de dicyclopenta-gefuseerde pyreen derivaten gerapporteerd die zijn verkregen met behulp 
van twee-dimensionale NMR technieken. De experimentele data zijn vergeleken met 
berekende ab initio CTOCD-PZ2 chemische verschuivingen. Een goede overeenkomst tussen 
de ab initio en experimentele data is gevonden. Substituent geïnduceerde chemische 
verschuivingen in pyreen ten gevolge van cyclopenta-fusie worden bediscussieerd.  
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Resumen  
Esta investigación describe la síntesis por medio de Flash Termólisis en Vacío (FVT) de una 
serie de compuestos aromáticos policíclicos con (múltiples) pentaciclos fusionados (CP-
PAH) que han sido recientemente identificados en mezclas de combustión. La obtención de 
dichos compuestos en alto grado de pureza ha brindado la oportunidad de evaluar su 
actividad mutagénica en el extensamente validado test bacterial de reversión a Histidina 
(His) para detectar agentes mutagénicos (Ames-test, bacteria Salmonella typhimurium cepa 
TA98) de forma sistemática. Además, los correspondientes CP-PAH hidrogenados en el 
pentaciclo externo, son sintetizados y a su vez evaluados en el mismo test. Los resultados 
demuestran que el doble enlace presente en el pentaciclo es necesario para que los CP-PAH 
muestren una actividad mutagénica positiva. Se propone la formación de epóxidos en el 
enlace doble del pentaciclo como la ruta de más importancia para CP-PAH para expresar su 
mutagénesis. De esta manera, son sintetizados y caracterizados (noveles) epóxidos en el 
pentaciclo y es además evaluada su actividad mutagénica. Los resultados obtenidos 
demuestran que estos epóxidos son las verdaderas formas mutagénicas de los CP-PAH y 
son avalados por cálculos semi-empíricos. Estos cálculos, junto a la caracterización físico-
química de los CP-PAH, son empleados para explicar las propiedades genotóxicas de estos 
compuestos. Además son a su vez evaluados en cuanto a actividad mutagénica, los 
pirolizados de FVT (mezcla de productos) ya que se pueden considerar como 
representaciones de partes de mezclas de combustión. Los resultados aquí presentados 
corroboran que tanto los criterios generalmente utilizados para evaluar las potenciales 
propiedades genotóxicas de mezclas de combustión (lista de los 16 PAH de la Agencia de 
Protección del Ambiente de los EE.UU. (US-Environmental Protection Agency, EPA) y el 
empleo de benzo[a]pireno como compuesto de referencia deberían ser reconsiderados. 
En el Capítulo I, se presenta una introducción general sobre la formación, 
distribución en el medio ambiente y propiedades genotóxicas de los compuestos aromáticos 
policíclicos (PAH). Se describe, así mismo, la importancia que representa la presencia de CP-
PAH. A su vez se realiza una descripción del método de síntesis en fase gaseosa FVT. 
Resumen 
 214
En el Capítulo II, es reevaluada en un único estudio la mutagenicidad en el 
sistema bacterial utilizado (Ames-test, TA98 ± S9-mix) de una serie de CP-PAH con un único 
pentaciclo, i.e. cyclopenta[cd]pireno, acefenantrileno, aceantrileno y pentaciclo[hi]criseno y 
comparada con la producida por sus correspondientes CP-PAH hidrogenados en el 
pentaciclo. Los resultados demuestran que la presencia del doble enlace en el pentaciclo es 
necesaria en los CP-PAH que presentan una actividad mutagénica positiva. Además son 
sintetizados los (noveles) epóxidos en el pentaciclo externamente fusionado y su actividad 
directa (sin mezcla de activación, -S9-mix) corrobora su papel como verdaderas formas 
mutagénicas cuando el correspondiente CP-PAH posee una actividad mutagénica positiva.  
En los tres capítulos siguientes (Capítulo III-VI), se presta especial atención a los 
derivados del pireno con dos pentaciclos externamente fusionados, viz. dipentaciclo[cd,mn]-, 
dipentaciclo[cd,fg]-, dipentaciclo[cd,jk]pireno, los cuales han sido recientemente 
identificados como constituyentes de mezclas de combustión y propuestos como 
precursores de fullerenos bajo condiciones de llama. El muy caracterizado 
pentaciclo[cd]pireno y sus derivados también son evaluados en todos los experimentos para 
de esta forma realizar comparaciones con los distintos isómeros.  
El Capítulo III describe la actividad mutagénica en el Ames-test (TA98, ±S9-mix) 
de los pirenos dicyclopenta substituidos. Los resultados son comparados con sus 
respectivos derivados parcialmente hidrogenados (en los pentaciclos) utilizando distintas 
concentraciones de proteína microsomal en la mezcla de activación metabólica (S9-mix: 2%, 
4% y 10% (v/v), respectivamente). Todos los dipentaciclo olefínicos presentan una gran 
actividad mutagénica con S9-mix, y la respuesta máxima es obtenida con bajo contenido de 
proteína. Esto último sugiere que la ruta de activación metabólica ocurre en un solo paso 
(one-step), i.e. formación de los epóxidos en los pentaciclos fusionados. Además, el hecho de 
que los derivados hidrogenados no presentaran ningún tipo de actividad mutagénica con o 
sin S9-mix, corrobora esta propuesta. Sorprendentemente, se observa una actividad 
mutagénica directa por dos de los derivados del pireno y esto permite su clasificación como 
los dos primeros contribuyentes a la mutagenicidad directa que ha sido previamente 
observada en la fracción no-polar de mezclas de combustión y cuyos responsables hasta 
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ahora eran desconocidos. Los resultados experimentales son verificados por cálculos AM1 
semi-empíricos de los propuestos metabolitos activos, i.e. los mono-, cis-di- y trans-
diepóxidos, y los hidroxi-carbocationes derivados de la apertura del epóxido y los radicales 
aniónicos.  
De esta manera, en el Capítulo IV se confirma experimentalmente el papel de los 
di-epóxidos como verdaderas formas mutagénicas. Los noveles di-epóxidos son 
sintetizados, caracterizados y evaluados en el Ames-test bajo las mismas condiciones para 
sus propiedades mutagénicas. Su actividad mutagénica directa junto con su alto grado de 
toxicidad demuestra que estos compuestos son las verdaderas formas mutagénicas de los 
CP-PAH evaluados en el Capítulo III.  
En el Capítulo V, es evaluada la actividad mutagénica de las mezclas obtenidas 
por medio de FVT que contienen los dipentaciclo-pirenos y sus correspondientes 
precursores bajo condiciones de combustión: bis-etinil- y mono-pentaciclo-etinil-pirenos, y 
una mezcla de los tres dipentaciclopirenos utilizando igualmente el Ames-test. En esta 
investigación se demuestra que la actividad mutagénica global de las mezclas desvía de la 
calculada por la suma de las actividades individuales de los constituyentes de la mezcla. 
Además, las mezclas de FVT son propuestas como modelos de partes de mezclas de 
combustión para establecer y evaluar las interacciones (adición, sinergismo o antagonismo) 
que pueden ser operacionales entre los constituyentes y afectar la actividad mutagénica total 
de mezclas de combustión reales.  
Junto a los dipentaciclos del pireno, el pentaciclo[cd]fluoranteno también ha sido 
identificado en mezclas procedentes de combustión. De esta manera, el Capítulo VI 
describe la actividad mutagénica de este novel CP-PAH en el Ames-test. Además ésta fue 
comparada con la de fluoranteno y el 3-etinilfluoranteno, el cual es reconocido como su 
precursor bajo condiciones de combustión. Este último, sorprendentemente, exhibe una 
actividad mutagénica dependiente en activación metabólica y también directa, mayor que la 
observada para el pentaciclo[cd]fluoranteno. Además, es también evaluada la mezcla de 
productos procedente del FVT constituida por los tres compuestos así como la del 
correspondiente epóxido en el pentaciclo del pentaciclo[cd]fluoranteno. 
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Finalmente, en el Capítulo VII la asignación total de las señales observadas en el 
1H y 13C espectros de RMN de los dipentaciclo-pirenos es obtenida por medio de técnicas de 
RMN de dos dimensiones (NOESY, HETCOR, LR-HETCOR). Los resultados experimentales 
son comparados desplazamientos químicos obtenidos con cálculos ab initio CTOCD-PZ2. Se 
demuestra la precisión de los cálculos ab initio ya que están en concordancia con los 
obtenidos experimentalmente. También son evaluados desplazamientos químicos por 
sustitución de pentaciclo en el perímetro del pireno y discutido el efecto de los pentaciclos 
con respecto a la aromaticidad.  
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